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Abstract
Bacteria encounter a plethora of environmental stresses and have evolved different mechanisms
to recognize and respond to various harmful conditions. Understanding and elucidating common
themes as well as unique aspects of the molecular mechanisms underlying stress adaptation is
important and can provide valuable strategies for applications. This study focuses on stress
responses in three different bacteria, namely, Acidothermus cellulolyticus, Mycobacterium
smegmatis and Escherichia coli. The thermophilic and acidophilic organism A. cellulolyticus was
used as a model system to understand the effects of lignin phenolic acids on cellulolytic bacteria.
Lignin phenolic acids pose a significant challenge to microbial deconstruction of lignocellulosic
biomass for the commercial production of renewable products. Analysis of total proteins profiles
of A. cellulolyticus revealed the enhanced expression of a predicted thiosulfate sulfurtransferase
(TST) protein (Acel_0059) during exposure to phenolic acids. Expression of genes involved in
sulfur assimilation into cysteine was also upregulated in the presence of phenolic acids.
Heterologous expression of the Acel_0059 gene in E. coli alleviated growth inhibition of
inhibitory phenolic acids. Analyses of the whole transcriptome of A. cellulolyticus revealed that
exposure to these inhibitory lignin components induced the expression of genes coding for
membrane proteins, efflux and transport proteins, oxidative stress response proteins, redoxsensors, TST, and sulfur assimilation pathway enzymes. Deletion of the Acel_0059 counterpart
gene (MSMEG_5879) in a surrogate host M. smegmatis increased the sensitivity of the organism
to a variety of stressors. The deletion of TST gene affected cysteine biosynthesis from inorganic
sulfate under hypoxic conditions in M. smegmatis. In another study, E. coli was used as a model
to assess the biological effects of oxidized graphene (OG), a carbon nanomaterial. Growth
analysis revealed that the addition of OG inhibited the growth of E. coli. Analyses of the whole

transcriptome of E. coli showed that the cytotoxicity of OG in E. coli could be attributed to
oxidative stress, membrane stress and DNA damage. Overall the above studies provided new
insights into the shared (eg. sulfur metabolism, oxidative stress adaptation) as well as unique (eg.
TST, membrane proteins) aspects of bacterial responses to diverse stresses.
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Chapter 1
Introduction
1.1 Background
Bacteria are among the first life forms to have existed on earth, and have consequently had
exposure to changing environmental conditions [1]. Bacterial genomes are highly adaptable and
have evolved unique strategies to sense and respond to harmful changes in their environment,
and these strategies are collectively refered to as stress response [2, 3]. Molecular understanding
of stress responses across bacteria aids in identifying shared and unique aspects of how different
bacteria deal with hostile environmental conditions. We looked at the response of three bacteria
viz. Acidothermus cellulolyticus, Mycobacterium smegmatis and Escherichia coli to different
stresses. A. cellulolyticus is a thermophilic, acidophilic and cellulolytic bacteria which is used for
the commercial hydrolysis of cellulose into glucose [4]. It is a promising candidate for the
conversion of lignocellulosic biomass into biofuels and numerous value added chemicals. M.
smegmatis is a fast-growing, non-pathogenic bacteria that shares many similarities with other
pathogenic mycobacteria. It has been widely used as a model system for understanding
mycobacterial physiology and development of drug targets for pathogenic mycobacteria. E. coli
is a Gram-negative, facultative anaerobe that is most studied and widely used model bacterium.
It is extensively used as a host organism for expression of recombinant proteins, and plays an
important role in biological engineering and industrial microbiology [40].

1.2 Overview of chapters
The research described Chapter 2 was aimed at understanding the response of Acidothermus
cellulolyticus 11B towards inhibitory lignin phenolic acids. A. cellulolyticus 11B is a
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thermophilic, acidophilic, Gram-positive, bacterium belonging to the high G+C Actinobacteria
group. It encodes genes for multiple plant cell wall degrading enzymes and is a promising
candidate for the bioconversion of lignocellulosic biomass into biofuels and other valuable
products [4-6]. Lignocellulosic biomass is often pretreated to breakdown and separate the
recalcitrant lignin from cellulose and hemicellulose components. The latter yield simple sugars
that can be converted into biofuels. The pretreatment of lignocellulosic biomass releases lignin
derived phenolic acids as free acids into the hydrolysate [7]. These phenolic acids are inhibitory
to the growth of many microorganisms, including A. cellulolyticus [8-11]. Understanding and
reducing the toxicity of lignin and its related phenolics is important towards improving the
efficiency of microbial bioconversion of lignocellulose [12].

Global gene expression profiling is a useful tool towards understanding the molecular
mechanisms of toxicity and the mechanisms by which organisms adapt to toxic environments
[13]. Chapter 3 discusses the genome-wide gene expression analysis of A. cellulolyticus in
response to lignin and its related phenolic acids. We observed that genes providing protection
against oxidative stress and membrane damage were induced in response to the compounds
tested. The information obtained about the genes involved in response to these inhibitory
compounds, could be used to engineer microbial strains with enhanced tolerance to toxic
lignocellulosic hydrolysate. One such candidate is the Acel_0059 gene that codes for a putative
thiosulfate sulfurtransferase (TST) enzyme. Analysis of the total protein profiles of A.
cellulolyticus grown in the presence of phenolic acids revealed that the expression of TST was
upregulated in the presence of phenolic acids (Chapter 2). The phenolic acids also upregulated
the expression of genes involved in the assimilation of sulfate into cysteine. Our studies reveal
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the importance of TST during survival under phenolic acid inhibition and its plausible role in the
sulfur metabolism. TSTs are enzymes that catalyze the transfer of sulfur from thiosulfate to
cyanide in vitro and therefore were initially proposed to be involved in cyanide detoxification
[14, 15]. However, several studies suggest that TSTs play important roles in various cellular
functions including the assembly of iron-sulfur clusters, cysteine biosynthesis, maintenance of
sulfane sulfur pools, etc. [16-19]. However, the precise biological function of TST is yet to be
understood.

It is important to study whether the role of TST during survival under stress is unique to A.
cellulolyticus or shared by other bacteria. The closest sequence homolog of A. cellulolyticus TST
in the UniProt/Swissprot database was found to be MSMEG_5789 protein (a putative TST)
belonging to Mycobacterium smegmatis mc2 155. M. smegmatis mc2 155 (basonym for
Mycolicibacterium smegmatis mc2 155), like A. cellulolyticus, is a Gram-positive, rod shaped,
high G+C Actinobacteria belonging to the order Actinomycetales. M. smegmatis is a fastgrowing, non-pathogenic bacterium that shares the distinct cell wall structure and a number of
homologous genes including those for stress adaptation with other mycobacterial species [20,
21]. It has thus been widely used as a surrogate host for genetic analysis of various pathogenic
mycobacteria such as M. tuberculosis, M. avium, and M. paratuberculosis [22-24]. Antibacterial
drugs aimed at targeting genes involved in stress response have been proposed as a possible
solution for combating drug resistance in pathogenic bacteria [25]. Chapter 4 discusses the
generation and phenotypic analysis of TST. Data from this chapter revealed the importance of
TST during survival under stress in M. smegmatis. Our studies revealed that the deletion of TST
coding gene, MSMEG_5789, in M. smegmatis increased its sensitivity to a variety of stressors.
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Chapter 5 discusses the cytotoxic effects of oxidized graphene (nanomaterial) on Escherichia
coli. E. coli is a Gram-negative, facultative anaerobe that is widely used as a model bacterium in
understanding bacterial physiology as well as a key tool in molecular biology [26]. Graphene is
the thinnest material known on earth that consists of a single layer of carbon atoms arranged in a
hexagonal honeycomb lattice structure [27, 28]. It exhibits a number of exceptional properties
including excellent mechanical strength, high thermal and electrical conductivity, impermeability
to gases, high optical transmittance etc. [29, 30]. Owing to these properties graphene-family
nanomaterials have attracted interest in applications such as nanoelectronics, super-capacitors,
electrochemical sensors and biosensors, drug delivery etc. [31-33]. It is therefore important to
evaluate the bioactivity and potential hazards of graphene on living organisms and environment,
to implement their use without disturbing the ecological balance [34]. There have been
contradictory results on the toxicity of graphene, which could be attributed to the differences in
size, solubility, surface chemistry etc. of the graphene tested [35, 36]. Graphene is often
chemically functionalized in order to tune its inertness, solubility and processability, a crucial
step for its end applications, resulting in variations in surface properties [37-39]. However,
chemical functionalization is thought to also impart bioactivity to inert graphene, rendering it
potentially toxic to living organisms. To evaluate and understand the bioactivity of oxidized
graphene, we studied the effect of pristine graphene (PG) and oxidized graphene (OG) on the
growth of E. coli. The OG tested in our study, was obtained by treating pristine graphene with
concentrated sulfuric acid and nitric acid, to increase its hydrophilicity [36]. OG was found to be
inhibitory to the growth of E. coli. The genome-wide gene expression profiles of E. coli upon
exposure to OG or PG were also studied. Exposure of E. coli to OG resulted in enhanced
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expression of genes encoding for stress response proteins, membrane proteins, transporters, and
proteins involved in sulfur metabolism.

Chapter 6 provides a summary of the results obtained from the studies discussed in Chapter 2-5.
Our studies reveal a link between phenolic acid stress and TST in A. cellulolyticus. The
importance of TST in M. smegmatis during survival upon exposure to a variety of stressors is
elucidated. We discuss the appositeness of sulfur assimilation into cysteine during survival under
stress conditions.
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Chapter 2
Molecular and genetic analyses of the effects of inhibitory lignin phenolic acids in Acidothermus
cellulolyticus 11B

2.1 Abstract
Acidothermus cellulolyticus strain 11B is an efficient cellulose-degrading bacterium that is of
high value in the production of biofuels from lignocellulose. However, antimicrobial phenolic
acids found in lignocellulose inhibit the growth of the organism. To understand the cellular
targets affected by this inhibition, we analyzed total proteins from bacteria grown in the presence
of phenolic acids, namely 4-hydroxybenzoic acid (HA), p-coumaric acid (CA), syringic acid
(SA), trans-ferulic acid (FA), and vanillic acid (VA). Expression of an approximately 30 kDa
protein was found to be upregulated in the presence of phenolic acids. Mass spectrometry
revealed the upregulated protein to be Acel_0059, a predicted thiosulfate sulfurtransferase
(TST). Expression of the Acel_0059 gene as well as genes predicted to be involved in sulfur
assimilation and cysteine biosynthesis (cysN, cysD, cysC, cysH, and cysM) were also upregulated
in the presence of phenolic acids. Supplementation of L-cysteine in the growth media containing
HA alleviated the upregulation of Acel_0059 while concurrently lowering the growth inhibition.
The Acel_0059 gene was cloned in Escherichia coli and the heterologous protein was partially
purified. Partially purified Acel_0059 protein showed rhodanese activity in vitro between 55°C
and 80°C. Expression of Acel_0059 in E. coli increased bacterial survival upon exposure to
inhibitory concentration of HA. These data suggest that Acel_0059 may be important for
survival of A. cellulolyticus in the presence of inhibitory phenolic acids and may play a role in
sulfur metabolism.
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2.2 Importance
Phenolic acids at sufficient concentrations are toxic to most organisms. However, the cellular
targets that are impacted by phenolic acids are not fully understood. Our study provided new
insights into genes affected by phenolic acids in A. cellulolyticus. In addition, it revealed a novel
link between growth inhibition by phenolic acids and thiosulfate sulfurtransferase (TST, a.k.a.
rhodanese). TST is a highly conserved enzyme that is found ubiquitously in Bacteria, Archaea,
and mitochondria of Eukaryotes. Although the rhodanese enzyme was discovered and
characterized in vitro more than eight decades ago, the true biological functions of rhodaneses
remain enigmatic till date. Our findings indicate a role for A. cellulolyticus TST in response to
growth inhibition by phenolic acids and suggest a plausible role for it in sulfur metabolism. The
data expand the realm of our understanding on the biological roles of rhodaneses.

2.3 Introduction
Acidothermus cellulolyticus strain 11B, a thermophilic Gram-positive bacterium belonging to
high G+C Actinobacteria, is one of the most efficient cellulose-degrading organisms that is
capable of degrading crystalline cellulose [1]. The genome of this organism has been completely
sequenced and analyzed [2]. Owing to its ability to produce biotechnologically important
hyperthemostable enzymes, A. cellulolyticus is of very high interest in the bioconversion of
lignocellulose to biofuels and value-added chemicals [1-3]. While we had previously reported
that phenolic acids found in lignocellulose are inhibitory to the organism [4], the cellular targets
affected by the phenolic acids were unknown. Identification of these molecular targets could
provide novel strategies to mitigate the inhibitory effects of phenolic acids and enhance A.
cellulolyticus for applications in cellulosic biofuels production [5].
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Phenolic acids constitute one of the most numerous and ubiquitously distributed group of plant
secondary metabolites. Phenolic acids are toxic to most organisms, including bacteria, fungi,
plants, and animals. They have been shown to inhibit the growth of cellulolytic and noncellulolytic bacteria and fungi [6-11]. Phenolic acids are also known to be allelopathic to plants
as they cause defects in germination, growth, survival, and reproduction [12-15]. Phenolic acids
also have the ability to inhibit the growth of cancer cells and induce apoptosis in animal cell
cultures [16-18]. The precise molecular effects of phenolic acids on cellular physiology are not
fully understood. Most phenolic acids act as antioxidants at low (nanomolar to micromolar)
concentrations and are beneficial to life, while at higher (millimolar) concentrations they act as
prooxidants and are toxic [19, 20]. Inhibitory effects of phenolic acids are generally thought to
be exerted through the disruption of integrity and function of cell membranes [21].

Cellular and genetic responses of organisms to inhibitory phenolic acids are diverse. We have
previously shown that phenolic acids induce the expression of efflux pumps in the Gramnegative bacterial plant pathogen Erwinia chrysanthemi [22-23]. In the opportunistic human
pathogen Serratia marcescens phenolic acids affect expression of enzymes involved in fatty acid
biosynthesis [24]. In the fungus Fusarium, phenolic acids inhibit the expression of mycotoxin
biosynthesis genes causing decreased toxin production [25]. Recently, phenolic acids were found
to induce stress pathways associated with programmed cell death in the fungal maize pathogen
Cochliobolus heterostrophus [26]. Few microorganisms have the ability to detoxify or degrade,
but not utilize phenolic acids as sole carbon source. For example, in certain Gram-positive
bacteria, such as Bacillus subtilis, Lactobacillus plantarum, and Pediococcus pentosaceus,
phenolic acids are known to induce the expression of phenolic acid decarboxylases, which are
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involved in detoxification of phenolic acids [27, 28]. While a few other bacteria have the ability
to utilize phenolic acids as sole carbon source as they produce enzymes that can catalyze the
aromatic ring cleavage via the ortho pathway [29]. However, A. cellulolyticus 11B can neither
utilize phenolic acids as a sole carbon source nor does its genome encode homologs of enzymes
known to be involved in detoxification and metabolism of phenolic acids.

In the present study, we studied the total protein profiles of A. cellulolyticus grown in the
presence of phenolic acids and found that the expression of Acel_0059 was upregulated in the
presence of phenolic acids. We confirmed this upregulation by studying the expression of the
Acel_0059 gene. We also found that phenolic acids upregulated the expression of genes involved
in assimilation of sulfate into cysteine. We found that supplementation of cysteine relieved both
growth inhibition and the upregulation of Acel_0059 in the presence of phenolic acids. We
cloned the Acel_0059 gene in Escherichia coli and overexpressed and partially purified the
protein. The partially purified Acel_0059 protein showed TST activity in vitro. E. coli cells
expressing the Acel_0059 gene showed increased survival in the presence of phenolic acids at
inhibitory concentrations. We discuss the relevance of Acel_0059 upregulation in response to
growth inhibition by phenolic acids and its plausible role in bacterial survival and sulfur
metabolism in A. cellulolyticus.

2.4 Materials and methods
2.4.1 Bacteria and growth conditions. All bacteria and plasmids used in this study are listed in
Table 1. A. cellulolyticus was grown in LPBM (low phosphate basal salts medium) as described
previously [3]. LPBM contained per liter 1 g NH4Cl; 0.1 g Na2HPO4.7H2O; 1 g KH2PO4; 0.2 g
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MgSO4.7H2O; 0.2 g CaCl2.2H2O; 0.5 g yeast extract; 5 g D-cellobiose. Phenolic acids were
prepared as 1 M stocks in dimethyl sulfoxide (DMSO), filter sterilized, and were added to the
sterilized growth medium at 1 mM final concentration. To media without any phenolic acids
(controls) equivalent amount of DMSO was added to account for any solvent effects. To study
the effect of sulfur supplementation in media, filter-sterilized solution of sulfur-containing amino
acids (L-cysteine or L-methionine), sodium thiosulfate, L-glutathione were added at 0.5 mM
final concentration or as indicated in the experiment, while MgSO4 was supplemented at 5X
higher concentration than in regular LPBM. The final pH of the all media was adjusted to 5.5 by
the addition of sterile 10% phosphoric acid or 10N NaOH. E. coli was grown in Luria-Bertani
(LB) medium containing appropriate selective antibiotics at 37°C as described previously [3].
Bacterial growth was measured using optical density at 600 nm.

2.4.2 RNA extraction. Total RNA was extracted from mid-exponential phase A. cellulolyticus
cultures using RNeasy Plant Mini kit (Qiagen). For the control, RNA was extracted from 100 ml
culture at 20 h (OD600 0.6), and for the phenolic acid treatments, RNA was extracted from 200
ml culture at 37 h (OD600 0.3). The total RNA was treated with two rounds of RNase-Free DNase
(Qiagen) to eliminate any contaminating genomic DNA. The quality of RNA was analyzed using
agarose (0.8%) gel electrophoresis. Complete elimination of genomic DNA from RNA samples
was confirmed using HotStartTaq Plus DNA Polymerase (Qiagen) using primers specific for the
Acel_0005 (gyrB) gene and Acel_0305 (rpsJ) gene. RNA was quantified using Qubit RNA HS
Assay Kit and Qubit 2.0 Fluorometer (Life Technologies).
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2.4.3 Quantitative Reverse Transcriptase PCR (qRT-PCR). The relative expression level of
genes of interest was quantified using QuantiFast SYBR Green RT-PCR kit (Qiagen) and
BioRad CFX96 Real-Time System. Gene-specific primers were designed using OligoPerfectTM
Designer (ThermoFisher Scientific). The specificity of primers was verified using genomic DNA
as template in a PCR reaction. All primers that were used in this study are listed in Table S3. 10
ng of total RNA was used as template in 25 µl reaction volume with 1 µM of each primer. The
reaction mix was incubated at 50°C for 10 minutes for RT reaction, followed by denaturation at
95°C for 5 minutes and 35 cycles of PCR (10 seconds at 95°C and 30 seconds at 60°C). PCR
products were run on 0.8% agarose gel in Tris-Borate-EDTA buffer (pH 8) to verify the
amplification of a single PCR product of expected size. Acel_0305 (rpsJ that encodes the 30S
ribosomal protein S10) was used as the internal normalizer gene. Relative gene expression was
calculated using the 2-∆∆CT method as described previously [22]. Briefly, transcript abundance for
each gene was first normalized to that of Acel_0305 and then fold expression was calculated
relative to the expression of the gene in the control treatment.

2.4.4 Extraction and analysis of total proteins from A. cellulolyticus. Total proteins were
extracted from mid-exponential phase cultures of A. cellulolyticus. For the control, proteins were
extracted from 25 ml culture at 20 h (OD600 0.6), and for the phenolic acid treatments, proteins
were extracted from 50 ml culture at 37 h (OD600 0.3) or at indicated times in the experiment.
Cells were harvested by centrifugation at 10,000 g for 10 min at room temperature and resuspended in sterile deionized water. Cells were lysed using a Branson Ultrasonic sonicator
(10% amplitude, 2 seconds pulse ON, 5 seconds pulse OFF, for a total of 90 seconds). Sonicated
samples were centrifuged at 10,000 g for 10 min 4°C to remove any cells and debris. Protein
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concentration in the lysate was measured using the Qubit Protein Assay kit (Life Technologies).
Proteins (30 µg) were separated on nUView 4-20% Tris-Glycine precast gels (NuSep) and
visualized using Biosafe Coomassie Brilliant Blue G-250 (BioRad).

2.4.5 Identification of Acel_0059. Protein bands of interest were excised and sent to the UAMS
Proteomics Core Facility for analysis using tandem mass spectrometry. Tandem mass spectra
were analyzed using Mascot (Matrix Science, London, UK; version 2.4.1). Mascot was set up to
search the A. cellulolyticus predicted proteome (2157 proteins) in UniProtKB. Mascot was
searched with a fragment ion mass tolerance of 0.50 Da and a parent ion tolerance of 2.0 PPM.
Carbamidomethyl of cysteine was specified in Mascot as a fixed modification. Oxidation of
methionine and acetyl of the N-terminus were specified in Mascot as variable modifications.
Scaffold (version Scaffold_4.5.0, Proteome Software Inc., Portland, OR) was used to validate
MS/MS based peptide and protein identifications. Peptide identifications were accepted if they
could be established at greater than 99.9% probability by the Scaffold Local FDR algorithm.
Protein identifications were accepted if they could be established at greater than 99.9%
probability and contained at least 5 identified peptides. Protein probabilities were assigned by the
Protein Prophet algorithm [61]. Proteins that contained similar peptides and could not be
differentiated based on MS/MS analysis alone were grouped to satisfy the principles of
parsimony. Proteins having a minimum of 10 normalized total spectra were identified.
Acel_0059 was identified based on the normalized total spectra.

2.4.6 Cloning of Acel_0059. The Acel_0059 gene was cloned in E. coli using pET expression
system. Full-length sequence (840 bp) of the gene was amplified from A. cellulolyticus genomic
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DNA using primers containing NcoI and XhoI restriction sites (see Table S3). PCR product was
purified and was restriction digested and ligated into pET-28a(+) expression vector (Novagen)
that had been predigested with the same restriction enzymes. The ligation mixture was
electroporated into subcloning efficiency electrocompetent E. coli DH5α cells (ThermoFisher
Scientific) using BioRad GenePulser using the manufacturer’s preset protocol. Transformants
were selected on kanamycin (50 µg/ml). Recombinant plasmid (pAc59) was isolated from E. coli
DH5α cells using QIAprep Spin Miniprep kit (Qiagen) and the presence of the Acel_0059 gene
insert was confirmed using restriction digestion as well as PCR. The insert was sequenced to
ensure correctness of the gene sequence and lack of any mutations.

2.4.7 Partial purification of Acel_0059. For partial purification of the Acel_0059 protein, the
pAc59 plasmid was electroporated into E. coli Rosetta™(DE3)pLacI competent cells (Novagen).
Transformed cells were selected on chloramphenicol (17 µg/ml) and kanamycin (25 µg/ml). E.
coli cells carrying pAc59 (ECRDL59) were grown in LB broth containing the above antibiotics.
For production of the Acel_0059 protein, cells were grown to OD600 between 0.3-0.5 and the
Acel_0059 gene was induced for 4 hours using 1 mM Isopropyl β-D-1-thiogalactopyranoside
(IPTG) with vigorous shaking at 300 rpm. For uninduced control, parallel cultures were grown
without the addition of IPTG. Cells were centrifuged at 15,000 g for 15 minutes at room
temperature. Cell pellets were re-suspended in 1/10th culture volume of lysis buffer (50 mM TrisCl pH 8, 5% glycerol, 50 mM sodium chloride, 10 mg/ml lysozyme) and mixed by vortexing.
Lysis was carried out by incubating the cell suspension at 37°C for 20 minutes, followed by a
cold shock at -20°C for 30 seconds, and immediate transfer to 37°C for 1 minute. To eliminate
any contaminating genomic DNA, the protein samples were treated with DNase (Qiagen) at
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37°C for 30 minutes. Cell debris was removed using centrifugation at 15,000 g for 15 minutes at
room temperature and the clear protein solution was obtained. The thermostable Acel_0059
protein was partially purified by denaturing and precipitating the host proteins at 55°C for 1
hour; precipitated host proteins were removed by centrifugation as done above. The protein
preparation was passed through centrifugal filters with 9 kDa membrane (Pierce) to concentrate
the Acel_0059 protein. Protein concentration was determined using Qubit Protein Assay kit (Life
Technologies). The partially purified protein was stored at -20°C in 50 mM Tris-Cl pH 8
containing 50% glycerol.

2.4.8 Rhodanese activity and Zymogram analysis of partially purified Acel_0059 protein.
Rhodanese activity and substrate preference of the Acel_0059 protein was determined using
either thiosulfate or mercaptopyruvate as sulfur donors and potassium cyanide as the sulfur
acceptor as described previously [62]. Briefly, rhodanese activity was determined by measuring
SCN formation as the red Fe(SCN)3 complex from cyanide and thiosulfate. The reaction mixture
(1 mL) contained 100 mM Tris-Acetate pH 9.0, 10 mM KCN, and 1 mg of partially purified
Acel_0059. Reaction was initiated by addition of 10 mM of either Na2S2O3 or 3mercaptopyruvate. After incubation at 50°C for 15 min the reaction was stopped by addition of
200 µL acidic iron reagent (per liter composition: 50 g of FeCl3, 200 ml of 65% HNO3). After
centrifugation at 13,000 g for 3 min the absorption was read at 460 nm. For control, thiocyanate
formation was determined in the absence of Acel_0059 protein in the reaction mixture. Amounts
of product formation were quantified using a standard curve done with NaSCN. The Vmax and Km
values of the enzyme were measured as follows: the reaction mixture (1 ml) containing 100 mM
Tris-Acetate (pH 8.5), 10 mM KCN, and 0.5 mg of partially purified Acel_0059 was
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supplemented with different substrate concentrations (Na2S2O3, 0-50 mM). The reaction was
carried out by incubation at 55°C for 3 min and the reaction was stopped by the addition of
200 µL acidic iron reagent. After centrifugation at 13,000 g for 3 min the absorption was read at
460 nm. The concentration of product obtained was quantified using a standard curve of
NaSCN. The data obtained was used to generate Lineweaver Burk plot, and the Lineweaver Burk
equation was used to calculate Vmax and Km values. For Zymogram analysis, activity was assayed
in non-denaturing polyacrylamide gels using thiosulfate and potassium cyanide as substrates as
described previously [63]. Briefly, 50 µg of partially purified protein from uninduced and
induced cultures of ECRDL59 was separated on Blue Native Polyacrylamide gel (BN-PAGE,
ThermoFisher Scientific). After electrophoresis, gels were either stained with Bio-Safe
Coomassie (BioRad) or used for zymogram assay. For zymograms, gels or gel lanes were
incubated at 70°C for 50 minutes in 5 volumes of reaction mixture containing 100 mM Trisacetate buffer pH 8.5, 200 mM sodium thiosulfate, 200 mM potassium cyanide and 300 mM
calcium chloride. Gels were washed with distilled water and 10% glacial acetic acid. A white
insoluble band resulting from the formation of CaSO3 precipitate in the zymogram indicates TST
activity. To evaluate the temperature optima for enzyme activity, gels were incubated different
temperatures as indicated in the experiment.

2.4.9 Survival assay and Agar diffusion assay. For survival assay, E. coli cells carrying the
pAc59 plasmid (ECRDL59) and control cells (ECRDL28) containing the pET28a vector were
grown in LB with chloramphenicol (17 µg/ml) and kanamycin (25 µg/ml). IPTG was used at 0.1
mM (one-tenth of the concentration that was used for protein overexpression) to allow for
induction of gene expression without the cessation of growth. Cells were grown at 37°C for 9
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hours to obtain an optical density of 0.6. Cultures were diluted to a density of 106 cells/ml and
were treated with 15 mM HA for 30 minutes. Colony forming units after dilution plating were
used to calculate the total number of surviving cells before and after HA treatment. For agar
diffusion assay, ECRDL59 and ECRDL28 cultures were grown in LB with chloramphenicol (17
µg/ml) and kanamycin (25 µg/ml) and IPTG at 0.1 mM concentration. Cells were grown at 37°C
for 9 hours to obtain an OD600 of 0.6. 100µl of 107 cells/ml were plated on LB agar plates
containing the same concentrations of antibiotics and IPTG as mentioned above. 50 µl of 0.5 M
phenolic acids (equimolar mixture of HA, VA, CA, FA, SA, adjusted to pH 7) was added to
sterile discs (Sigma). Air dried discs were placed in the center of the agar plates and incubated at
37°C for 18-20 hours. Distance from the edge of the disc to edge of the zone was measured.
Mean values from biological replications were used for statistical analysis. To analyze the effect
of Acel_0059 on the growth in the presence of PA, overnight grown ECRDL59 and ECRDL28
were inoculated (105 cells/ml final concentration) in LB with chloramphenicol (17 µg/ml) and
kanamycin (25 µg/ml) in either the absence or presence of 20 mM PA. Cells were grown at 37°C
and 300 rpm for 25 hours and growth was monitored using optical density 600 nm.

2.5 Results
2.5.1 Expression of an approx. 30 kDa band containing the Acel_0059 protein was
enhanced in the presence of phenolic acids. Plant phenolic acids, namely 4-hydroxybenzoic
acid (HA), vanillic acid (VA), trans-ferulic acid (FA), p-coumaric acid (CA), and syringic acid
(SA) inhibited the growth of A. cellulolyticus at 1 mM concentration (Fig. 1). To identify the
proteins whose expression was affected during the inhibition, total protein profiles of the bacteria
grown in the absence or presence of phenolic acids were analyzed using Coomassie-stained
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sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Analysis of the SDSPAGE gel revealed that intensity of a protein around 30 kDa was prominently elevated in
cultures grown in the presence of phenolic acids (Fig. 2A). Gel slices containing the 30 kDa band
were excised from all lanes and the proteins in each slice were analyzed using tandem mass
spectrometry (LC-MS/MS). Mass spectrometry identified ten proteins with molecular weights
between 30-32 kDa (Table S1). Of these, the Acel_0059 protein (GenBank accession
ABK51835.1) with a predicted mass of 31.7 kDa had the highest normalized total spectra
(between 53 and 110). Other proteins had substantially fewer number of normalized total spectra
(between 10 and 28). Also, compared to the control sample, only Acel_0059 showed
substantially higher number of normalized total spectra in samples corresponding to phenolic
acids. Specifically, compared to the control lane, HA and VA lanes had approx 2-fold more
normalized total spectra for the Acel_0059 protein, while CA and FA lanes had approx 1.4-fold
more normalized total spectra (Fig. 2B). Normalized total spectra in the SA lane was comparable
to that of the control. However, it should be noted that gel excision is variable and therefore
normalized total spectra may not be reflective of actual protein abundances. For most of the
downstream analyses, HA was selected as a representative phenolic acid. To further understand
the expression pattern of Acel_0059 during growth, total proteins profiles were analyzed at
regular intervals for 37 hours. The data indicated that the expression of Acel_0059 protein
steadily increased during growth in the presence of HA, while there was no visible upregulation
of the expression of Acel_0059 protein in the control (Fig. 2C). To rule out any effects of the
acidic properties of phenolic acids on Acel_0059 upregulation, total proteins were analyzed from
cultures grown in control medium (without phenolic acids) that was adjusted to different initial
pH. Acidic pH did not result in upregulation of Acel_0059 expression (Fig. S1).
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2.5.2 Expression of Acel_0059 gene was upregulated in the presence of phenolic acids. To
confirm the genetic upregulation of Acel_0059 protein in the presence of phenolic acids,
expression of the Acel_0059 gene was analyzed in the presence of phenolic acids. For this, the
transcript abundance of Acel_0059 was analyzed using quantitative reverse transcriptase PCR
(qRT-PCR). The data confirmed that the transcript abundance of Acel_0059 was increased in the
presence of HA and VA by approx 16-fold and 8-fold, respectively (Fig. 4A). The higher
transcript abundance of Acel_0059 in HA and VA validated the higher protein amounts seen in
the SDS-PAGE gels and the mass spectrometry data discussed above. The relative transcript
abundance of Acel_0059 was higher than that of housekeeping genes rpsJ and gyrB (Fig. 4B).
The rpsJ (Acel_0305) gene encodes the small subunit ribosomal protein S10P that is required for
ribosome assembly, while the gyrB (Acel_0005) gene encodes the DNA gyrase subunit B that is
required for DNA replication. The relatively high expression of Acel_0059 gene corroborated
with the prominence of the Acel_0059 protein in SDS-PAGE gels. To check if Acel_0059 was
possibly upregulated for the metabolism and detoxification of phenolic acids, the concentration
of HA was measured in culture supernatants at regular intervals during growth. The
concentration of HA showed no decline during growth (Fig. S2), which suggested that the
upregulation of Acel_0059 had a different purpose. Based on the genomic annotation of
Acel_0059 as a putative thiosulfate sulfurtransferase (TST), we hypothesized that it may play a
role in sulfur metabolism or homeostasis.

2.5.3 Bioinformatic analysis of sulfur assimilation genes in A. cellulolyticus. To identify the
putative sulfur assimilation pathway in A. cellulolyticus, amino acid sequences of known proteins
involved in key sulfur assimilation pathways were obtained from the MetaCyc and KEGG

21

databases [30, 31], and were used to identify the corresponding homologs in A. cellulolyticus.
Five genes that encoded homologs of enzymes involved in the assimilatory sulfate reduction
pathway were found in single copy in the A. cellulolyticus genome (GenBank accession
NC_008578) (Table S2). These included sulfate adenylyltransferase subunit 1 (CysN,
Acel_1617), sulfate adenylyltransferase subunit 2 (CysD, Acel_1618), adenylylsulfate kinase
(CysC, Acel_1619), phosphoadenylyl-sulfate reductase (CysH, Acel_2054), and sulfite reductase
(CysI, Acel_2055). In addition, the A. cellulolyticus genome encodes homologs of the
mycobacterial CysM/CysO/mec+ pathway for cysteine synthesis [32, Table S2]. The
mycobacterial CysM protein (Rv1336) encodes an O-phosphoserine sulfhydrylase that was
shown to function along with a small sulfur-carrier protein CysO (Rv1335) and a CysO-cysteine
peptidase protein mec+ (Rv1334) proteins in cysteine synthesis in vitro [32]. More recently, the
adenylyltransferase/sulfurtransferase protein MoeZ (Rv3206c) was shown to transfer sulfur from
an unknown source to CysO [33]. The A. cellulolyticus genome encodes a homolog of MoeZ
(Acel_1777). Surprisingly, the A. cellulolyticus genome did not contain identifiable homologs of
the O-acetylserine-dependant cysteine synthase (CysK1, Rv2334) and the serine
acetyltransferase (CysE, Rv2335) that is required for the synthesis of O-acetylserine [34, 35].
Further, the A. cellulolyticus genome also did not encode CysK2 (Rv0848), a second Ophosphoserine-dependent cysteine synthase [36]. Thus, these data suggested that A. cellulolyticus
likely encodes a single pathway for cysteine synthesis that involves the CysM (Acel_1687),
CysO (Acel_1688), mec+ (Acel_1689), and MoeZ (Acel_1777) proteins [32]. All four proteins
appear to be encoded in a single copy in the genome. The predicted pathway for assimilatory
sulfate reduction pathway and cysteine synthesis in A. cellulolyticus, along with the
corresponding homologs, is provided in Figure 3.
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2.5.4 Expression of genes for assimilatory sulfate reduction was upregulated in the presence
of phenolic acids. To study the expression of the assimilatory sulfate reduction genes, relative
transcript abundance of five genes was quantitated using quantitative real-time RT-PCR (Fig.
4A). Expression of all genes was significantly increased in the presence of HA and VA.
Depending on the gene, transcript abundance was enhanced between 5- and 31-fold in the
presence of HA, and between 6- and 29-fold in the presence of VA. No significant differences
were observed in the presence of CA, while only three genes each were significantly upregulated
in the presence of SA or FA. The cysH gene showed the highest relative increase in transcript
abundance in the presence of HA and VA, approx 31- and 29-fold, respectively. The cysC gene
showed approx 23- and 13-fold increase in relative transcript abundance in the presence of HA
and VA, respectively. Both cysN and cysD showed approx 13-fold increase in relative transcript
abundance in the presence of HA and VA. The cysM gene showed approx 5- and 6-fold increase
in relative transcript abundance in the presence of HA and VA, respectively. Taken together, the
upregulation of the assimilatory sulfate reduction pathway and cysteine synthesis genes
suggested that there may be an increased need for cysteine synthesis from sulfate during
exposure to phenolic acids. Increased cysteine biosynthesis may be important for increasing thiol
pools (antioxidants) in the cells for mitigating the oxidative effects of the phenolic acids [37].

2.5.5 Supplementation of cysteine in the growth medium relieved the inhibition by HA. We
studied the effect of L-cysteine supplementation in the media on the growth inhibition by HA.
Under normal growth (i.e., in the absence of phenolic acids), addition of L-cysteine had no
significant effect on the growth of bacterial culture (Fig. 5A). However, in the presence of HA,
addition of L-cysteine in the media significantly increased the growth of A. cellulolyticus (Fig.
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5B). On the contrary, addition of L-methionine (the other sulfur-containing amino acid)
decreased the growth of A. cellulolyticus significantly in the presence of HA. Supplementation of
HA-containing media with 5X the normal concentration of inorganic sulfate also lowered the
growth of A. cellulolyticus, albeit to a lesser extent than L-methionine. In the absence of HA, Lmethionine did not significantly affect growth while 5X sulfate enhanced the growth of A.
cellulolyticus. Elevated sensitivity to HA in the presence of L-methionine or 5X sulfate hints at a
complex regulation of sulfur assimilation in the organism. Additionally, we evaluated the effects
of the addition of thiosulfate and glutathione, a small molecular weight thiol, on the growth of
bacteria in the presence of HA. It should be noted that A. cellulolyticus does not produce
glutathione, but is instead predicted to produce mycothiol. However, due to the ease of
availability we used glutathione as a low molecular weight redox agent. In the presence of HA,
while the addition of glutathione resulted in growth similar to regular medium, thiosulfate
addition substantially enhanced the growth (Fig. 5B). In the absence of HA, both glutathione and
thiosulfate enhanced growth during the exponential phase (Fig. 5A). Overall, the data suggested
that cysteine is important for A. cellulolyticus to mitigate the inhibitory effects of phenolic acids,
which is consistent with the known role of cysteine in combating stress [37].

2.5.6 Cysteine supplementation alleviated the upregulation of Acel_0059 in the presence of
HA. We hypothesized that if Acel_0059 was upregulated for increased cysteine synthesis during
phenolic inhibition then supplementation of L-cysteine in the growth medium would relieve the
upregulation of Acel_0059 in the presence of phenolic acids. To evaluate this, we studied the
expression of the Acel_0059 protein in A. cellulolyticus grown in media supplemented with 0,
0.25, or 0.5 mM L-cysteine. The data showed that supplementation of L-cysteine in the growth
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medium substantially alleviated the upregulation of Acel_0059 in the presence of HA (Fig. 6).
Furthermore, in the presence of HA, there was an inverse correlation between the amount of Lcysteine added to the growth medium and the relative amount of the Acel_0059 protein. Thus,
addition of 0.5 mM L-cysteine to HA-containing medium resulted in lesser upregulation of
Acel_0059 protein than the addition of 0.25 mM L-cysteine. These data suggested that
Acel_0059 has a role in cysteine biosynthesis in A. cellulolyticus.

2.5.7 Acel_0059 encodes a functional enzyme that shows TST activity in vitro. In the
GenBank database, the Acel_0059 gene was annotated as TST. We confirmed this annotation
using BLAST search against the nr and swissprot databases and bioinformatics analyses.
Acel_0059 has a predicted length of 279 amino acids and a predicted molecular mass of 31.68
kDa. The protein has no secretion signals and the subcellular localization is predicted to be
cytoplasmic based on the pSORTb database v3.0 [38]. Based on BLAST search against all
functionally studied TSTs, the closest homolog of Acel_0059 was CysA from S. erythraea
(accession P16385.1). Acel_0059 shared 75% sequence identity with the S. erythraea CysA, and
31% sequence identity with the human mitochondrial rhodanese (accession Q16762.4). Similar
to the functionally characterized TSTs, Acel_0059 is a tandem rhodanese-domain protein with a
catalytically inactive N-terminal domain and a catalytically active C-terminal domain that
contains the active site cysteine at position 233 (Cys233). Also, the amino acid motif CRIGER
that is next to the active site cysteine matches with the consensus motif CRxGx[R/T] for TSTs
[39, 40]. To know whether Acel_0059 encodes a functional TST enzyme, the Acel_0059 gene
was cloned and overexpressed in E. coli. The overexpressed Acel_0059 protein was partially
purified (Fig. 7A). To demonstrate the rhodanese activity of the Acel_0059 protein, we used
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zymogram analysis. A single white band corresponding to the Acel_0059 protein was obtained in
the zymogram (Fig. S3). Partially purified proteins from un-induced E. coli cells did not show
the band confirming that the rhodanese activity was specific to Acel_0059 and was not due to
host proteins. A linear increase in the intensity of the white band was observed with increasing
amounts of Acel_0059 protein (Fig. 7B, panel 1). Zymogram analysis at different reaction
temperatures showed that the partially purified Acel_0059 was active in vitro at 55°C, 70°C, and
80°C but showed no activity at 25°C and 37°C (Fig. 7B, panel 2). These data demonstrated that
Acel_0059 encoded a thermostable TST enzyme. In addition, the Acel_0059 protein was used to
determine enzyme activity using either thiosulfate or mercaptopyruvate as the sulfur donor
substrates. With thiosulfate as the sulfur donor, the reaction yielded approx. four times more
product than with mercaptopyruvate as the sulfur donor (Fig. 7C). Thus, as expected for TSTs,
the Acel_0059 enzyme showed substrate preference for thiosulfate over mercaptopyruvate in
vitro. The dependence of enzyme activity of Acel_0059 on sodium thiosulfate concentration was
measured. The activity was found to plateau above 10 mM sodium thiosulfate (Fig. 7D). The Km
and Vmax of Acel_0059 for sodium thiosulfate was 4.71±1.06 mM and 13.204±1.26 nmoles/min
(Fig. 7E).

2.5.8 Acel_0059 enhanced the survival of cells exposed to inhibitory concentration of HA.
Tools for the genetic manipulation of A. cellulolyticus are lacking currently. Therefore, we used
E. coli as a heterologous host to further study the role of Acel_0059 in bacterial survival upon
exposure to phenolic acids. For this, we evaluated the ability of E. coli expressing the Acel_0059
gene to survive in the presence of inhibitory concentrations of HA. It was experimentally
determined that much higher concentration of HA was required to inhibit E. coli (15 mM)
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compared to A. cellulolyticus (1 mM) because E. coli is a Gram-negative bacterium with an outer
membrane that offers enhanced protection against antimicrobial compounds [41]. Differences in
inhibitory concentrations could partly be due to the differences in the media used for the two
organisms. Despite the differences, we observed substantial protection by Acel_0059 against HA
in E. coli. To quantitate the effect of short exposure to HA on cell survival, 1.50±0.24 x 105 cells
of parent E. coli cells (ECRDL28) and 2.56±0.58 x 105 E. coli cells expressing the Acel_0059
gene (ECRDL59) were exposed to 15 mM HA for 30 minutes. While approx 18% of the parent
E. coli cells (0.27±0.04 x 105 cells) survived after 30 minutes of exposure to HA, approx 62% of
the E. coli cells that expressed Acel_0059 (1.59±0.65 x 105 cells) survived upon exposure to HA.
Additionally, we studied the growth of ECRDL28 and ECRDL59 cells in the presence of an
equimolar mixture if five phenolic acids (PA; Fig. 8A). The data show that while ECRDL28 and
ECRDL59 cells grew comparably in the absence of 20 mM PA, ECRDL59 grew significantly
better than ECRDL28 in the presence of PA. In addition, ECRDL59 produced smaller zone of
inhibition (p < 0.05) on agar plates carrying discs containing 0.5 M PA, compared to ECRDL28
(Fig. 8B). The sizes of the zone of inhibition were 8.75±0.25 mm and 7.25±0.48 mm for
ECRDL28 and ECRDL59, respectively.

2.6 Discussion
The present study on the molecular effects of phenolic acids in A. cellulolyticus revealed novel
information on the expression, activity, and the role of Acel_0059. There were no prior
experimental data on Acel_0059. Our study revealed that Acel_0059 is a functional enzyme with
rhodanese activity that is expressed in relatively high abundance in A. cellulolyticus and is
upregulated during bacterial growth in the presence of inhibitory phenolic acids. TSTs a.k.a.
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rhodaneses (E.C. 2.8.1.1) are an important family of proteins that are ubiquitous across Bacteria,
Archaea, and Eukarya [39]. Rhodanese was first discovered from rabbit liver more than eight
decades ago [42]. Ubiquity of rhodanese domain proteins in nature signifies an important role for
these proteins. Previous reviews have discussed the significance of rhodaneses in the normal
growth and health of humans, animals, plants, and microbes [39, 40]. Based largely on in vitro
data, rhodaneses have been proposed to function in cyanide detoxification. While in vitro
rhodaneses carry out transsulfuration of cyanide to thiocyanate using thiosulfate as the sulfur
donor, their precise in vivo function remains elusive. Proposed physiological roles of TSTs
include cyanide detoxification, regeneration of iron–sulfur clusters in Fe-S proteins, and
maintenance of the intracellular sulfane pool [43-45]. While most studies have focused on the
enzymatic functions of rhodaneses, less is known about their expression and regulation. Our data
showing a higher level of expression of the Acel_0059 gene compared to housekeeping genes
(rpsJ and gyrB) (Fig. 4B) suggest an important metabolic function for TST. This idea is
bolstered by the transcriptome data on M. smegmatis published by Li et al [46]. Our analysis of
the data published by Li et al revealed that the orthologous TST gene (MSMEG_5789) in M.
smegmatis is among the top 1% of highly expressed genes under normal growth. Thus, the data
suggest that TSTs may have an important cellular function. It should be noted that the A.
cellulolyticus genome encodes a paralog of Acel_0059, which is Acel_1417. While Acel_1417 is
annotated as a TST, it shows homology to mercaptopyruvate sulfurtransferase (MST) from other
bacteria. This protein was not detected in our mass spectrometry data. It is possible that it is
either not expressed under the conditions used in the present study or is expressed at very low
levels. In this regard, the transcriptome data on M. smegmatis published by Li et al [46] also
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indicate that the expression level of its MST ortholog (MSMEG_3238) is at least 12-fold lower
than that of its TST ortholog (MSMEG_5789).

Upregulation of Acel_0059 in response to growth inhibition by phenolic acids is a new finding.
In particular, we found that expression of Acel_0059 protein and its gene was elevated in the
presence of inhibitory concentration of HA and VA. While several studies have reported on the
inhibitory effects of plant phenolic acids on microbes, the involvement of rhodanese homologs in
cellular response to stress induced by phenolic acid has not emerged previously. With regards to
the effects of antimicrobial plant chemicals on bacterial TST expression, we found only one
report where plant extracts of Radix Ranuncoli Ternati (a Chinese herb) significantly affected
(although downregulated) the expression of the TST (cysA2) in M. tuberculosis [47]. Significant
upregulation of rhodanese homologs has been reported in human and animal pathogenic bacteria
that experience oxidative stress in the host environment [48, 49]. For example, in clinical isolates
of M. tuberculosis, the TST homolog Rv0815c (cysA2) was found to be upregulated during
intracellular growth in macrophages [48]. While in M. avium subspecies paratuberculosis the
TST homolog SseA was found to be upregulated during natural infection in sheep [49].
Oxidative stress induced during growth on phenanthrene was reported to significantly induce
sulfurtransferase activity in environmental strains of Rhodococcus aetherovorans, R. opacus and
M. smegmatis [50]. However, the physiological significance of TST upregulation in the above
studies was not investigated. In the present study, upregulation of Acel_0059 may point to its
plausible role in mitigating the inhibitory effects of phenolic acids. Phenolic acids are known to
disrupt membranes causing loss of cellular integrity, which exposes cellular contents to oxidizing
environments that can oxidize thiols and damage labile Fe-S clusters in critical metabolic

29

enzymes [14, 51]. Rhodaneses have been shown to function both as an antioxidant for reducing
oxidized thiols and in the restoration of iron–sulfur centers in Fe–S proteins [52, 53]. It is
possible that Acel_0059 plays a role in these functions during phenolic acid inhibition in A.
cellulolyticus.

There is very limited in vivo data on the functions of bacterial TST homologs and much less is
known about the role of TST in sulfur metabolism and cysteine synthesis. In the cyanogenic
Pseudomonas aeruginosa, studies on rhodanese function have primarily focused on its role in
cyanide detoxification [54]. In Saccharopolyspora erythraea, mutation in the rhodanese
encoding gene (cysA) was found to result in cysteine auxotrophy [55]. In Streptomyces
clavuligerus, the rhodanese enzyme RhlA was proposed to be involved in the formation of the
cysteine precursor for the synthesis of the antibiotic holomycin [56]. In Azotobacter vinelandii,
deletion of the rhodanese RhdA was found to increase sensitivity to oxidative growth conditions
and the enzyme was proposed to play a role in maintaining redox homeostasis and in the
regeneration of glutathione [53, 57]. Our data suggest that the A. cellulolyticus Acel_0059 has a
role in assimilation of sulfur towards cysteine biosynthesis. Firstly, the Acel_0059 gene and
sulfur assimilation genes were simultaneously upregulated in the presence of phenolic acids. And
secondly, supplementation of cysteine in HA-containing medium alleviated the upregulation of
Acel_0059. Supplementation of both cysteine and thiosulfate was able to relieve growth
inhibition of A. cellulolyticus in the presence of HA. These data suggest that thiosulfate and
cysteine are important for mitigating the inhibitory effects of phenolic acids. Cysteine plays an
important role in defense against oxidative stress as well as in the regeneration of oxidized Fe-S
clusters and low molecular weight thiol antioxidants. Cysteine auxotrophs are known to be
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sensitive to oxidative stress [37]. The S. erythraea cysA mutant, a cysteine auxotroph, could only
utilize thiosulfate among inorganic sulfur sources for growth [55]. The genome of the S.
erythraea strain that was used in the above published study on the cysA mutant has not been
sequenced. Also, additional reports on cysteine synthesis in this strain are lacking. Therefore, it
is unknown if cysteine synthesis in this strain is solely dependent on the CysM-CysO-mec+
pathway. Although TSTs use thiosulfate as a substrate in vitro, their role in the generation of
thiosulfate has been proposed [39, 40]. We hypothesize that Acel_0059 may play a role in
generating thiosulfate that may be required for cysteine biosynthesis (Fig. 4).

Thiosulfate has been shown to serve as a sulfur source for cysteine synthesis. In vitro, rat liver
mitochondrial lysate was demonstrated to incorporate the sulfane sulfur from thiosulfate into
cysteine without intermediate formation of free sulfide ions [58]. The E. coli cysteine synthase
has been shown to use thiosulfate as the substrate along with O-acetylserine [59]. However, the
A. cellulolyticus genome lacks the cysE gene that is required for the synthesis of O-acetylserine.
Moreover, the single cysteine synthase (Acel_1687) that is encoded in the A. cellulolyticus
genome appear to be an orthologs of the M. tuberculosis CysM, an O-phosphoserine
sulfhydrylase [32]. The M. tuberculosis CysM was shown in vitro to preferentially use a small
CysO-thiocarboxylate protein as a sulfur donor, and sulfide to a much lower degree, for cysteine
synthesis. The cysM gene occurs in an operon, where it clusters with a small sulfur carrier
protein cysO (sulfur carrier protein) and a zinc-dependent hydrolase mec+ (CysO-cysteine
peptidase). The CysM protein has much higher specificity for O-phosphoserine compared to Oacetylserine as a substrate, and is upregulated under conditions of oxidative stress [60]. The
sulfur source for the CysO-thiocarboxylate formation remains unknown, however. And it
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remains to be seen if either thiosulfate or sulfide could serve as in vivo sulfur donors for CysOthiocarboxylate. Future in vivo data may provide additional insights that may help define the
precise function of Acel_0059 in sulfur metabolism in A. cellulolyticus.
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2.7 Tables
Table 1. Bacterial strains and plasmids.
Material
Description/genotype
(A) Strains
ACEL11B
A. cellulolyticus strain 11B
ECDHA00
E. coli DH5α. Genotype: F- Φ80lacZΔM15
Δ(lacZYA-argF) U169 recA1 endA1 hsdR17(rk-,
mk+) phoA supE44 thi-1 gyrA96 relA1 λECRDL00
E. coli Rosetta™(DE3)pLacI. Genotype: F– ompT
hsdSB (rB– mB–) gal dcm (DE3) pLacIRARE
(CamR)
ECRDL28
ECRDL00 carrying pET-28a(+)
ECRDL59
ECRDL00 carrying pAcTST
(B) Plasmids
pET-28a(+)
pAcTST

Expression vector
pET-28a(+) carrying the Acel_0059 gene cloned in
NcoI and XhoI restriction sites
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Source
ATCC (#43068)
ThermoFisher Scientific
(#18265017)
Novagen (#70920)
This study
This study
Novagen (#69864)
This study

2.8 Figures

Figure 1. Effect of phenolic acids on the growth of A. cellulolyticus. Bacteria were grown either
in the absence of phenolic acids (open circles) or in the presence of 1 mM of HA (black circles),
VA (cross marks), CA (white squares), SA (black triangles), or FA (gray triangles). Growth was
monitored using optical density at 600 nm. Data represent the mean values with standard error
from three biological replicates.
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Figure 2. Expression of Acel_0059 is increased in the presence of phenolic acids. (A) SDSPAGE showing the enhanced expression of ~30 kDa protein band in the presence of phenolic
acids. Total proteins (30 µg) isolated from bacteria grown in the absence (control, C) or presence
of phenolic acids (HA, VA, CA, SA, or FA) were separated on nUView 4-20% Tris-Glycine
precast gel (NuSep) and visualized using Biosafe Coomassie Brilliant Blue G-250 (BioRad).
Lane M: molecular weight ladder showing the 25 and 37 kDa protein standards from the
Precision Plus Protein Dual Color Standard (BioRad). The upregulated ~30 kDa protein band is
indicated with an arrow. (B) Relative quantity of Acel_0059 protein from tandem mass
spectrometry. The ~30kDa protein band seen in panel A was excised from each lane and
subjected to tandem mass spectrometry. The graph shows the normalized total spectral counts for
Acel_0059. (C) SDS-PAGE image of time course analysis of the Acel_0059 expression from
bacteria grown in the absence or presence of HA. Bacterial cultures grown in the absence
(control, C) or presence of HA were harvested at 0, 7, 14, 22, 30, 37 hours after inoculation.
Total proteins (30 µg) were separated and visualized as described above. The Acel_0059 protein
band is indicated with an arrow.
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Figure 3. Putative sulfate assimilation pathway and proposed role of Acel_0059. Dashed lines
represent possible steps in A. cellulolyticus. Details of the reactions catalyzed along with
structures of the metabolites are available in the KEGG database [31]. APS: adenosine-5’phosphosulfate (or adenylylsulfate); PAPS: 3’-phosphoadenosine-5’-phosphosulfate (or
phosphoadenylylsulfate); CysN (Acel_1617): sulfate adenylyltransferase subunit 1; CysD
(Acel_1618): sulfate adenylyltransferase subunit 2; CysC (Acel_1619): adenylylsulfate kinase;
CysH (Acel_2054): phosphoadenylylsulfate reductase; CysI (Acel_2055): sulfite reductase
(ferredoxin); CysM (Acel_1687): O-phosphoserine sulfhydrylase (cysteine synthase), CysO
(Acel_1688): sulfur carrier protein , mec+ (Acel_1689): CysO-cysteine peptidase, MoeZ
(Acel_1777): adenylyltransferase/sulfurtransferase, MshA (Acel_0073): D-inositol 3-phosphate
glycosyltransferase, MshB (Acel_1868): 1D-myo-inositol 2-acetamido-2-deoxy-alpha-Dglucopyranoside deacetylase, MshC (Acel_1172): L-cysteine:1D-myo-inositol-2-amino-2deoxy-D-glucopyranoside ligase, MshD (Acel_2026): mycothiol acetyltransferase.
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Figure 4. Analysis of relative transcript abundance using quantitative reverse-transcriptase PCR.
(A.) Effect of phenolic acids on the expression of the Acel_0059 gene as well as sulfur
assimilation genes in A. cellulolyticus. Total RNA was isolated from bacteria grown in the
absence (control) or presence of phenolic acids (HA, VA, CA, SA, or FA). Relative transcript
abundance was quantified using qRT-PCR and normalized to the expression of a housekeeping
gene, rpsJ (Acel_0305). Fold expression of the genes in the presence of phenolic acids relative to
their expression in the control (black bars, normalized to 1) is shown. Data represent mean
values with standard error from three biological replicates. ** indicates statistically significant (p
< 0.05) differences compared to the control. (B.) Relative transcript abundance of different A.
cellulolyticus genes. Transcript abundance was quantified using qRT-PCR and normalized to the
expression of the housekeeping gene, rpsJ (Acel_0305). Data represent mean values across all
experiments and replicates (n=18). Error bars represent standard error of the mean. *** indicates
statistically significant (p < 0.001) difference compared to the rpsJ gene.
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Figure 5. Effect of supplementation of different sulfur sources on the growth of A. cellulolyticus.
(A) Growth in the absence of phenolic acids. (B) Growth in the presence of HA. All cultures
were grown in either regular medium (black circles) or medium supplemented with 0.5 mM
sodium thiosulfate (black squares), 0.5 mM L-cysteine (white squares), 0.5 mM L-methionine
(gray triangles), 5-fold higher concentration of MgSO4 (gray diamonds), or 0.5 mM glutathione
(white circles, dashed line). Growth was monitored using optical density at 600 nm. Data
represent mean values with standard error from three biological replicates.
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Figure 6. Effect of supplementation of L-cysteine in the growth medium on the expression of the
Acel_0059 protein. Bacteria were grown in the absence (control, C) or presence of 1 mM HA in
medium supplemented with L-cysteine (L-cys) at 0, 0.25, or 0.5 mM. Total proteins were
isolated and analyzed as described for Fig. 2. The Acel_0059 protein band is indicated with an
arrow.
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Figure 7. Characterization of Acel_0059 activity. (A.) Overexpression and partial purification of
Acel_0059 protein from E. coli. The Acel_0059 gene was cloned in pET28a expression vector
and the overexpressed protein was partially purified (see methods for details). Lane M: Page
Ruler Plus Prestained Protein Ladder (Thermo Scientific); Lane 1: total proteins (30 µg) from
lysate of un-induced cells; Lane 2: total proteins (30 µg) from lysate of IPTG-induced cells
showing the overexpressed Acel_0059 protein, Lane 3: partially purified Acel_0059 (30 µg).
(B.) Zymogram analysis of TST activity of Acel_0059. Partially purified Acel_0059 was
separated on native gel and incubated with reaction mixture at 70°C for 50 minutes to detect TST
enzyme activity (see the methods section for details). A white band resulting from the formation
of CaSO3 precipitate indicates TST activity. In panel 1, 0-100 µg of protein was separated in the
different lanes as indicated. In panel 2, 50 µg of protein was separated in each lane; gel lanes
were cut and incubated at the indicated temperatures for enzyme assay. (C.) Rhodanese activity
of partially purified Acel_0059 protein. Rhodanese activity of the Acel_0059 protein was
measured using either thiosulfate or 3-mercaptopyruvate as sulfur substrates (see Methods
section for details). Enzyme activity was expressed as nanomoles of the product formed per
milligram of protein per minute. (D.) Dependence of TST activity of Acel_0059 on sodium
40

thiosulfate concentration. Activity was calculated using a standard curve for sodium thiocyanate.
Data represent mean values with standard error from biological replicates. (E.) Double-reciprocal
plot for calculating the Km and Vmax values for Acel_0059 with sodium thiosulfate as substrate.
The rate of TST activity (y-axis) was calculated at different substrate concentrations using a
standard curve for sodium thiocyanate. Representative graph from biological replicates is shown.
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Figure 8. Effect of heterologous expression of Acel_0059 in E. coli. (A.) Effect of Acel_0059 on
the growth of E. coli in the presence of PA. Bacteria were grown either in the absence (circles) or
presence (squares) of 20 mM PA at 37°C and 300 rpm. ECRDL28: E. coli carrying the plasmid
vector (white); ECDRL59: E. coli expressing the Acel_0059 from the plasmid (black). Data
represent mean values with standard error from biological replicates. (B.) Agar diffusion assay.
ECRDL28 and ECRDL59 cells were grown to OD600 0.6 and 107 cells/ml were spread
separately on agar plates. Sterile filter discs containing 0.5 M PA were placed and plates were
incubated at 37°C overnight. Degree of inhibition was noted by measuring the mean distance (in
mm) from the edge of the disc to the edge of the clear zone. The distances were 8.75±0.25 mm
and 7.25±0.48 mm for ECRDL28 and ECRDL59, respectively. Data represent mean values with
standard error, from biological replicates. The difference in mean values were statistically
significant (p < 0.05), calculated using Student’s t-test. Representative images are shown.
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2.9 Supplementary tables
Table S1. Normalized total spectra for proteins identified in tandem mass spectrometry analysis
of the ~30 kDa band from SDS-PAGE gel shown in Figure 2A.
#
1
2
3
4
5
6
7
8
9

UniProtKB
identifier
A0LQX5_ACIC1
A0LU59_ACIC1
DAPA_ACIC1
RL2_ACIC1
A0LUY1_ACIC1
EFTS_ACIC1
A0LSN8_ACIC1
A0LTE7_ACIC1
A0LVR0_ACIC1

Identified Proteins

MW

Sulfurtransferase
Short-chain dehydrogenase/reductase SDR
4-hydroxy-tetrahydrodipicolinate synthase
50S ribosomal protein L2
Exodeoxyribonuclease III
Elongation factor Ts
Thioredoxin domain protein
Uncharacterized protein
Uncharacterized protein
Phosphoribosylaminoimidazole10 A0LWU1_ACIC1
succinocarboxamide synthase
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32 kDa
30 kDa
32 kDa
30 kDa
31 kDa
30 kDa
31 kDa
32 kDa
32 kDa

C
53
25
23
20
20
19
19
15
15

32 kDa

15

Normalized Total Spectra
HA VA CA SA
97 110 73
56
18
20
19
25
25
17
23
26
14
15
14
28
14
10
19
19
23
26
18
18
22
17
16
23
17
13
14
13
16
19
17
15
16

17

16

13

FA
76
27
21
16
18
22
22
14
14
18

Table S2. Bioinformatic analysis of the A. cellulolyticus genome for putative sulfur assimilation and cysteine biosynthesis genes.
Locus tag, genome
Annotated gene product
coordinates (strand)
Acel_0059,
Thiosulfate sulfurtransferase
tst
64187-65026 (+)
(EC:2.8.1.1)
1. Genes for assimilatory sulfate reduction
Acel_1617,
Sulfate adenylyl-transferase
cysN
1820457-1821752 (-) subunit 1 (EC:2.7.7.4)
Gene

Size
(aa)

MW
(kDa)

279

31.7

431

46.5

Acel_1618,
1821756-1822742 (-)

Sulfate adenylyl-transferase
subunit 2 (EC:2.7.7.4)

328

37.3

cysC

Acel_1619,
1822739- 1823428 (-)

Adenylyl-sulfate kinase
(EC:2.7.1.25)

229

24.4

cysH

Acel_2054,
2328112-2328882 (-)

Phosphoadenylylsulfate
reductase (EC:1.8.4.8)

256

29.3

Acel_2055,
2328885-2330804 (-)
2. Genes for cysteine synthesis
Acel_1687,
cysM
1898789-1899736 (-)
Acel_1688,
cysO
1899745- 1900017 (-)
Acel_1689,
mec+
1900046- 1900486 (-)
Acel_1777,
moeZ
2019943-2018753 (-)

Sulfite reductase (ferredoxin)
(EC:1.8.7.1)

639

69.9

O-phosphoserine sulfhydrylase
(cysteine synthase (EC:2.5.1.47)

315

33.9

90

9.7

CysO-cysteine peptidase

148

16.6

Adenylyltransferase/
sulfurtransferase

396

42.6

cysE

Not found

Serine acetyltransferase

-

-

cysK1

Not found

O-acetylserine sulfhydrylase

-

-

cysK2

Not found

-

-

serA

Acel_0114,
117787- 118920 (-)

377

40.7

44

cysD

cysI

Sulfur carrier protein

S-sulfocysteine synthase /
cysteine synthase
Phosphoserine aminotransferase
apoenzyme

Closest sequence homolog in the Uniprot/Swissprot database using the
NCBI blastp search (default parameters)
A0R4C9.1 (Mycobacterium smegmatis str. MC2 155) E-value 1e-161,
Identities 211/277(76%)
P9WNM4.1 (Mycobacterium tuberculosis CDC1551) E-value 1e-156,
Identities 233/419(56%)
Q9X5U0.1 (Streptomyces lavendulae) E-value 1e-175, Identities
243/303(80%)
A4T8Q2.1 (Mycobacterium gilvum PYR-GCK) E-value 2e-149,
Identities 206/295(70%)
Q2JUC0.1 (Synechococcus sp. JA-3-3Ab) E-value 9e-59, Identities
91/173(53%)
P9WNM4.1 (Mycobacterium tuberculosis CDC1551) E-value 2e-41,
Identities 78/151(52%)
Q9RFS6.1 (Burkholderia cepacia) E-value 8e-56, Identities
91/215(42%)
P65669.1 (Mycobacterium bovis AF2122/97) E-value 2e-39, Identities
88/200(44%)
Q73YC1.1 (Mycobacterium avium subsp. paratuberculosis K-10) Evalue 1e-80, Identities 187/539(35%)
P63874.1 (Mycobacterium bovis AF2122/97) E-value 3e-156, Identities
238/321(74%)
P9WP33.1 (Mycobacterium tuberculosis H37Rv) E-value 1e-31,
Identities 53/93(57%)
P9WHS1.1 (Mycobacterium tuberculosis H37Rv) E-value 2e-63,
Identities 94/136(69%)
P9WMN6.1 (Mycobacterium tuberculosis CDC1551) E-value 0.0,
Identities 265/395(67%)
NP_216851.1 (Mycobacterium tuberculosis H37Rv) was used for
searching the A. cellulolyticus genome
YP_177868.1 (Mycobacterium tuberculosis H37Rv) was used for
searching the A. cellulolyticus genome
YP_177762.1 (Mycobacterium tuberculosis H37Rv) was used for
searching the A. cellulolyticus genome
NP_215399.1 (Mycobacterium tuberculosis H37Rv) Evalue 2e-176,
Identities 237/372(64%)

Table S2 (con’t)
Locus tag, genome
Annotated gene product
coordinates (strand)
Acel_0709,
D-3-phosphoglycerate
serC
775135- 776727 (+)
dehydrogenase
3. Mycothiol biosynthesis genes
D-inositol 3-phosphate
Acel_0073,
mshA
glycosyltransferase (EC
78012-79358 (+)
2.4.1.250)
1D-myo-inositol 2-acetamido-2Acel_1868,
mshB
deoxy-alpha-D-glucopyranoside
2110571-2111449 (+)
deacetylase (EC 3.5.1.103)
L-cysteine:1D-myo-inositol 2Acel_1172,
amino-2-deoxy-alpha-DmshC
1301464-1302675 (+) glucopyranoside ligase (EC
6.3.1.13)
Gene

mshD

Acel_2026,
2299351-2300334 (+)

Mycothiol acetyltransferase (EC
2.3.1.189)
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Size
(aa)

MW
(kDa)

Closest sequence homolog in the Uniprot/Swissprot database using the
NCBI blastp search (default parameters)
YP_886720.1 (Mycobacterium smegmatis str. MC2 155) Evalue 0.0,
Identities 300/527(57%)

530

55.7

448

48.0

P9WMY7.1 (Mycobacterium tuberculosis H37Rv) was used for
searching the A. cellulolyticus genome, Evalue 3e-153, Identities
241/420(57%)

292

31.2

P9WJN3.1 (Mycobacterium tuberculosis H37Rv) was used for
searching the A. cellulolyticus genome, 8e-55, Identities 133/298(45%)

403

43.9

P9WJM9.1 (Mycobacterium tuberculosis H37Rv) was used for
searching the A. cellulolyticus genome, Evalue 2e-142, Identities
223/414(54%)

327

35.9

P9WJM7.1 (Mycobacterium tuberculosis H37Rv) was used for
searching the A. cellulolyticus genome, Evalue 5e-67, Identities
137/316(43%)

Table S3. Primers used in the study.
Locus_tag

Experiment

Forward and reverse primers
1.

Acel_0059

Cloning

Acel_0059

RT-PCR

Acel_1617

RT-PCR

Acel_1618

RT-PCR

Acel_1619

RT-PCR

Acel_1687

RT-PCR

Acel_2054

RT-PCR

2.
1.
2.
1.
2.
1.
2.
1.
2.
1.
2.
1.
2.

AAACCATGGCCAGACAGCAGGTACTCGTC (underlined
sequence is NcoI site)
AAACTCGAGTCAGGACCCGCTCCCCAGCTC (underlined
sequence is XhoI site)
GCCGACAGCGAAGAATGT
CTGAAATCGACGCCTGCT
CTGGTCGTTCTGCTTGTTGA
ATCACGGTATGGTCGCTGAT
GAATTTGAGCGTCCTGTGCT
CGGCGTCAATGTAGTCTTGA
TAGTAGGCAGGATCGGGAGA
GGTTCCTCATAGGGGTCGTC
GGCTTTGTCCCTGAGCTGTA
CGGTGGAGAGGTATTTCCAG
ACGACTTGGAAATCGGTGAG
AGAATTTCCCACCGTGTCTG
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Product
length
867 bp
108 bp
209 bp
220 bp
282 bp
238 bp
265 bp
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Figure S1. Effect of pH of culture medium on the expression of Acel_0059. A. cellulolyticus was
grown in LPBM medium that had been adjusted to different pH (5.00, 5.25, 5.75, or 6.00). Cells
were harvested at mid-exponential growth (OD 0.6) and total proteins were isolated. Total
proteins (30 µg) were separated on nUView 4-20% Tris-Glycine precast gel (NuSep) and
visualized using Biosafe Coomassie Brilliant Blue G-250 (BioRad). Lane M: Precision Plus
Protein Dual Color Standard (BioRad).
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Figure S2. Amount of HA in A. cellulolyticus culture supernatants. Cell free supernatants were
isolated from cultures at 7, 14, 23, 30, 37, 48 and 56 hours during growth in the presence of 1
mM HA (refer to Fig. 1 for bacterial growth). The amount of HA in the supernatants was
analyzed using High Performance Liquid Chromatography (HPLC, Hitachi Model l–400) using a
reverse-phase C-18 column and UV detector. A binary gradient of 2% aqueous acetic acid
(solvent A) and methanol (solvent B) was used at a flow rate of 1 mL min−1 and oven
temperature of 30°C. The following gradient of A in B (v/v) was used: 0–5 min = 100% A; 5–10
min = gradient 100–90% A; 10–15 min = 90% A; 15–20 min = gradient 90–80% A; 20–25 min
= 80% A; 25–40 min = gradient 80–40% A; 40–50 min = gradient 40–20% A. HA was detected
at at 254 nm. A calibration curve was generated using a range (0.125-2.0 mM) of HA standards.
HA concentration in the culture supernatants was calculated using the built-in software. Data
represent mean values with standard error from replicates.

48

U

I

U

A.

I

B.

Figure S3. Zymogram analysis of TST activity of Acel_0059. Partially purified proteins from
uninduced (U) and induced (I) cultures of ECRDL59 were separated on native gels and either
stained with Coomassie blue (panel A) or used for zymogram analysis (panel B). For zymogram
analysis, gel was incubated with reaction mixture at 70°C for 50 minutes to detect TST enzyme
activity (see methods for details). A white band resulting from the formation of CaSO3
precipitate in the zymogram indicates TST activity.
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Chapter 3
Whole transcriptome analyses of Acidothermus cellulolyticus 11B exposed to lignin and lignin
phenolic acids

3.1 Introduction
Acidothermus cellulolyticus 11B is a Gram-positive acidophilic, thermophilic and cellulolytic
rod-shaped bacteria belonging to the class Actinobacteria, order Actinomycetales and suborder
Frankineae. It is the only known species of the genus Acidothermus and family Acidothermaceae
[1]. A. cellulolyticus 11B (ATCC 43068) was first isolated from acidic hot springs at
Yellowstone National Park in a research program dedicated towards production of biofuels from
cellulosic biomass [2]. The 2.44 Mb genome of A. cellulolyticus consists of 2,157 protein coding
genes and has a high G+C content at ~66.9% [3]. A. cellulolyticus encodes for multiple plant cell
wall-degrading enzymes and is an important candidate for the conversion of lignocellulosic
biomass into biofuels.

Cellulose is the most prevalent biopolymer on earth, that can be broken down into simple sugars
which are further fermented to form ethanol. Ethanol that is obtained from cellulosic biomass has
the ability to decrease the need for petroleum fuel [4]. Lignocellulosic biomass serves as a
renewable and sustainable source of bioenergy; its effective and low cost enzymatic conversion
to simple sugars is essential for production of biofuels [5]. However, most of the bacteria that
can degrade cellulose are either not thermophilic or acidophilic or both [2]. Low pH and high
temperature conditions are prevalent in ethanolic fermentations [6]. For this reason, A.
cellulolyticus was isolated from acidic hot springs in an enrichment culture using specific
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criteria: pH range: 3-6, temperature range: 50-60°C, and the ability to degrade cellulose [2]. The
A. cellulolyticus genome encodes for 17 plant cell-wall-degrading enzymes, and 10 fungal cellwall degrading enzymes [3]. The hyperthermostable enzymes from this organism exhibit high
specificity to their substrates and are of commercial interest in microbial lignocellulosic
deconstruction [7-11]. Heterologous expression of its enzymes in hosts such as transgenic rice
seeds, tobacco, maize, yeast etc., has been suggested to create bio-ethanol without addition of
any exogenous enzymes in the process [12-16].

A major barrier to the production of biofuels from lignocellulosic biomass is biomass
recalcitrance, the natural resistance of plant cell walls to microbial deconstruction [17].
Lignocellulose consists of three components: cellulose, hemicellulose and lignin. Lignin binds
the cellulose and hemicellulose fractions together in a hydrophobic network, and therefore,
hinders their accessibility to enzymatic hydrolysis. Therefore, a harsh physical pretreatment
aimed at solubilizing and separating the cellulose, hemicellulose and lignin fractions is required
for lignocellulose breakdown [18]. The pretreatment releases lignin-derived phenolic compounds
into the hydrolysate [19]. Both complete lignin and lignin-derived phenolic compounds hamper
enzyme hydrolysis and reduce sugar yields [19-21]. The lignin phenolic acids have been found to
be much more toxic than other pretreatment inhibitors due to hydrophobicity associated
membrane damage and irreversible inhibition of enzymes [22-25]. In A. cellulolyticus, the
presence of phenolic monomers was shown to reduce growth and enzyme activity yield [26]. The
ability to deconstruct plant biomass without the use of conventional pretreatment methods is an
important attribute for any organism being considered for biofuel production [27].
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If A. cellulolyticus can survive in the presence of lignin, it could be used as a whole-cell
biocatalyst for the production of biofuel from cellulosic biomass at high rate. Understanding and
reducing the inhibition due to phenolics is important in improving the efficiency of
bioconversion of lignocellulose [19]. Regulation of gene expression is an adaptive response
which ensures that appropriate proteins are expressed in response to environmental stresses or
changing metabolic conditions [28]. Transcriptional profiling is a useful tool that could be
employed at understanding global molecular targets affected by a stress and the mechanisms by
which organisms adapt to a particular stress [29, 30]. This technique has been used to understand
the genomic response of ethanologenic strain Zymomonas mobilis ZM4 to the phenolic aldehyde
inhibitors derived from lignocellulose pretreatment. The study identified several reductases and
transporters as potential phenolic aldehydes-tolerant genes [31]. Similar studies aimed at
understanding the molecular stress response mechanism in Z. mobilis, revealed the importance of
simultaneous regulation of carbohydrate metabolism, DNA replication, recombination and
repair, transcriptional regulation, and universal stress responses etc. in providing tolerance to
pretreatment inhibitors [32-35].

Transcriptomic studies of Saccharomyces cerevisiae strains exhibiting improved tolerance to
lignocellulose derived inhibitors, revealed 52 genes potentially associated with stress response to
inhibitors. These included genes functioning in cell wall and membrane stability, fatty acid
metabolism, cellular metabolism (alcohol and aldehyde dehydrogenases, glyceraldehyde-3phosphate dehydrogenase), several multidrug transporters, and oxidative and DNA stress
response genes. [36]. Ferulic acid, a lignin derived phenolic acid, has been shown to induce the
expression of the mar regulon efflux-system genes, and heat shock response genes in E. coli
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[37]. DNA microarray analyses of the Clostridium beijerinckii NCIMB 8052, revealed the downregulation of two-component systems and strong upregulation of efflux systems, heat shock and
redox reaction proteins in response to ferulic acid [38]. In this study, we discuss the genomewide gene expression induced by lignin and lignin-derived phenolic compounds in A.
cellulolyticus. The information on the genes involved in providing tolerance to these inhibitory
compounds could be used to develop strategies to enhance A. cellulolyticus survival in the
presence of such inhibitors.

3.2 Materials and methods
3.2.1 Bacteria, media and growth conditions. A. cellulolyticus was grown in low phosphate
basal salts medium (LPBM). The medium contained 1 g/L NH4C1; 0.1 g/L Na2HPO4.7H2O; 1
g/L KH2PO4; 0.2 g/L MgSO4.7H2O; 0.2 g/L CaCl2.2H2O; 0.5 g/L yeast extract; 5/L g Dcellobiose [10]. The phenolic acid, 4-hydroxybenzoic acid (HA), was prepared as 1 M stock in
dimethyl sulfoxide (DMSO), filter sterilized, and added to the sterilized growth medium at 1 mM
final concentration. An equimolar mixture of five different phenolic acids (PA) i.e. 4hydroxybenzoic acid (HA), vanillic acid (VA), coumaric acid (CA), syringic acid (SA) and
ferulic acid (FA) was prepared at 0.5 M stock in DMSO, filter sterilized, and added to the
sterilized growth medium at 0.5 mM final concentration. Lignin was added to the media at
0.01% (w/v), and sterilized along with media by autoclaving. The pH of all media was adjusted
to 5.5 by the addition of either 10% phosphoric acid or 10 N NaOH. Growth was measured using
optical density at 600 nm (OD600).
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3.2.2 RNA extraction and mRNA enrichment. Total RNA was extracted from A. cellulolyticus
cultures using RNeasy Plant Mini kit (Qiagen). In case of phenolic acid treatments, 200 ml
culture containing either HA or PA was grown for 37 hours. In case of control, 100 ml culture
was grown for 20 hours. Cells were harvested by centrifugation at 15,000 g for 15 minutes. For
lignin treatment, 200 ml culture containing lignin was grown for 37 hours. The lignin was
separated from cell culture by allowing the culture to stand for 10 minutes followed by
centrifugation of supernatant at 100 g for 2 minutes. Approximately, 150 ml lignin-free culture
was centrifuged at 15,000 g for 15 minutes to harvest cells. The cell pellets were immediately
frozen and ground to powder using liquid nitrogen, and RNA was isolated using manufacturer’s
instructions. The isolation included two rounds of on-column treatments with RNase-Free DNase
(Qiagen) to remove any remaining genomic DNA. RNA was quantified using Qubit RNA HS
Assay Kit and Qubit 2.0 Fluorometer (Life Technologies).

The total RNA was further processed for mRNA enrichment using MICROBExpress kit
(Ambion, Life Technologies) according to manufacturer’s protocol. Briefly, 3.4 µg of total RNA
was treated with a binding buffer. Oligonucleotides present in the buffer hybridized to
homologous regions in rRNAs. The rRNA-bound oligonucleotides were then bound to magnetic
beads and the complex was captured on a magnetic stand. The supernatant (~350 µl) containing
enriched mRNA was aspirated and further purified using the Agencourt RNAClean XP system
(Beckman Coulter). 40 µl of purified enriched mRNA obtained was quantified using Qubit RNA
HS Assay Kit and Qubit 2.0 Fluorometer (Life Technologies). The depletion of rRNA was
verified using 2100 Bioanalyzer (Agilent) and Agilent RNA ScreenTape system (Agilent
Technologies). The RNA was stored at -80° until use.
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3.2.3 cDNA library preparation. The template library was prepared from mRNA using the
TruSeq Stranded mRNA LT Sample Preparation kit (Illumina) following the TruSeq Stranded
mRNA Sample Preparation Guide (Illumina). Approximately 100 ng of purified mRNA was
denatured, fragmented and primed using random hexamers (Illumina) for cDNA synthesis by
reverse transcriptase. The first strand cDNA was then synthesized from the primed mRNA using
SuperScript II Reverse Transcriptase (ThermoFisher Scientific) and First Strand Synthesis Act D
mix (Illumina). The mix contained random primers and Actinomycin D to specifically allow only
RNA-dependent synthesis. The RNA template was removed and first strand cDNA was used as a
template for second strand cDNA synthesis using DNA polymerase I and RNase H present in the
Second Strand Master Mix (Illumina). The blunt ended double stranded cDNA obtained was
purified using Agencourt AMPure XP beads (Beckman Coulter). The cDNA was adenylated at
3’ ends and ligated with indexing adapters containing complementary ‘T’ nucleotide. For control
samples, Adapter index 6 (AR006; GCCAAT) was used, and for treatment samples (HA, PA or
lignin), Adapter index 12 (AR012; CTTGTA) was used.

The adapter ligated cDNA was purified using AMPure XP beads and selectively amplified
through PCR using adapter specific primers present in PCR Primer Cocktail (Illumina). The PCR
products were purified using AMPure XP beads and enriched DNA library was quantified using
Qubit dsDNA BR Assay Kit and Qubit 2.0 Fluorometer (Life Technologies). The quality and the
average library size for each sample were analyzed using 2100 Bioanalyzer (Agilent) and
Agilent High Sensitivity D1K ScreenTape system (Agilent Technologies).
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3.2.4 Denaturation, normalization, pooling of libraries and sequencing on the MiSeq. The
libraries were prepared for sequencing according to the ‘Preparing Libraries for Sequencing on
MiSeq Guide’ (Illumina). The concentration of libraries in nano molar (nM) were calculated
using the following formula:
!"# %&'%(')*+),&' ('.) =

%&'%(')*+),&' ('1⁄µ2)
× 10A
4660 (1⁄7&2) × #9(*+1( 2,:*+*; <,=( (:>)?

A 4 nM of treatment (HA, PA or lignin) DNA library was pooled with 4 nM of the
simultaneously prepared respective control library. The pooled libraries were then denatured
using 0.2 N NaOH. This resulted in dilution of the denatured libraries to a final concentration of
20 pM DNA library in 1 mM NaOH. A PhiX control was used to balance for the low diversity
libraries. The 10 nM PhiX library (Illumina) was diluted and denatured as described above,
resulting in 20 pM PhiX library. The recommended PhiX control spike-in of 5% was prepared by
addition of 30 µl 20 pM PhiX library to 570 µl 20 pM sample library. The MiSeq Reagent Kit
v2, 250 cycles (Illumina) was used and the libraries were sequenced on the MiSeq platform
(Carbonero lab).

3.2.5 Sequence assembly and analysis. The sequencing results were output to BaseSpace
(Illumina) and generated intermediate analysis files in the FASTQ format. The files containing
base calls and quality values per read for each sample in the BaseCalls folder
(Data/Intensities/BaseCalls) (Illumina) were then exported to a local computer. The FASTQ files
for each sample including both reads 1 and 2 (reverse complemented) were uncompressed using
7-zip (Copyright(C) 2018 Igor Pavlov) and further used for secondary analysis. The undetermined
reads containing mostly PhiX reads and unindexed reads were not used for the downstream
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analyses. The reads were mapped onto A. cellulolyticus 11B backbone using SeqMan NGen
(DNAStar, Madison, WI, USA). The GenBank file containing reference genome for the
complete sequence of A. cellulolyticus 11B (NC_08578.gbk) was obtained from NCBI FTP
(ftp://ftp.ncbi.nlm.nih.gov/). Assembly was performed on a local computer by launching SeqMan
NGen using Transcriptome/RNA-seq workflow. The mapping of sequence reads onto the
reference genome was then performed using the default settings for haploid genome with few
changes (merSkipQuery:2; maxGap: 25; minDepth: 5; pNotRef: 75). The data for control and
treatment were run as separate assemblies.

The RNA-seq assemblies generated were analyzed using ArrayStar (DNASTAR, Inc., Madison,
USA). All assemblies generated using SeqMan NGen were combined at this step for analysis.
The replicates were grouped together at this step. The ‘Mean’ was used as the averaging method
for replicates. The processing was done using QSeq to quantify gene expression. The entire data
set was normalized by assigning the number of reads per kilobase of template coding sequence
per million mapped reads (RPKM). Gene expression levels were obtained based on log2 fold
change values, and significant differences in expression were determined using the Student t-test
(linear correlation) with threshold set at p £ 0.01, 0.05 or 0.10. Multiple testing correction for
false discovery rate was based on Benjamini-Hochberg procedure in ArrayStar [39]. The heat
map showing gene expression for all four experiments (control, HA, PA and lignin) was obtained
using hierarchical clustering, Euclidean (distance metric) and centroid (fast) linkage method in
ArrayStar. The scatter plots showing log2 expression levels of all genes compared to control
were generated using ArrayStar. The genes whose expression was consistently up or
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downregulated among different treatments at ³ 2-fold change and p £ 0.05 were used for further
downstream analyses.

3.2.6 Hierarchical clustering of genes. Hierarchical clustering of the gene expression data was
performed using Gene Cluster 3.0 [40]. The gene expression data as fold change of HA, PA and
lignin with respect to control was obtained from ArrayStar. The fold change values were log2
transformed before clustering. The genes were centered on mean and normalized to represent
relative gene expression by subtracting mean values for a gene from each treatment. The genes
were clustered with calculated weight at 0.4 cutoff, using centered Pearson correlation as the
similarity metric, and centroid-linkage clustering method for clustering. The *.cdt file produced
was visualized by Java Treeview to generate dendrogram and to obtain the list of genes that
cluster together [41].

3.3 Results
3.3.1 Sequencing analysis and differentially expressed genes. The mRNA enrichment by
rRNA depletion from total RNA samples is shown in Fig. S1. The average library size of cDNA
libraries that were prepared from mRNA-enriched samples ranged between 236-280 bp (Fig. S2).
Denatured, normalized and pooled libraries were sequenced using the Illumina MiSeq platform.
The sequencing generated close to 50 million reads for most of the samples. The quality scores
for the runs ranged around 90% and the percent reads identified ranged around 96%. The run
information is provided in Table 1. The ArrayStar generated heat map displaying four
experiments (control, HA, PA, lignin) clustered by similarities among their gene-expression
profiles showed that the HA and PA were more similar to each other, while the expression
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profile of lignin was more similar to control (Fig. S3).Scatter plots showing gene expression
pattern in each treatment compared to control are shown in Fig. S4. The Cross R2 feature from
ArrayStar was used to perform R2 statistical test for all pairwise combinations of experiments.
The R2 value ranges between 0.0-1.0 and is a statistical measure of how close the data are to the
fitted regression line, with the value of 1.0 indicating that the gene expression profile of the two
treatments is same. The R2 values across the four experiments are presented in Table 2. With
respect to control, the lignin-dependent gene expression profile was most similar (0.813),
followed by HA (0.785) and PA (0.753). Among the three treatments, HA shared more similarity
with PA (0.873) than with lignin (0.709).

The number of significantly differentially expressed genes among each treatment with respect to
control at ³ 2-fold change, ³ 4-fold change and ³ 8-fold change with p £ 0.01, p £ 0.05 or p £
0.10 are shown in Table 3. The differentially expressed genes at ³2-fold change, p £ 0.05 were
used for further analysis. These included 470 genes from HA treatment, 521 genes from PA
treatment and 559 genes from lignin treatment (Table 4a). Of these, 225 genes, 168 genes and
448 genes were upregulated in HA, PA and lignin, respectively (Table 4b); and 245 genes, 353
genes and 111 genes were downregulated in HA, PA and lignin, respectively (Table 4c). Among
the differentially expressed genes: 99 genes were common among all three treatments; 184 genes
were common between HA and PA; 81 genes were common between PA and lignin; 45 genes
were common between HA and lignin (Figure 1a). Among the upregulated genes: 38 genes were
common among all three treatments; 53 genes were common between HA and PA; 39 genes
were common between PA and lignin; 26 genes were common between HA and lignin (Figure
1b). Among the downregulated genes: 43 genes were common among all three treatments; 142
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genes were common between HA and PA; 39 genes were common between PA and lignin; 1
gene was common between HA and lignin (Figure 1c). Most number of genes were upregulated
in lignin followed by HA and then PA (Figure 1b). However, PA showed the most number of
downregulated genes, followed by HA and then lignin (Figure 1c). The list of genes consistently
up or downregulated among all the three treatments (HA, PA and lignin) are provided in Table 5
and 6, respectively.

3.3.2 Upregulated operons and pathways. All of the upregulated genes were analyzed to check
if multiple genes present in the same putative operon were upregulated. Genes with ³ 2 fold
change in a treatment compared to control with p £0.05 were selected for operon prediction.
Putative operons were identified under the criterion where participating genes were located with
£40 bp intergenic distance among genes, being transcribed in same direction. Most of the
putative operons identified, contained genes with intergenic distance £15 bp. Table 7 shows the
list of upregulated putative operons, in which at least two of the genes in a putative operon were
upregulated in at least one of the treatments. Some of upregulated putative operons genes code
for: thiosulfate sulfurtransferase and its regulators (Acel_0059-Acel_0060); sulfur assimilation
pathway proteins (Acel_1616-Acel_1619; Acel_1685-Acel_1689; Acel_2053-Acel_2055); MarR
family regulators and MFS transporters (Acel_0109-Acel_0110; Acel_0112-Acel_0114;
Acel_0606-Acel_0607; Acel_1889-Acel_1890); thioredoxin thiol transporter and redox sensing
proteins (Acel_0236-Acel_0239; Acel_0541-Acel_0542; Acel_0700-Acel_0703; Acel_1103Acel_1104; Acel_2053-Acel_2055); TetR regulators (Acel_1435-Acel_1437); glycoside
hydrolases and sugar breakdown enzymes (Acel_0579-Acel-0582); sigma factors (Acel_0057-
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Acel_0058; Acel_0350-Acel_0351; Acel_0538-Acel_0539; Acel_1410-Acel_1412). Most of the
genes present in these operons were upregulated by at least of the treatments.

KEGG pathway annotations were used to assign pathways to upregulated genes. Of the 2157
predicted protein coding genes and 53 RNA genes, only 832 genes were annotated with KEGG
pathways. Out of the 647 total upregulated genes, only 229 genes were assigned pathway
annotations. Based on these annotations it was observed that 62 pathways were upregulated (out
of 109 annotated pathways) in at least one of the treatments. List of upregulated pathways
containing at least three upregulated genes is provided in Table 8. Table 8 lists the number of
genes upregulated and the total number of genes annotated for the upregulated pathways.
However it should be noted that these results are not highly reliable. Since not all the genes in a
particular pathway are annotated for A. cellulolyticus and only 229 genes out of 647 upregulated
genes have been annotated, there could be bias introduced in the results due to lack of all genes
being annotated for a pathway and some of the genes being assigned to multiple pathways.

3.3.3 Hierarchical clustering of genes. Hierarchical clustering of genes based on fold change in
expression in HA, PA and lignin treatments with respect to control was performed using either
the gene expression data from all the genes (Fig. 2) or from gene expression data of significantly
differentially expressed genes (³2-fold change, p £ 0.05) (Fig. 3). The clustering pattern was
similar in both cases, wherein, the transcriptome response of HA and PA was more related than
lignin. The clustering profile obtained after clustering of significantly differentially expressed
genes (Fig. 3) was further analyzed to select gene clusters of interest. The fold upregulation in
gene expression in a treatment compared to control was referred to as positive expression, and
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the fold downregulation in gene expression in a treatment compared to control was referred to as
negative expression. Eleven clusters of interest were selected (Fig. S5). Cluster 1 consisted of 25
genes showing positive expression for PA, negative expression for HA and lignin. Some of the
genes present in Cluster 1 are predicted to code for betaine-aldehyde dehydrogenase
(Acel_1100), catecholic dioxygenase (Acel_1101), 5-carboxymethyl-2-hydroxymuconate
isomerase (Acel_1102), ferredoxin (Acel_1103), FAD-dependent pyridine nucleotide-disulfide
oxidoreductase (Acel_1104), DNA topoisomerase (Acel_1105), serine/threonine protein kinase
(Acel_0931), L-glutamine synthetase (Acel_1096), acetoacetate decarboxylase (Acel_1097),
AsnC family transcriptional regulator (Acel_1286), tellurium resistance protein TerC
(Acel_0869), holliday junction resolvase RuvX (Acel_1329), glycoside hydrolase family protein
(Acel_1701). The genes Acel_1100-Acel_1102, Acel_1103-Acel_1104 occur in an operon (Table
7).

Cluster 2 consisted of 27 genes showing positive expression for HA and PA, negative expression
for lignin. Some of the genes present in Cluster 2 are predicted to code for glycosyl hydrolase
family 5 (Acel_0135), thioredoxin family protein (Acel_0241), glycosyltransferase family 28
protein (Acel_0478), N-acetylglucosamine-6-phosphate deacetylase (Acel_0557), Cupin 2,
conserved barrel domain protein (Acel_0692), nicotinate-nucleotide-dimethylbenzimidazole
phosphoribosyltransferase (Acel_0940), UDP-N-acetylmuramate--L-alanine ligase (Acel_1011),
DNA-binding protein (Acel_1589), two-component sensor histidine kinase (Acel_1605), DNAbinding response regulator (Acel_1606), DNA-binding response regulator (Acel_1765), amino
acid permease (Acel_1853), ECF subfamily RNA polymerase sigma-24 factor (Acel_2057). The
genes Acel_1605-Acel_1606 occur in an operon (Table 7). Cluster 3 (15 genes) and Cluster 4 (33
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genes) consisted of genes showing positive expression for HA, negative expression for PA and
lignin. Some of the genes present in Cluster 3 are predicted to code for nitrilase/cyanide
hydratase and apolipoprotein N-acyltransferase (Acel_0030), phosphoketolase (Acel_0531),
ABC transporter-like protein (Acel_0888), carboxymuconolactone decarboxylase (Acel_0891),
TPP-dependent acetoin dehydrogenase complex (Acel_1047), ABC transporter (Acel_1131),
WYL domain-containing protein (Acel_1201), membrane protein (Acel_1212), N-acetyl-gammaglutamyl-phosphate reductase (Acel_1263), MBL fold hydrolase (Acel_1997).

Some of the genes present in Cluster 4 are predicted to code for phosphomethylpyrimidine
synthase (Acel_0052), phospholipid carrier-dependent glycosyltransferase (Acel_0172), DNAbinding response regulator (Acel_0365), acyl-CoA dehydrogenase (Acel_0405), TraR/DksA
family transcriptional regulator (Acel_0537), nitrate/sulfonate/bicarbonate ABC transporter
protein (Acel_0889), oxidoreductase (Acel_0896), 6-phosphogluconate dehydrogenase
(Acel_0898), ABC transporter (Acel_0910), cell wall anchor domain-containing protein
(Acel_0946), WYL domain-containing protein (Acel_1200), dolichol-phosphate
mannosyltransferase (Acel_1211), transcriptional regulator (Acel_1346), heavy metal transport
protein (Acel_1651), PadR family transcriptional regulator (Acel_2137), inositol-3-phosphate
synthase (Acel_2138). Cluster 4 consisted of several ABC transporter coding genes.

Cluster 5 consisted of 53 genes showing positive expression for HA and lignin, negative
expression for PA. Some of the genes present in Cluster 5 are predicted to code for RNA
polymerase sigma factor SigL (Acel_0057), D-inositol-3-phosphate glycosyltransferase
(Acel_0073), MFS transporter (Acel_0458), (4Fe-4S)-binding protein (Acel_0499), RNA
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polymerase subunit sigma-24 (Acel_0538), mycothiol system anti-sigma-R factor (Acel_0539),
ABC transporter permease (Acel_0580), manganese transporter (Acel_0596), 2-oxoacid:acceptor
oxidoreductase subunit gamma (Acel_0700), 2-ketoisovalerate ferredoxin oxidoreductase subunit
alpha (Acel_0701), nitrate ABC transporter substrate-binding protein (Acel_0893), innermembrane translocator (Acel_0908), ABC transporter protein (Acel_0909), Fe-S cluster
assembly protein SufB (Acel_1135), Fe-S cluster assembly protein SufD (Acel_1136), Fe-S
cluster assembly scaffold protein NifU (Acel_1139), metal-sulfur cluster biosynthetic enzyme
(Acel_1140), cysteine synthase (Acel_1687). The genes Acel_0538-Acel_0539, Acel_0700Acel_0701 occur in an operon (Table 7). Cluster 5 consisted of multiple genes coding for ABC
transporters and Fe-S cluster containing proteins.

Cluster 6 consisted of 28 genes showing positive expression for PA and lignin, negative
expression for HA. Some of the genes present in Cluster 6 are predicted to code for
phosphoribosyltransferase (Acel_0137), glycosyl transferase family protein (Acel_0460), FADdependent oxidoreductase (Acel_0569), quinone oxidoreductase (Acel_0584), MFS transporter
(Acel_0724), glutamine amidotransferase (Acel_1094), type II secretion system protein
(Acel_1737), type II secretion system protein F (Acel_1738), dihydropteroate synthase
(Acel_1839), hybrid sensor histidine kinase/response regulator (Acel_1873).

The Cluster 7 (78 genes), Cluster 8 (17 genes), Cluster 9 (22 genes) and Cluster 10 (34 genes)
consisted of genes showing positive expression for lignin, negative expression for HA and PA.
Some of the genes present in Cluster 7 are predicted to code for chloride channel protein
(Acel_0041), OsmC family protein (Acel_0042), phosphate ABC transporter permease subunit
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PstC (Acel_0092), phosphate ABC transporter, permease protein PstA (Acel_0093), adenine
glycosylase (Acel_0221), glutamate-1-semialdehyde 2,1-aminomutase (Acel_0231), anti-sigma
factor (Acel_0351), diaminopimelate decarboxylase (Acel_0629), homoserine kinase
(Acel_0632), pyruvate ferredoxin oxidoreductase (Acel_0702), 3-isopropylmalate dehydrogenase
(Acel_0710), sugar ABC transporter (Acel_0719), flagellar biosynthesis protein FlgN
(Acel_0833), flagellar FlbD family protein (Acel_0850), ferredoxin-NADP reductase
(Acel_0866), mannitol dehydrogenase (Acel_0905), (Fe-S)-cluster assembly protein (Acel_1433),
oxidoreductase (Acel_1454), MFS transporter (Acel_1922), hydroxyglutarate oxidase
(Acel_1941), 4'-phosphopantetheinyl transferase (Acel_1943), trehalose-6-phosphate synthase
(Acel_1953), DNA starvation/stationary phase protection protein (Acel_2007). The genes
Acel_0092-Acel_0093 occur in an operon (Table 7).

Some of the genes present in Cluster 8 are predicted to code for sulfate ABC transporter ATPbinding protein (Acel_0192), delta-aminolevulinic acid dehydratase (Acel_0235), UDP-Nacetylenolpyruvoylglucosamine reductase (Acel_0291), ABC transporter-like protein
(Acel_0421), ATP synthase subunit gamma (Acel_0652), DNA polymerase III subunit delta
(Acel_0775), alanine dehydrogenase (Acel_1288), NADH dehydrogenase (Acel_1902),
thymidylate kinase (Acel_1971). Some of the genes present in Cluster 9 are predicted to code for
phosphoserine aminotransferase (Acel_0114), DNA helicase PcrA (Acel_0375), cell enveloperelated transcriptional attenuator (Acel_0411), flagellar hook-associated protein FlgK
(Acel_0832), ABC transporter (Acel_1050), dihydropyrimidine dehydrogenase subunit A
(Acel_1079), WhiB family transcriptional regulator (Acel_1779), MarR family transcriptional
regulator (Acel_1889), metal ABC transporter (Acel_2087). Some of the genes present in Cluster
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10 are predicted to code for cell division protein FtsI (Acel_0020), cell division protein
(Acel_0021), beta-N-acetylhexosaminidase (Acel_0072), MFS transporter (Acel_0113), shortchain dehydrogenase/reductase SDR (Acel_0571), D-beta-D-heptose 1-phosphate
adenosyltransferase (Acel_0720), DNA-binding protein (Acel_1194), ABC-2 type transporter
(Acel_1368), polar amino acid ABC transporter permease (Acel_1640), malate dehydrogenase
(Acel_1647), beta-glucosidase (Acel_1659), pyridine nucleotide-disulfide oxidoreductase
(Acel_1745), MFS transporter (Acel_1747), ABC transporter ATP-binding protein (Acel_1769),
MarR family transcriptional regulator (Acel_2084). No pattern of gene functions could be found
among gene clusters showing positive expression specifically in lignin (Clusters 7-10).

Cluster 11 consisted of 52 genes showing positive expression for HA and lignin, negative
expression for lignin. Some of the genes present in Cluster 11 are predicted to code for
magnesium transporter CorA (Acel_0053), deferrochelatase/peroxidase EfeB (Acel_0190),
GNAT family N-acetyltransferase (Acel_0520), ABC transporter ATP-binding protein
(Acel_0540), zinc permease (Acel_0605), ABC-2 type transporter (Acel_0745), ABC transporter
(Acel_0746), ferredoxin (Acel_0803), riboflavin synthase subunit alpha (Acel_1273), peptide
deformylase (Acel_1279), glycosyl hydrolase family 32 protein (Acel_1363), oxidoreductase
FAD-binding subunit (Acel_1439), 30S ribosomal protein S15 (Acel_1509), ribosome-binding
factor A (Acel_1513), two-component sensor histidine kinase (Acel_1594), peroxiredoxin
(Acel_1608), xanthine dehydrogenase (Acel_1631), ferredoxin (Acel_1637), carbonic anhydrase
(Acel_1672), glyceraldehyde 3-phosphate reductase (Acel_1715), nitrite reductase large subunit
(Acel_1744), sugar ABC transporter substrate-binding protein (Acel_1806), thioredoxin domain-
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containing protein (Acel_1883), acetyltransferase (Acel_1935), NAD-dependent epimerase
(Acel_1936), thioredoxin-disulfide reductase (Acel_2148).

3.4 Discussion
Plant phenolic acids bind the complex lignin polymer to the hemicellulose and cellulose in the
plant cell wall [42]. These are benzene ring compounds with one or more hydroxyl groups, that
play important role in plant development, structural integrity and protection against stress by
killing microorganisms [43]. Enzymatic hydrolysis or industrial pre-treatments are employed to
separate and degrade the cell wall. As a result, phenolic acids such as ferulic, p-coumaric, caffeic
acids etc. are released as free acids [42, 44]. These are natural toxins that have been shown to
inhibit growth and lead to specific stress responses in microorganisms [22, 45]. The amounts of
phenolic compounds present in switchgrass, a lignocellulosic substrate, have been found to be
higher than the threshold for growth inhibition in A. cellulolyticus [46]. Both lignin and ligninrelated phenolic acids are toxic to cell, however, the mechanism of toxicity could be different. It
is important to understand how lignin and its phenolic acid derivatives affect the cell, in order to
develop strategies to enhance adaptation or confer resistance against these compounds.

We looked at the gene expression profiles of A. cellulolyticus upon exposure to sub-lethal
concentrations of HA, PA and lignin. Lignin showed the most number of differentially expressed
genes at ³2-fold change (p£0.05), followed by PA and then HA. This is correlated with the
structural complexity of these compounds. However, the transcriptomic profiles of HA and PA
were more related to each other than lignin (Fig. S3). The gene expression profile of lignin was
more similar to control (Fig. S3). Our preliminary growth studies showed that HA and PA were
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more toxic than lignin. Qin et al. observed that lignin-blocking agents such as calcium chloride
and BSA had no effect the inhibition effect of phenolics, indicating that inhibition mechanism of
phenolics on cell wall degrading enzymes is different from lignin [19]. The authors suggested
that this could be due to the dispersity and multiple binding sites of phenolics than insoluble
lignin.

It has been shown that low molecular weight phenolic compounds are more inhibitory to the
fermentation of lignocellulosic biomass [47]. Our studies showed that out of the five phenolic
acids tested, HA with the lowest molecular weight was most toxic to A. cellulolyticus cultures
(Chapter 1). Based on its abundance in lignocellulosic hydrolysate and inhibitory effect on
fermentation, HA has previously been used as a model to study the influence of phenolic
compounds on fermentation [48-50]. Therefore, it was chosen as a representative single phenolic
acid tested. Our preliminary growth studies showed that combination of five different phenolic
acids (PA) was more inhibitory than inhibition by each individual phenolic acids, suggesting a
synergistic effect on toxicity. Similar observations were seen in E. coli, where the combination
of fermentation inhibitors: acetic acid, aromatic aldehydes and alcohols, 2-furfural and furfuryl
alcohol was shown to increase the inhibitory potential of these compounds [22-24].

Understanding of the mechanism of inhibition might provide clues to the factors functioning in
relieving the inhibition. The mechanism of cytotoxicity of phenolic acids and several other
pretreatment byproducts, has been proposed to involve enzyme inhibition, intracellular pH
imbalance, DNA damage, membrane disruption and interference with the function of
intracellular hydrophobic targets [51, 52]. It has been reported that within the same phenol
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functional group, the inhibition depends on the amount of methoxyl substituents and thus
hydrophobicity, as the hydrophobic parts of proteins, enzymes, and membrane transport systems
are possible targets for inhibitory action [53]. Phenolic compounds have been shown to partition
into biological membranes and cause loss of membrane integrity, dissipation of proton/ion
gradients and compromising the ability of cellular membranes to act as selective barriers [54].
Membrane disruption leads to release of proteins, RNAs, ATP, ions, out of the cytoplasm,
consequently causing reduced ATP levels, diminished proton motive force and impaired protein
function and nutrient transport [54]. A means to cope up with these phenolic acids could be the
membrane proteins and membrane related efflux proteins that could act as a protective barrier
against the influx of inhibitory compounds and/or their efflux through the plasma membrane
[55]. Lignin upregulated genes coding for proteins that reside in membrane: membrane protein
(Acel_0347), inner membrane translocator (Acel_0352), integral membrane protein (Acel_1955),
membrane protein (Acel_2110). The homologs of Acel_0347 are predicted to be a putative drug
exporter of the RND superfamily. The Acel_0352 is predicted to be a monosaccharide ABC
transporter membrane protein. The homologs of Acel_1955 are predicted to be EamA
drug/metabolite family transporter. The homologs of Acel_2110 are predicted to be homologs of
DoxX family membrane proteins with an unknown function. An inner membrane translocator
(Acel_1130) was upregulated in an operon along with ABC transporters (Acel_1129-Acel_1131)
(Table 7). These genes are predicted to be involved in sugar transport.

Efflux system of living cells is an efficient mechanism for detoxification of external toxic
compounds and internal damaging intermediates [31]. We found a number of transporters
upregulated in the presence of HA, PA and lignin. These included ATP-dependent transporters,
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secondary transporters and few ion channels. A number of genes coding for proteins of ATPBinding Cassette (ABC) superfamily were upregulated: Acel_1360, Acel_0540 (Upregulated in
HA and PA); Acel_0558, Acel_0577, Acel_0906, Acel_1119, Acel_1131, Acel_1132, Acel_1142,
Acel_1281, Acel_1414 (Upregulated in HA); Acel_0093, Acel_0094, Acel_0192, Acel_0193,
Acel_0352, Acel_0434, Acel_0578, Acel_0580, Acel_0597, Acel_0719, Acel_1050, Acel_1055,
Acel_1368, Acel_1626, Acel_1769 (Upregulated in lignin). Among these, sulfate ABC
transporter ATP-binding protein (Acel_0192), ABC-2 type transporter (Acel_0193), ABC
transporter ATP-binding protein (Acel_1055), ABC transporter (Acel_1142), ABC-2 type
transporter/ Transport permease protein (Acel_1368), ABC transporter related protein
(Acel_1414) are multi-drug resistance ABC transporters. Multidrug resistance efflux pump
assemblies have been shown to be involved in active efflux of xenobiotics, antibiotics,
antiseptics, cationic dyes etc. has been shown to involve [56].

The rest of the upregulated ABC transporter genes code for carbohydrate transporters
(Acel_1360, Acel_0558, Acel_0577, Acel_1131, Acel_1132, Acel_0352, Acel_0434, Acel_0578,
Acel_0580, Acel_0719, Acel_1050), amino acid/amide transporter (Acel_0906),
oligopeptide/dipeptide transporter (Acel_1119), phosphate transporters (Acel_0093, Acel_0094),
thiol reductant ABC exporter subunit (Acel_0597). Phenolic acids and other secondary
metabolites from plants have been shown to inhibit ABC transporters and thereby reversing the
resistance of microorganisms to antimicrobial agents [57]. We observed that several genes
coding for ABC transporters being downregulated in the presence of HA, PA and lignin (Table
6). Owing to their lipophilicity, plant phenolics have been predicted to act as substrates, resulting
in competitive inhibition by direct binding or complex formation with ABC transporters [57].
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Membrane permeabilization and efflux pump inactivation have been proposed to contribute to
antibacterial and anti-biofilm synergy of phenolic-rich maple syrup extract [58].

Cytoplasmic membrane acts as a selectively permeable barrier for small ions whose gradient
between the intra- and extracellular environment functions in the regulation of cytoplasmic pH
and generation of energy [59]. Vanillin, the aldehyde form of vanillic acid, has been shown to
cause partial disruption of K+ gradients in E. coli MC1022 membranes, leading to loss of ion
gradients [59]. A few ion channels were found to be induced: ammonia channel protein
(Acel_1566), cation transporter (Acel_1221) were upregulated in lignin; potassium transporter
(Acel_1398) was upregulated in HA; anion permease (Acel_1957) was upregulated in HA and
PA. In addition to ion channels, bacterial cells have been shown to maintain intracellular pH by
the activation of an amino acid decarboxylase coupled with an antiporter. Amino acid
decarboxylases (lysine, arginine, glutamate, histidine) are greatly induced under acidic
conditions and are hypothesized to play a role in pH homeostasis [60-63]. These pump in amino
acids and pump out respective decarboxylated products which results in the expulsion of ions,
e.g. 2H+ molecules per decarboxylated product in case of glutamate, leading to increase in
intracellular pH [63]. Upregulation of aromatic acid decarboxylase (Acel_0257), acetoacetate
decarboxylase (Acel_1097), diaminopimelate decarboxylase (Acel_0629), glycine decarboxylase
(Acel_1222), carboxymuconolactone decarboxylase (Acel_0891) was observed. The upregulation
of these decarboxylases could possibly be in response to the intracellular pH decrease in the
presence of HA, PA or lignin in A. cellulolyticus [85].
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Lignin-derived phenolic compounds have been shown to enhance the generation of reactive
oxygen species such as hydrogen peroxide (H2O2), super oxides (O2-) and super hydroxyl (OH-)
that interact with proteins, resulting in their denaturation, damaging other hydrophobic
intracellular targets, DNA mutagenesis, and induction of programmed cell death [64]. We
observed that a polyisoprenoid-binding protein (Acel_0530) was consistently upregulated in HA,
PA and lignin. This protein interacts with isoprenoid quinones that play essential roles in
respiratory electron transport and in controlling oxidative stress and gene regulation [65]. A
quinone oxidoreductase (Acel_0584) was upregulated in PA and lignin (Cluster 6) and an
NAD(P)H-quinone dehydrogenase (Acel_0394) was upregulated in lignin. An operon consisting
of genes coding for NADH-quinone oxidoreductases (Acel_0726-Acel_0731) was upregulated in
the presence of lignin (Table 7). Quinone oxidoreductases are considered as detoxification
enzymes with the ability to deactivate reactive oxygen species by reducing xenobiotic quinones,
azo compounds etc., and have been proposed to play broader antioxidant roles by acting as
superoxide scavengers [66].

An operon (Acel_1103-Acel_1104) consisting of a ferredoxin (Acel_1103) and FAD-dependent
pyridine nucleotide-disulfide oxidoreductase (Acel_1104) was upregulated (Table 7). The
pyridine nucleotide-disulphide reductases use the isoalloxazine ring of FAD to shuttle reducing
equivalents from NAD(P)H to disulfide bridge of cysteine residue which the eventually reduces
the substrate [67]. Likewise, genes coding for redox-sensing transcriptional repressor Rex
(Acel_0239) and a thioredoxin family protein (Acel_0241) were also upregulated. Acel_0241 was
upregulated in HA and PA, however was downregulated in lignin (Cluster 2). A thiol reductase
thioredoxin gene (Acel_0542) was upregulated by lignin, and the two upstream genes coding for
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an ABC transporter and osmotically induced protein were upregulated in HA and lignin. The
exposure to lignin also upregulated the expression of a thioredoxin-disulfide reductase gene
(Acel_2148). The higher expression of these genes indicates that the compounds tested possibly
induced oxidative stress in A. cellulolyticus.

We looked at the expression of phenylacetic acid degradation genes. Phenylacetic acid is
structurally similar to the phenolic compounds tested. An induction in the expression of these
genes could indicate their possible role in metabolism of structurally similar phenolic acids in A.
cellulolyticus. A. cellulolyticus contains several homologs of paa genes. A paaR, transcriptional
regulator of phenylacetic acid degradation, TetR family was found to be upregulated in lignin.
However, the upstream gene paaZ (Acel_1435) did not show any significant change. In the
operon paaABCDE (Acel_1439-Acel_1443), pad (Acel_1440) and paaE (Acel_1439) were found
to be upregulated, while there was no significant change in the expression of the other genes in
the operon. The phenolic acid stress response regulator gene, padR (Acel_2137) was found to be
upregulated in HA, but was downregulated in PA and lignin (Cluster 4). Phenylacetic acid
degradation genes were therefore found not to be affected in the presence of phenolic acids.

Sulfur metabolism plays an important role as cell’s anti-oxidative stress system [68]. We
hypothesized that sulfur metabolism could be a key factor involved in A. cellulolyticus survival
in the presence of lignin phenolic compounds. We observed that the genes involved in sulfur
assimilation pathway dedicated towards the biosynthesis of cysteine were upregulated by the
compounds tested. An operon (Acel_0059-Acel_0060) containing the thiosulfate
sulfurtransferase gene (Acel_0059) was upregulated upon exposure to HA, PA. Thiosulfate
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sulfurtransferase (TST), has been proposed to function in the metabolism of sulfur compounds
and maintenance of redox balance, wherein its deletion was found to cause oxidative imbalance
in cells and cysteine auxotrophy [69-72]. The expression of TST protein was highly induced in
the presence of each of the five phenolic compounds tested (Chapter 2). Its over-expression
enhanced the survival of E. coli in the presence of HA (Chapter 2). In case of Mycobacterium
smegmatis, a knockout mutant of MSMEG_5789 (ortholog of Acel_0059) was more sensitive to
stressors such as H2O2, formaldehyde etc., and oxygen limitation conditions compared to the
wild type strain (see Chapter 4).

The operon consisting of genes involved in the sulfur assimilation pathway (Acel_1616Acel_1619) was also upregulated in the presence of HA, PA and lignin (Table 7). The sulfate
adenylyltransferases, CysND (Acel_1617, Acel_1618) convert inorganic sulfate into adenylyl
sulfate, which is then converted into phosphoadenosine phosphosulfate by adenylyl-sulfate
kinase, CysC (Acel_1619). The phosphoadenosine phosphosulfate is reduced to sulfite by
phosphoadenosine phosphosulfate reductase, CysH (Acel_2054). The Acel_2054 is present in an
operon, which was also upregulated (Acel_2053-Acel_2055) (Table 7). The RT-PCR results were
consistent in the trend of upregulation of the expression these genes in the presence of different
phenolic acids (discussed in Chapter 2). The ferredoxin nitrite/sulfite reductase, CysI
(Acel_2055) reduces sulfite into sulfide, which is then incorporated into cysteine. The sulfite
reductase and nitrite reductase are structurally similar in their architecture and often catalyze the
reduction of both sulfite and nitrite [73, 74]. The genes coding for the expression of nitrite
reductases (Acel_1744, Acel_1746) were found to be upregulated in the presence of lignin.
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The operon cysHIJ was found to be upregulated in ethanologen E. coli during the fermentation of
alkali-pretreated corn stover hydrolysate [75]. Miller et al. (2009) found that furfural, an
inhibitor released during lignin breakdown, inhibits the growth of E. coli by inhibiting sulfur
assimilation, resulting in the induction of many related genes, including the cysCND and cysHIJ
[76]. The authors observed that expression of genes and regulators associated with the
biosynthesis of cysteine and methionine (cysC, cysH, cysI, cysM, cysN, cysQ, metA, metB, metC,
metL, sbp, tauA, tauB, tauC, and tauD) was increased by furfural and the supplementation of
cysteine, methionine and thiosulfate increased furfural tolerance. Similar results were observed
in our study, where, addition of cysteine and thiosulfate relieved phenolic acid stress (Chapter 2).
However, we did not observe any effect with methionine and the stress response was specific to
cysteine (see Chapter 2).

Another proposed mechanism for relieving stress is by expression of MarR (multiple antibiotic
resistance regulator) family transcriptional regulators. MarR homologs regulate the activity of
genes involved in stress responses, oxidative stress, virulence, or degradation/export of harmful
chemicals such as phenolic compounds, xenobiotics and antibiotics [77, 78]. MarR homolog is
conventionally encoded together with a gene under its regulation and can act as both repressors
and activators of gene expression [79]. Small phenolic compounds have been shown to act as
ligands that bind to MarR homologs and induce the expression of degradation genes [80-82]. The
genes coding for MarR regulators (Acel_0109, Acel_0606,Acel_1098, Acel_1889, Acel_1958,
Acel_2060, Acel_2084) were found to be upregulated. A number of MarR homologs also control
the multidrug efflux pumps in response to environmental stresses [83]. We found three genes
coding for MarR regulators associated with MFS (major facilitator superfamily) transporters to
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be upregulated: Acel_0109-Acel_0110, Acel_0606-Acel_0607, Acel_1889-Acel_1890. The
MarR-MFS operon (Acel_1889-Acel_1890) belonging to the MFS Drug resistance transporter,
EmrB/QacA subfamily, was however found to be downregulated in the presence of HA and PA
and upregulated specifically in lignin. A MarR regulator not present in an operon (Acel_2060)
was found to be upregulated in the presence of PA and lignin. MarR homologs have been shown
to respond to oxidative stress by oxidation of specific cysteine residues [84].

The knowledge obtained from this study helps in understanding the effect of phenolic acids in A.
cellulolyticus and could serve in the development of more robust strains able to adapt better in
the presence of toxic lignocellulosic hydrolysate.

85

3.5 Tables
Table 1. MiSeq run information of each control vs treatment library sequencing. The HA, PA,
lignin represent treatment; numbers 1 and 2 represent the first and second replicate. Total Reads:
the total number of reads; PF Reads: the total number of passing filter reads; % Reads Identified
(PF): the total fraction of passing filter reads assigned to an index; Q-Score (%³Q30): the
percentage of bases with a quality score of >30; CV: the coefficient of variation for the number
of counts across all indexes; Yield: the number of bases sequenced.
Treatment Total
PF Reads
% Reads
Q-Score
CV
Yield
Reads
Identified (PF)
(Gbp)
(%³Q30)
HA1
46,004,805 26,185,652 92.76
81.35
0.2291 4.06
HA2
47,144,181 40,888,045 97.63
94.31
0.3651 6.34
PA1
50,657,331 39,405,958 98.02
92.70
0.3769 6.11
PA2
45,869,195 39,366,594 97.38
94.26
0.2315 6.10
Lignin1
49,566,083 37,792,898 97.59
42.92
0.0291 22.86
Lignin2
85,306,904 72,306,692 98.00
94.75
0.1803 5.60
Table 2. Cross-comparison R2 values of all pairings of four experiments i.e. control, HA, PA and
lignin. The values were obtained from statistical analyses using Student’s t-test and BenjaminiHochberg procedure (false discovery rate) using ArrayStar.
Experiment Control HA
PA
Lignin
Control

0.785 0.753 0.813

HA

0.873 0.709

PA

0.748
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Table 3. Number of genes significantly differentially expressed. The number of differentially
expressed genes (³ 2-fold, 4-fold or 8-fold change) was obtained for each treatment compared to
control: HA (a), PA (b), lignin (c). The total number of significant genes were obtained using the
Student’s t-test with threshold set at either p £ 0.01 (genes at 99% confidence), 0.05 (genes at
95% confidence) or 0.10 (genes at 90% confidence).
HA
Total genes Genes at 2-fold Genes at 4-fold Genes at 8-fold
change
change
change
Genes at 99% confidence 691
376
118
50
Genes at 95% confidence 1024
470
125
50
Genes at 90% confidence 1187
506
127
50
(a)
PA
Genes at 99% confidence
Genes at 95% confidence
Genes at 90% confidence
(b)
Lignin
Genes at 99% confidence
Genes at 95% confidence
Genes at 90% confidence
(c)

Total genes Genes at 2-fold
change
763
453
1104
521
1274
542

Genes at 4-fold
change
132
137
140

Genes at 8-fold
change
57
58
58

Total genes Genes at 2-fold
change
674
407
1104
559
1313
590

Genes at 4-fold
change
96
114
116

Genes at 8-fold
change
34
41
42

Table 4. Number of differentially expressed genes at p £ 0.05 and ³ 2-fold change. Control was
used as a baseline to calculate fold-change values for each set. (a): total number of differentially
expressed genes; (b) number of upregulated genes; (c) number of downregulated genes.
Treatment
(a)
(b)
(c)
HA
470
225
245
PA
521
168
353
Lignin
559
448
111
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Table 5. List of genes consistently upregulated genes in HA, PA and lignin treatments compared to control
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Locus tag

NCBI gene name

New locus tag

Acel_0073

D-inositol-3-phosphate
glycosyltransferase

ACEL_RS00390

NCBI
product
length
448

HA up
fold
change
6.72

PA up
fold
change
2.12

Lignin
up fold
change
4.66

Acel_0110

MFS transporter

ACEL_RS00580

429

D-inositol 3-phosphate glycosyltransferase (EC
2.4.1.250) (N-acetylglucosamine-inositolphosphate N-acetylglucosaminyltransferase)
(GlcNAc-Ins-P Nacetylglucosaminyltransferase)
Major facilitator superfamily MFS_1

2.61

2.02

2.19

Acel_0160

heat-shock protein Hsp20

ACEL_RS00845

147

Heat shock protein Hsp20

4.34

2.59

3.28

Acel_0202

tRNA(Ile)-lysidine
synthetase

ACEL_RS01065

398

tRNA(Ile)-lysidine synthase (EC 6.3.4.19)
(tRNA(Ile)-2-lysyl-cytidine synthase)
(tRNA(Ile)-lysidine synthetase)
tRNA pseudouridine synthase A (EC 5.4.99.12)
(tRNA pseudouridine(38-40) synthase) (tRNA
pseudouridylate synthase I) (tRNA-uridine
isomerase I)
Phosphoglucosamine mutase (EC 5.4.2.10)

2.20

3.73

2.69

Acel_0336

tRNA pseudouridine(38-40)
synthase TruA

ACEL_RS01745

297

2.96

2.47

5.53

Acel_0343

ACEL_RS01780

450

ACEL_RS01890

202

ACEL_RS02725

Acel_0555

phosphoglucosamine
mutase
DNA-binding response
regulator
EAL domain-containing
protein
polyisoprenoid-binding
protein
ATPase

2.71

2.62

2.98

3.27

2.15

2.19

378

Two component transcriptional regulator, LuxR
family
Diguanylate phosphodiesterase

11.61

4.75

6.03

ACEL_RS02730

186

YceI family protein

21.56

2.63

9.20

ACEL_RS11365

299

ATPase, BadF/BadG/BcrA/BcrD type

2.06

2.14

2.86

Acel_0660

hypothetical protein

ACEL_RS03400

340

Uncharacterized protein

2.80

2.85

3.22

Acel_0704

hypothetical protein

ACEL_RS03620

654

Uncharacterized protein

3.81

3.84

2.80

Acel_0855

ACEL_RS04425

123

Flagellar motor switch protein FliN

6.73

5.09

10.38

Acel_0959

flagellar motor switch
protein FliN
signal peptidase I

ACEL_RS04950

244

Peptidase S26B, signal peptidase

2.79

3.32

6.60

Acel_1012

cell division protein FtsZ

ACEL_RS05210

460

Cell division protein FtsZ

2.87

2.17

2.61

Acel_1013

hypothetical protein

ACEL_RS05215

240

Uncharacterized protein

3.59

2.16

3.34

Acel_1028

hypothetical protein

ACEL_RS05300

152

Uncharacterized protein

2.87

3.02

2.66

Acel_0365
Acel_0529
Acel_0530

Uniprot protein name

Table 5 (con’t)
Locus tag

NCBI gene name

New locus tag

Acel_1102

ACEL_RS05670

Acel_1289

5-carboxymethyl-2hydroxymuconate isomerase
primosomal protein N'

NCBI
product
2length
290

89

HA up
fold
change
2.14

PA up
fold
change
21.04

Lignin
up fold
change
2.50

ACEL_RS06635

699

Acel_1324

hypothetical protein

ACEL_RS06810

428

5-carboxymethyl-2-hydroxymuconate deltaisomerase (EC 5.3.3.10)
Probable primosomal protein N' (EC 3.6.4.-)
(ATP-dependent helicase PriA)
Uncharacterized protein

2.81

2.53

2.74

2.28

2.99

2.90

Acel_1411

hypothetical protein

ACEL_RS07270

149

Uncharacterized protein

2.12

2.66

2.61

Acel_1424

hypothetical protein

ACEL_RS07335

96

Uncharacterized protein

14.01

6.52

2.74

Acel_1513

ribosome-binding factor A

ACEL_RS07800

150

Ribosome-binding factor A

3.28

2.77

3.39

Acel_1615

hypothetical protein

ACEL_RS08325

221

6.43

6.60

3.91

ACEL_RS08330

475

3.97

3.48

2.65

Acel_1625

uroporphyrinogen-III Cmethyltransferase
hypothetical protein

ACEL_RS08375

179

Cobalamin (Vitamin B12) biosynthesis CbiX
protein
Uroporphyrinogen-III C-methyltransferase (EC
2.1.1.107)
Uncharacterized protein

Acel_1616

3.90

2.45

2.26

Acel_1772

NrdH-redoxin

ACEL_RS09160

89

Glutaredoxin-like protein

47.42

10.83

4.34

Acel_1778

hypothetical protein

ACEL_RS09190

324

Alpha/beta hydrolase fold protein

3.74

4.95

2.53

Acel_1779

hypothetical protein

ACEL_RS09195

243

Uncharacterized protein

4.48

2.81

2.23

Acel_1789

ACEL_RS09250

379

Chemotaxis response regulator proteinglutamate methylesterase (EC 3.1.1.61)

2.16

2.09

2.59

ACEL_RS09425

571

Type II secretion system protein E

2.92

3.72

5.21

Acel_1857

chemotaxis response
regulator protein-glutamate
methylesterase
type II secretory protein
GspE
hypothetical protein

ACEL_RS09590

418

GCN5-related N-acetyltransferase

3.20

6.10

3.19

Acel_1948

pirin

ACEL_RS10065

346

Pirin domain protein

10.97

2.11

8.11

Acel_1959

MFS transporter

ACEL_RS10120

484

9.32

6.48

2.14

Acel_1966

helicase

ACEL_RS10155

1162

Drug resistance transporter, EmrB/QacA
subfamily
Helicase domain protein

3.95

2.10

3.04

Acel_1994

hypothetical protein

ACEL_RS11725

150

Uncharacterized protein

2.24

3.30

3.01

Acel_2053

hypothetical protein

ACEL_RS10615

161

Uncharacterized protein

7.61

3.38

2.33

Acel_2144

hypothetical protein

ACEL_RS11125

354

NLP/P60 protein

2.53

3.02

3.59

Acel_1823

Uniprot protein name

Table 6. List of genes consistently downregulated genes in HA, PA and lignin treatments compared to control
Locus tag

NCBI gene name

New locus tag

NCBI
product
length

Uniprot_protein_name

HA
down
fold
change
20.41

PA
down
fold
change
49.04

Lignin
down
fold
change
11.13

Acel_0049

ferric reductase

ACEL_RS00265

453

Acel_0050

ACEL_RS00270

188

ACEL_RS00485

391

Acel_0173

FMN-binding domaincontaining protein
phosphate ABC transporter
substrate-binding protein
PstS
hypothetical protein

Oxidoreductase FAD/NAD(P)-binding domain
protein
FMN-binding domain protein

25.70

65.97

8.90

Phosphate-binding protein PstS

3.18

4.04

2.21

ACEL_RS11275

357

Uncharacterized protein

5.85

10.10

9.28

Acel_0233

hypothetical protein

ACEL_RS01220

409

Uncharacterized protein

14.70

17.97

2.32

Acel_0392

cold-shock protein

ACEL_RS02025

68

Cold-shock DNA-binding protein family

3.92

3.46

2.84

Acel_0411

ACEL_RS02125

520

Cell envelope-related transcriptional attenuator

18.99

22.01

2.66

Acel_0440

cell envelope-related
transcriptional attenuator
hypothetical protein

ACEL_RS02280

228

Uncharacterized protein

5.39

4.99

2.71

Acel_0442

hypothetical protein

ACEL_RS02300

509

Uncharacterized protein

9.31

8.42

3.97

Acel_0443

hypothetical protein

ACEL_RS02305

585

Uncharacterized protein

8.50

6.25

3.07

Acel_0444

ACEL_RS02310

391

UDP-sulfoquinovose synthase (EC 3.13.1.1)

13.66

11.28

5.06

Acel_0487

NAD-dependent
dehydratase
hypothetical protein

ACEL_RS02520

160

Uncharacterized protein

4.01

5.18

2.40

Acel_0488

undecaprenyl-diphosphatase

ACEL_RS02525

219

Undecaprenyl-diphosphatase (EC 3.6.1.27)

5.17

4.99

2.54

Acel_0611

hypothetical protein

ACEL_RS03125

305

Phosphoesterase, PA-phosphatase related protein

4.79

4.84

3.32

Acel_0893

ACEL_RS04620

305

5.42

3.26

ACEL_RS11425

209

ABC-type nitrate/sulfonate/bicarbonate transport
systems periplasmic components-like protein
Carboxymuconolactone decarboxylase

2.58

Acel_0895

nitrate ABC transporter
substrate-binding protein
hypothetical protein

2.32

14.04

9.00

Acel_0904

hypothetical protein

ACEL_RS04675

552

Uncharacterized protein

21.61

44.62

4.07

Acel_1446

cysteine--tRNA ligase

ACEL_RS07450

347

Cysteine--tRNA ligase (EC 6.1.1.16)

9.07

9.81

4.68

Acel_1447

hypothetical protein

ACEL_RS11520

190

Uncharacterized protein

123.69

144.16

43.24

Acel_1448

two-component sensor
histidine kinase

ACEL_RS07460

524

Periplasmic sensor signal transduction histidine
kinase

4.55

6.14

2.81

Acel_0091
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Table 6 (con’t)
Locus tag

NCBI gene name

New locus tag

NCBI
product
length

Uniprot_protein_name

HA
down
fold
change
7.38

PA
down
fold
change
9.04

Lignin
down
fold
change
2.95

Acel_1449

DNA-binding response
regulator
hypothetical protein

ACEL_RS07465

246

ACEL_RS11525

628

Two component transcriptional regulator, winged
helix family
Efflux transporter, RND family, MFP subunit

170.46

245.55

55.83

ACEL_RS07480

254

ACEL_RS07485

Acel_1453

macrolide ABC transporter
ATP-binding protein
macrolide ABC transporter
permease
hypothetical protein

ABC transporter related protein

11.05

11.73

14.07

393

Uncharacterized protein

231.11

317.26

84.57

ACEL_RS11530

214

Uncharacterized protein

86.13

93.07

10.56

Acel_1456

hypothetical protein

ACEL_RS07505

412

Uncharacterized protein

6.86

7.43

4.24

Acel_1457

hypothetical protein

ACEL_RS07510

653

4.67

4.79

3.66

Acel_1592

ACEL_RS08190

238

3.76

2.74

2.33

ACEL_RS08195

512

Peptidase S1 and S6, chymotrypsin/Hap

9.09

13.34

6.99

ACEL_RS08200

523

8.22

3.72

ACEL_RS08205

227

2.60

6.15

3.09

ACEL_RS08560

897

Periplasmic sensor signal transduction histidine
kinase
Two component transcriptional regulator, winged
helix family
Beta-glucosidase (EC 3.2.1.21)

4.63

Acel_1659

IclR family transcriptional
regulator
peptidase S1 and S6,
chymotrypsin/Hap
two-component sensor
histidine kinase
DNA-binding response
regulator
beta-glucosidase

Peptidoglycan-N-acetylmuramate Oacetyltransferase
Transcriptional regulator, IclR family

76.85

68.59

4.62

Acel_1671

acetyl-CoA carboxylase

ACEL_RS08615

202

BioY protein

2.68

2.29

2.03

Acel_1672

carbonic anhydrase

ACEL_RS08620

179

4.96

8.19

4.63

Acel_1715

glyceraldehyde 3-phosphate
reductase
hypothetical protein

ACEL_RS08845

341

Carbonic anhydrase (EC 4.2.1.1) (Carbonate
dehydratase)
Aldo/keto reductase

2.82

3.82

2.49

ACEL_RS08850

379

Peptidase S1 and S6, chymotrypsin/Hap

82.06

112.75

76.51

5methyltetrahydropteroyltrigl
utamate--homocysteine Smethyltransferase

ACEL_RS08875

794

5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase (EC 2.1.1.14)
(Cobalamin-independent methionine synthase)
(Methionine synthase, vitamin-B12 independent
isozyme)

2.81

3.12

2.10

Acel_1450
Acel_1451
Acel_1452
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Acel_1593
Acel_1594
Acel_1595

Acel_1716
Acel_1723

Table 6 (con’t)
Locus tag

NCBI gene name

New locus tag

NCBI
product
length

Uniprot_protein_name

Acel_1737

ACEL_RS08950

311

ACEL_RS08955

Acel_1739

type II secretion system
protein
type II secretion system
protein F
pilus assembly protein CpaF

Acel_1740
Acel_1826

Acel_1738

Acel_1833

Type II secretion system protein

HA
down
fold
change
9.83

PA
down
fold
change
2.94

Lignin
down
fold
change
2.28

286

Type II secretion system protein

4.90

2.04

2.38

ACEL_RS08960

414

Type II secretion system protein E

8.07

3.32

3.49

hypothetical protein

ACEL_RS08965

835

Diguanylate cyclase/phosphodiesterase

2.80

8.72

7.42

RNA polymerase sigma
factor SigE
hypothetical protein

ACEL_RS09440

235

RNA polymerase, sigma 29 subunit, SigE

3.36

5.42

7.79

ACEL_RS11605

161

Anti-sigma factor antagonist

59.61

47.17

15.87

92

Table 7. List of upregulated operons where at least two of the genes were upregulated in at least one of the treatments. Genes with ³2
fold change in a treatment compared to control with p £0.05 were selected for operon prediction. The listed putative operons contain
genes with £40 bp intergenic distance being transcribed in same direction.
Upregulated operon

Genes upregulated

Acel_0030 - Acel_0033 Acel_0030
Acel_0031
Acel_0032
Acel_0033

Upregulated gene description
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Acel_0057 - Acel_0058 Acel_0057
Acel_0058
Acel_0059 - Acel_0060 Acel_0059
Acel_0060
Acel_0061 - Acel_0062 Acel_0061
Acel_0062
Acel_0079 - Acel_0081 Acel_0079
Acel_0080
Acel_0081
Acel_0091 - Acel_0094 Acel_0092
Acel_0093

nitrilase/cyanide hydratase and apolipoprotein N-acyltransferase
dehydrogenase catalytic domain-containing protein
2-oxoisovalerate dehydrogenase subunit beta
pyruvate dehydrogenase (acetyl-transferring) E1 component subunit
alpha
RNA polymerase sigma factor SigL
hypothetical protein
sulfurtransferase
hypothetical protein
transcriptional repressor
folate-binding protein
PIN/TRAM domain-containing protein
4-diphosphocytidyl-2C-methyl-D-erythritol synthase
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase
phosphate ABC transporter permease subunit PstC
phosphate ABC transporter, permease protein PstA

Acel_0095 - Acel_0096 Acel_0095
Acel_0096
Acel_0109 - Acel_0110 Acel_0109
Acel_0110
Acel_0112 - Acel_0114 Acel_0113
Acel_0114
Acel_0120 - Acel_0122 Acel_0121
Acel_0122

penicillin-binding protein
GGDEF domain-containing protein
MarR family transcriptional regulator
MFS transporter
MFS transporter
phosphoserine aminotransferase
hypothetical protein
hypothetical protein

Treatments that
showed upregulation
HA
HA
HA
HA
HA
HA, PA
HA
HA, PA
HA
HA
PA, lignin
lignin
lignin
lignin
lignin
lignin
lignin
PA, lignin
HA, PA, lignin
lignin
lignin
HA
HA, lignin

Table 7 (con’t)
Upregulated operon

Genes upregulated
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Acel_0222 - Acel_0224 Acel_0222
Acel_0223
Acel_0224
Acel_0232 - Acel_0235 Acel_0234
Acel_0235
Acel_0236 - Acel_0239 Acel_0237
Acel_0239
Acel_0305 - Acel_0315 Acel_0308
Acel_0309
Acel_0311
Acel_0312

chemotaxis response regulator protein-glutamate methylesterase
hypothetical protein
hypothetical protein
hypothetical protein
delta-aminolevulinic acid dehydratase
hydroxymethylbilane synthase
redox-sensing transcriptional repressor Rex
50S ribosomal protein L23
50S ribosomal protein L2
50S ribosomal protein L22
30S ribosomal protein S3

Treatments that
showed upregulation
PA, lignin
PA, lignin
HA, PA, lignin
lignin
lignin
lignin
HA, PA
lignin
lignin
lignin
lignin

Acel_0314
Acel_0335 - Acel_0336 Acel_0335

50S ribosomal protein L29
50S ribosomal protein L17

lignin
HA, lignin

Acel_0336
Acel_0350 - Acel_0351 Acel_0350

tRNA pseudouridine(38-40) synthase TruA
ECF subfamily RNA polymerase sigma-24 factor

HA, PA, lignin
lignin

Acel_0351
Acel_0355 - Acel_0357 Acel_0355

anti-sigma factor
alanine racemase

lignin
lignin

DNA polymerase
tRNA (adenosine(37)-N6)-threonylcarbamoyltransferase complex
ATPase subunit type 1 TsaE
hypothetical protein
hypothetical protein
amidinotransferase
ornithine--oxo-acid transaminase
glycosyl transferase family protein
hypothetical protein

lignin
PA, lignin

Acel_0356
Acel_0357
Acel_0429 - Acel_0430 Acel_0429
Acel_0430
Acel_0453 - Acel_0454 Acel_0453
Acel_0454
Acel_0460 - Acel_0461 Acel_0460
Acel_0461

Upregulated gene description

HA, PA
HA, PA
HA, PA
HA, PA
PA, lignin
HA, PA, lignin

Table 7 (con’t)
Upregulated operon

Genes upregulated

Upregulated gene description
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Acel_0494 - Acel_0495 Acel_0494
Acel_0495
Acel_0538 - Acel_0539 Acel_0538
Acel_0539
Acel_0541 - Acel_0542 Acel_0541
Acel_0542
Acel_0553 - Acel_0556 Acel_0555
Acel_0556
Acel_0579 - Acel_0582 Acel_0580
Acel_0581
Acel_0582

hemerythrin HHE cation binding domain-containing protein
hypothetical protein
RNA polymerase subunit sigma-24
mycothiol system anti-sigma-R factor
osmotically inducible protein OsmC
thiol reductase thioredoxin
ATPase
glucosamine-6-phosphate deaminase
ABC transporter permease
hypothetical protein
xylose isomerase

Treatments that
showed upregulation
lignin
lignin
HA, lignin
HA, lignin
HA, lignin
lignin
HA, PA, lignin
HA
HA, lignin
HA
HA

Acel_0606 - Acel_0607 Acel_0606
Acel_0607

MarR family transcriptional regulator
MFS transporter

lignin
HA, lignin

Acel_0637 - Acel_0639 Acel_0637
Acel_0638

hypothetical protein
UDP-N-acetylglucosamine 2-epimerase (non-hydrolyzing)

PA, lignin
HA, PA, lignin

Acel_0639
Acel_0651 - Acel_0654 Acel_0652

HAD family hydrolase
ATP synthase subunit gamma

PA, lignin
lignin

Acel_0654
Acel_0659 - Acel_0661 Acel_0659
Acel_0660
Acel_0661
Acel_0700 - Acel_0703 Acel_0700
Acel_0701
Acel_0702
Acel_0703

ATP synthase F1 subunit epsilon
ATPase
hypothetical protein
hypothetical protein
2-oxoacid:acceptor oxidoreductase subunit gamma
2-ketoisovalerate ferredoxin oxidoreductase subunit alpha
pyruvate ferredoxin oxidoreductase
glutamate synthase

lignin
HA, lignin
HA, PA, lignin
PA, lignin
HA, lignin
HA
lignin
HA

Table 7(con’t)
Upregulated operon

Genes upregulated

Upregulated gene description
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Acel_0709 - Acel_0710 Acel_0709
Acel_0710
Acel_0716 - Acel_0719 Acel_0716
Acel_0719
Acel_0721 - Acel_0722 Acel_0721
Acel_0722
Acel_0726 - Acel_0731 Acel_0726
Acel_0727
Acel_0728
Acel_0729
Acel_0730

phosphoglycerate dehydrogenase
3-isopropylmalate dehydrogenase
nucleoside/nucleotide kinase family protein
sugar ABC transporter
hypothetical protein
carbohydrate kinase
NADH/ubiquinone/plastoquinone (complex I)
NADH ubiquinone oxidoreductase
NADH-quinone oxidoreductase subunit D
NADH dehydrogenase
hydrogenase

Treatments that
showed upregulation
lignin
lignin
lignin
lignin
HA, lignin
lignin
lignin
lignin
lignin
lignin
lignin

Acel_0731
Acel_0734 - Acel_0735 Acel_0734

NADH dehydrogenase subunit 1
DNA mismatch repair protein MutS

lignin
lignin

Acel_0735
Acel_0758 - Acel_0759 Acel_0758

DNA mismatch repair protein MutS domain-containing protein
GTPase ObgE

HA, lignin
lignin

Acel_0759
Acel_0773 - Acel_0775 Acel_0774

glutamate 5-kinase
hypothetical protein

lignin
lignin

Acel_0775
Acel_0789 - Acel_0793 Acel_0792
Acel_0793
Acel_0820 - Acel_0821 Acel_0820
Acel_0821
Acel_0830 - Acel_0833 Acel_0830
Acel_0832
Acel_0833

DNA polymerase III subunit delta
hypothetical protein
GTPase Era
metallophosphoesterase
SMC domain-containing protein
flagellar assembly protein FliW
flagellar hook-associated protein FlgK
flagellar biosynthesis protein FlgN

lignin
PA, lignin
lignin
lignin
lignin
lignin
lignin
lignin

Table 7 (con’t)
Upregulated operon

Genes upregulated

flagellar hook-associated 2 domain-containing protein
hypothetical protein
flagellar basal-body rod protein FlgB
flagellar basal body rod protein FlgG
flagellar M-ring protein FliF
flagellar biosynthesis/type III secretory pathway protein-like protein
ATP synthase
hypothetical protein
lytic transglycosylase
flagellar FlbD family protein
motility protein A

Treatments that
showed upregulation
lignin
lignin
lignin
lignin
lignin
HA, PA, lignin
lignin
lignin
lignin
lignin
lignin

Acel_0852
Acel_0853

OmpA/MotB domain-containing protein
flagellar basal body-associated protein FliL

lignin
lignin

Acel_0854
Acel_0855

hypothetical protein
flagellar motor switch protein FliN

lignin
HA, PA, lignin

Acel_0857
Acel_0860

flagellar biosynthetic protein FliP
type III secretion exporter

lignin
lignin

hypothetical protein
hypothetical protein
ribulokinase
L-ribulose-5-phosphate 4-epimerase
L-arabinose isomerase
nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase
adenosylcobinamide kinase
ECF transporter S component

lignin
lignin
HA, lignin
HA, lignin
lignin
HA, PA
HA
HA, lignin

Acel_0835 - Acel_0837 Acel_0835
Acel_0837
Acel_0838 - Acel_0839 Acel_0838
Acel_0839
Acel_0840 - Acel_0848 Acel_0841
Acel_0843
Acel_0844
Acel_0845
Acel_0846
Acel_0850 - Acel_0860 Acel_0850
Acel_0851
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Acel_0863 - Acel_0864 Acel_0863
Acel_0864
Acel_0871 - Acel_0873 Acel_0871
Acel_0872
Acel_0873
Acel_0939 - Acel_0945 Acel_0940
Acel_0941
Acel_0942

Upregulated gene description

Table 7 (con’t)
Upregulated operon

Genes upregulated

Upregulated gene description

Acel_0944
Acel_1002
Acel_1003
Acel_1041
Acel_1042
Acel_1078
Acel_1079
Acel_1090
Acel_1091
Acel_1092
Acel_1093

cobalt transport protein
ribosomal RNA small subunit methyltransferase H
hypothetical protein
cupin
hypothetical protein
glutamate synthase subunit alpha
dihydropyrimidine dehydrogenase subunit A
hypothetical protein
dephospho-CoA kinase
gamma-aminobutyraldehyde dehydrogenase
aspartate aminotransferase family protein

Treatments that
showed upregulation
HA, PA
HA
HA
HA
HA
lignin
lignin
lignin
lignin
PA, lignin
PA, lignin

glutamine amidotransferase
betaine-aldehyde dehydrogenase

PA
HA, PA

catecholic dioxygenase
5-carboxymethyl-2-hydroxymuconate isomerase

HA, PA
HA, PA, lignin

Acel_1103 - Acel_1104 Acel_1103
Acel_1104

ferredoxin
FAD-dependent pyridine nucleotide-disulfide oxidoreductase

PA
HA, PA, lignin

Acel_1129 - Acel_1130 Acel_1129
Acel_1130
Acel_1200 - Acel_1201 Acel_1200
Acel_1201
Acel_1221 - Acel_1222 Acel_1221
Acel_1222
Acel_1255 - Acel_1262 Acel_1260
Acel_1262

ROK family protein
inner-membrane translocator
WYL domain-containing protein
WYL domain-containing protein
cation transporter
glycine dehydrogenase (aminomethyl-transferring)
aspartate aminotransferase family protein
bifunctional ornithine acetyltransferase/N-acetylglutamate synthase

HA
HA
HA
HA
lignin
lignin
lignin
lignin

Acel_1002 - Acel_1003
Acel_1040 - Acel_1043
Acel_1078 - Acel_1079
Acel_1090 - Acel_1091
Acel_1092 - Acel_1094
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Acel_1094
Acel_1100 - Acel_1102 Acel_1100
Acel_1101
Acel_1102

Table 7 (con’t)
Upregulated operon

Genes upregulated

Acel_1271 - Acel_1274 Acel_1273
Acel_1274
Acel_1295 - Acel_1302 Acel_1296
Acel_1299
Acel_1301
Acel_1302

Upregulated gene description

Treatments that
showed upregulation
HA, lignin
lignin
lignin
HA
HA
HA
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Acel_1310 - Acel_1313 Acel_1312
Acel_1313
Acel_1327 - Acel_1336 Acel_1329
Acel_1334
Acel_1335

riboflavin synthase subunit alpha
riboflavin biosynthesis protein RibD
dihydroorotate dehydrogenase
carbamoyl-phosphate synthase small subunit
aspartate carbamoyltransferase
bifunctional pyr operon transcriptional regulator/uracil
phosphoribosyltransferase
hypothetical protein
pilus biosynthesis protein PilM
Holliday junction resolvase RuvX
aspartate--tRNA ligase
histidine--tRNA ligase

Acel_1336
Acel_1401 - Acel_1402 Acel_1401
Acel_1402
Acel_1410 - Acel_1412 Acel_1410

hydrolase
hypothetical protein
deoxyuridine 5'-triphosphate nucleotidohydrolase
ECF subfamily RNA polymerase sigma-24 factor

HA, lignin
lignin
lignin
lignin

hypothetical protein
hypothetical protein
hypothetical protein
carboxymethylenebutenolidase
hypothetical protein
TetR family transcriptional regulator
DNA repair protein
oxidoreductase FAD-binding subunit
phenylacetate-CoA oxygenase subunit PaaJ
ATP-dependent helicase

HA, PA, lignin
PA
PA
HA, PA, lignin
HA, PA, lignin
lignin
lignin
HA, lignin
HA, lignin
lignin

Acel_1413 - Acel_1415
Acel_1423 - Acel_1424
Acel_1435 - Acel_1437
Acel_1439 - Acel_1443
Acel_1480 - Acel_1481

Acel_1411
Acel_1413
Acel_1414
Acel_1423
Acel_1424
Acel_1436
Acel_1437
Acel_1439
Acel_1440
Acel_1480

HA, lignin
lignin
PA
lignin
lignin

Table 7 (con’t)
Upregulated operon

Genes upregulated

Upregulated gene description

Acel_1481
Acel_1505
Acel_1506
Acel_1507
Acel_1508
Acel_1512
Acel_1513
Acel_1514
Acel_1558
Acel_1559
Acel_1562

GGDEF domain-containing protein
FAD-dependent oxidoreductase
4-hydroxy-tetrahydrodipicolinate reductase
peptidase M16
polyribonucleotide nucleotidyltransferase
tRNA pseudouridine(55) synthase TruB
ribosome-binding factor A
hypothetical protein
tRNA (guanosine(37)-N1)-methyltransferase TrmD
16S rRNA-processing protein RimM
hypothetical protein

Treatments that
showed upregulation
lignin
lignin
lignin
lignin
lignin
HA, PA, lignin
HA, PA, lignin
HA, lignin
lignin
lignin
lignin

Acel_1564
Acel_1566

[protein-PII] uridylyltransferase
ammonia channel protein

PA, lignin
lignin

Acel_1605 - Acel_1606 Acel_1605
Acel_1606

two-component sensor histidine kinase
DNA-binding response regulator

HA, PA
HA, PA

Acel_1616 - Acel_1619 Acel_1616
Acel_1617

uroporphyrinogen-III C-methyltransferase
sulfate adenylyltransferase

HA, PA, lignin
HA, PA

Acel_1618
Acel_1619
Acel_1625 - Acel_1627 Acel_1625
Acel_1626
Acel_1630 - Acel_1631 Acel_1630
Acel_1631
Acel_1633 - Acel_1639 Acel_1638
Acel_1639

sulfate adenylyltransferase subunit 2
adenylyl-sulfate kinase
hypothetical protein
macrolide ABC transporter ATP-binding protein
hypothetical protein
xanthine dehydrogenase
carbon monoxide dehydrogenase
Asp/Glu racemase

HA, PA
HA, PA
HA, PA, lignin
lignin
HA, lignin
HA, lignin
lignin
lignin

Acel_1505 - Acel_1508

Acel_1512 - Acel_1514

Acel_1558 - Acel_1561
Acel_1562 - Acel_1566
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Tabel 7 (con’t)
Upregulated operon

Genes upregulated
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Acel_1685 - Acel_1689 Acel_1685
Acel_1686
Acel_1687
Acel_1688
Acel_1705 - Acel_1707 Acel_1705
Acel_1706
Acel_1718 - Acel_1719 Acel_1718
Acel_1719
Acel_1742 - Acel_1744 Acel_1742
Acel_1744
Acel_1745 - Acel_1746 Acel_1745

MBL fold metallo-hydrolase
glutamate racemase
cysteine synthase
molybdopterin synthase sulfur carrier subunit
glutamine amidotransferase
hypothetical protein
hypothetical protein
hypothetical protein
uroporphyrinogen-III synthase
nitrite reductase large subunit
pyridine nucleotide-disulfide oxidoreductase

Treatments that
showed upregulation
lignin
lignin
HA
HA
lignin
lignin
HA
PA, lignin
lignin
lignin
lignin

Acel_1746
Acel_1889 - Acel_1890 Acel_1889

nitrite reductase
MarR family transcriptional regulator

lignin
lignin

Acel_1890
Acel_1892 - Acel_1896 Acel_1892

MFS transporter
magnesium chelatase

lignin
lignin

VWA domain-containing protein
hypothetical protein

lignin
lignin

exopolyphosphatase
phosphatase
helicase
hypothetical protein
DNA polymerase III subunit delta
thymidylate kinase
type II secretion system protein
putative integral membrane protein

lignin
lignin
HA, PA, lignin
HA, PA, lignin
lignin
lignin
lignin
lignin

Acel_1893
Acel_1894
Acel_1906 - Acel_1907 Acel_1906
Acel_1907
Acel_1966 - Acel_1967 Acel_1966
Acel_1967
Acel_1970 - Acel_1971 Acel_1970
Acel_1971
Acel_1980 - Acel_1983 Acel_1980
Acel_1981

Upregulated gene description

Table 7 (con’t)
Upregulated operon

Acel_1989 - Acel_1992

Acel_2018 - Acel_2019
Acel_2053 - Acel_2055

Acel_2094 - Acel_2095

Genes upregulated

Upregulated gene description

Acel_1983
Acel_1989
Acel_1990
Acel_1991
Acel_2018
Acel_2019
Acel_2053
Acel_2054
Acel_2055
Acel_2094
Acel_2095

hypothetical protein
hypothetical protein
alpha/beta hydrolase
coenzyme A pyrophosphatase
tRNA-specific adenosine deaminase
hypothetical protein
hypothetical protein
phosphoadenosine phosphosulfate reductase
ferredoxin--nitrite reductase
catalase
transcriptional repressor

Treatments that
showed upregulation
lignin
lignin
lignin
lignin
lignin
lignin
HA, PA, lignin
HA, PA
HA, PA
HA
HA, PA
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Table 8. List of KEGG annotated pathways/functions of upregulated genes.
Metabolic pathway/function

Number of
upregulated genes
(fold change ≥2
and p ≤0.05)
19

ABC transporters

54

14

Ribosome

56

14

Glycolysis / Gluconeogenesis

33

12

Purine metabolism

49

12

Flagellar assembly

27

11

Glycine, serine and threonine
metabolism

26

11

Two-component system

47

10

Porphyrin and chlorophyll
metabolism

18

8
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Aminoacyl-tRNA biosynthesis

Number of
annotated
genes in the
category
70

Locus tag of the upregulated genes (treatment under which
upregulated, H: HA, P: PA, L: Lignin)
Acel_1334 (L), Acel_1335 (L), Acel_R0002 (L), Acel_R0007 (L),
Acel_R0010 (H), Acel_R0015 (L), Acel_R0017 (L), Acel_R0018
(L), Acel_R0024 (L), Acel_R0039 (L), Acel_R0040 (L),
Acel_R0042 (L), Acel_R0043 (PL), Acel_R0047 (L), Acel_R0054
(L), Acel_R0059 (L), Acel_R0063 (HL), Acel_R0064 (L),
Acel_R0066 (HL)
Acel_0092 (L), Acel_0093 (L), Acel_0434 (L), Acel_0558 (H),
Acel_0577 (H), Acel_0578 (HL), Acel_0580 (HL), Acel_0597 (L),
Acel_0719 (L), Acel_0944 (HP), Acel_1131 (H), Acel_1132 (H),
Acel_1281 (H), Acel_1360 (HP)
Acel_0297 (L), Acel_0298 (L), Acel_0308 (L), Acel_0309 (L),
Acel_0311 (L), Acel_0312 (L), Acel_0314 (L), Acel_0319 (L),
Acel_0322 (L), Acel_0335 (HL), Acel_2130 (H), Acel_R0034 (PL),
Acel_R0035 (P), Acel_R0036 (P)
Acel_0031 (H), Acel_0032 (H), Acel_0033 (H), Acel_0138 (PL),
Acel_0394 (L), Acel_0590 (H), Acel_0700 (HL), Acel_0701 (H),
Acel_0702 (L), Acel_0721 (HL), Acel_1068 (HP), Acel_1611 (L)
Acel_0299 (L), Acel_0300 (HL), Acel_0775 (L), Acel_0802 (L),
Acel_1508 (L), Acel_1617 (HP), Acel_1618 (HP), Acel_1619 (HP),
Acel_1906 (L), Acel_1910 (L), Acel_1970 (L), Acel_2129 (L)
Acel_0832 (L), Acel_0835 (L), Acel_0838 (L), Acel_0839 (L),
Acel_0841 (L), Acel_0843 (HPL), Acel_0844 (L), Acel_0845 (L),
Acel_0857 (L), Acel_0860 (L), Acel_0861 (L)
Acel_0100 (L), Acel_0114 (L), Acel_0632 (L), Acel_0686 (L),
Acel_0709 (L), Acel_1092 (PL), Acel_1100 (HP), Acel_1222 (L),
Acel_1285 (PL), Acel_1425 (HP), Acel_1846 (HL)
Acel_0089 (PL), Acel_0222 (PL), Acel_0223 (PL), Acel_0834 (L),
Acel_0851 (L), Acel_1564 (PL), Acel_1765 (HP), Acel_1789
(HPL), Acel_1873 (PL), Acel_2032 (L)
Acel_0235 (L), Acel_0237 (L), Acel_0940 (HP), Acel_0941 (H),
Acel_1381 (PL), Acel_1616 (HPL), Acel_1742 (L), Acel_1892 (L)

Table 8 (con’t)
Metabolic pathway/function

Number of
annotated
genes in the
category
22

Number of
upregulated genes
(fold change ≥2
and p ≤0.05)
7

31

7

32

7

Nitrogen metabolism

20

5

Oxidative phosphorylation

38

5

Arginine biosynthesis
Bacterial chemotaxis

13
18

4
4

Acel_0556 (H), Acel_1078 (L), Acel_1079 (L), Acel_1093 (PL),
Acel_1288 (L), Acel_1750 (H), Acel_1956 (L)
Acel_0291 (L), Acel_0343 (HPL), Acel_0557 (HP), Acel_0638
(HPL), Acel_1460 (L), Acel_1947 (L), Acel_2033 (PL)
Acel_1296 (L), Acel_1299 (H), Acel_1301 (H), Acel_1302 (H),
Acel_1402 (L), Acel_1540 (L), Acel_1971 (L)
Acel_1744 (L), Acel_1745 (L), Acel_1746 (L), Acel_1747 (L),
Acel_2055 (HP)
Acel_0273 (L), Acel_0650 (L), Acel_0652 (L), Acel_0654 (L),
Acel_1902 (L)
Acel_1096 (HP), Acel_1260 (L), Acel_1262 (L), Acel_1263 (H)
Acel_0852 (L), Acel_0854 (L), Acel_0855 (HPL), Acel_1786 (H)

Base excision repair
Nucleotide excision repair

12
9

4
4

Acel_0118 (HP), Acel_0221 (HPL), Acel_0356 (L), Acel_1903 (P)
Acel_0375 (L), Acel_1771 (L), Acel_1775 (L), Acel_1913 (L)

Starch and sucrose metabolism
Metabolic pathways
Pentose and glucuronate
interconversions
Phenylalanine metabolism
Terpenoid backbone biosynthesis
Thiamine metabolism
Ubiquinone and other terpenoidquinone biosynthesis

26
437
11

4
3
3

Acel_0614 (P), Acel_0615 (P), Acel_1601 (L), Acel_1701 (P)
Acel_0220 (L), Acel_1211 (H), Acel_1484 (PL)
Acel_0871 (HL), Acel_0872 (HL), Acel_0873 (L)

13
14
10
11

3
3
3
3

Acel_1439 (HL), Acel_1440 (HL), Acel_1836 (PL)
Acel_0080 (L), Acel_0081 (L), Acel_0181 (L)
Acel_0989 (H), Acel_1583 (L), Acel_1584 (PL)
Acel_0105 (L), Acel_0257 (P), Acel_0259 (L)

Alanine, aspartate and glutamate
metabolism
Amino sugar and nucleotide sugar
metabolism
Pyrimidine metabolism

Locus tag of the upregulated genes (treatment under which
upregulated, H: HA, P: PA, L: Lignin)
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3.6 Figures

HAxPA
(184)
HA
(142)

PA
(157)

HAxPAxLignin
(99)
HAxLignin
(45)

PAxLignin
(81)

Lignin
(334)

(a)
Figure 1. Venn diagrams showing unique and shared differentially expressed genes among the
three treatments. Differential expression was calculated using threshold values at p £ 0.05 and ³
2-fold change. Control (no treatment) was used as a baseline to calculate fold-change values for
each set. (a): total number of differentially expressed genes; (b) number of upregulated genes; (c)
number of downregulated genes. Experiment IDs are as follows: A - HA x Control; B - PA x
Control; C - Lignin x Control. The number of genes in each set are shown in brackets.
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HA
(108)

HAxPA
(53)

PA
(38)

HAxPAxLignin
(38)
HAxLignin
(26)

PAxLignin
(39)

Lignin
(345)

(b)
Figure 1 (con’t)
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HA
(59)

HAxPA
(142)

PA
(140)

HAxPAxLignin
(43)
HAxLignin
(1)

PAxLignin
(28)

Lignin
(39)

(c)
Figure 1 (con’t)
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Figure 2. Dendrogram showing clustering tree and heat map generated using hierarchical
clustering of genome wide gene expression data. Each row represents an individual gene (2213
rows). The yellow color indicates positive expression (greater fold change compared to control);
the blue color indicates negative expression (lesser fold change compared to control). The
missing genes are shown in white and genes with zero values are shown in grey.
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Figure 3. Dendrogram showing clustering tree and heat map generated using hierarchical
clustering of gene expression data of only significantly differentially expressed genes (³2-fold
change, p £ 0.05). Each row represents an individual gene (1042 rows). The yellow color
indicates positive expression (greater fold change compared to control); the blue color indicates
negative expression (lesser fold change compared to control). The missing genes are shown in
white and genes with zero values are shown in grey.
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3.7 Supplementary figures

Figure S1. mRNA enrichment from total RNA. The images represent snapshots of RNA quality
analyses before and after rRNA depletion. The x-axis represent size (nucleotides); the y-axis
sample intensity [FU] or [FU](10^3). (a) total RNA from control sample; (b) rRNA depleted
RNA from control sample; (c) total RNA from HA sample; (d) rRNA depleted RNA from HA
sample; (e) total RNA from PA sample; (f) rRNA depleted RNA from PA sample; (g) total RNA
from lignin sample; (h) rRNA depleted RNA from lignin sample. The images show one
representative sample of the two replicates.
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Figure S2. Assessment of DNA library quality and average library size. The x-axis represent
size (bp); the y-axis sample intensity [FU]. (a) control DNA library (261 bp); (b) HA DNA
library (238 bp); (c) PA DNA library (236 bp); (d) lignin DNA library (279 bp). The images
show one representative sample of the two replicates.
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Figure S3. Heat map displaying the expression levels of different genes across control, HA, PA
and lignin treatments. Each row corresponds to one gene and each column represents a treatment
(2213 rows).
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(a)
Figure S4. The scatter plots of gene expression levels. Each gene (2213 genes total) is
represented as an individual data point and is plotted on a log2 scale based on its expression in
control and treatment. The x-axis represents control, the y-axis represents treatment: (a) HA, (b)
PA and (c) lignin. The middle blue line is the identity line showing genes expressed at the same
level in both control and treatment. The outer two blue lines show genes with at least 2-fold
change in expression value in either control (green data points) or treatment (red data points).
The increase in color intensity of a data point represent increase in expression level. The dashed
purple line is the linear regression (R2) line that passes as near to as many data points as possible.
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(b)
Figure S4 (con’t)

114

(c)
Figure S4 (con’t)

115

Lignin
Lignin

HA

PA

Cluster 2
Lignin

PA

PA

HA

Lignin

PA

HA
HA

Cluster 1

Cluster 3

Cluster 4
Figure S5. Gene clusters of interest. Dendrogram showing heat map of gene clusters generated
using hierarchical clustering of gene expression data of differentially expressed genes. Each row
represent an individual gene. The yellow color indicates positive expression; the blue color
indicates negative expression. The missing genes are shown in white and genes with zero values
are shown in grey.
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Cluster 5

Cluster 7

Figure S5 (con’t)
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Lignin

PA
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Cluster 11

Figure S5 (con’t)
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Chapter 4
Generation and phenotypic analysis of knockout mutant of a thiosulfate sulfurtransferase gene in
Mycobacterium smegmatis

4.1 Introduction
Mycobacterium smegmatis (basonym for Mycolicibacterium smegmatis) is an aerobic, fast
growing, non-pathogenic, acid-fast Actinobacteria belonging to the family Mycobacteriaceae. It
is a high G+C bacillus (67.4% G+C content) with the genome size of 6.9 Mb. M. smegmatis mc2
155 strain containing the efficient plasmid transformation (ept) mutation is one of the widely
used strains of M. smegmatis for genetic manipulation. This strain has higher transformation
efficiency compared to the wild-type strain ATCC 607 [1]. Etienne et al., (2005) used
biochemical analysis to study the cell surface properties of the transformable strain mc2 155 and
suggested that the variation in composition and structure of the cell envelope might be
responsible for the enhanced transformation efficiency of the strain [2]. M. smegmatis shares the
peculiar cell wall structure and a number of homologous genes including those involved in
adaptation to stress in M. tuberculosis and other mycobacterial species [3, 4]. It has thus been
widely used as a model organism and a surrogate host for genetic analysis of various pathogenic
mycobacteria such as M. tuberculosis, M. avium, M. paratuberculosis [5-7].

M. tuberculosis, the causative agent of tuberculosis (TB), is a facultative intracellular pathogen
that resides within the macrophages of its host. Approximately one-third of the world’s
population is thought to be infected with M. tuberculosis [8]. A vast number of research groups
are dedicated towards identifying novel antimycobacterial agents. The drug targets are highly
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diverse and aim at growth inhibition by targeting various metabolic pathways such as cell wall
biosynthesis especially mycolic acid biosynthesis, reductive sulfur assimilation pathway,
mycothiol biosynthesis, amino acid and DNA synthesis etc. [9]. Many potential drug targets have
been identified so far, however antibiotic resistance has become a huge concern. There have been
increasing number of cases of multidrug-resistant TB (MDR-TB), which is caused by bacteria
that are resistant to the most effective first line anti-TB drugs (isoniazid and rifampicin), and
extensively drug-resistant TB (XDR-TB) including resistance to both first and second line TB
drugs [10].

It has been proposed that drug targets aiming at genes involved bacterial stress responses can be
exploited to combat antibiotic tolerance and multidrug resistance in bacteria [11]. In
Pseudomonas aeruginosa, the loss of a two-component regulator involved in membrane stress
response, reduced the virulence of the bacteria as well as enhanced the action of aminoglycoside
antibiotic tobramycin [12]. In our studies with the phenolic acid induced stress in Acidothermus
cellulolyticus, we observed that a putative thiosulfate sulfurtransferase protein (Acel_0059) was
highly upregulated when the bacteria was exposed to phenolic acids (see Chapter 2). We
hypothesized that this protein might be an important candidate involved in the phenolic acid
stress response in A. cellulolyticus possibly through the biosynthesis of cysteine. It is of interest
to know whether the role of TST under stress is specific to A. cellulolyticus, or shared among
different bacteria. Over the years, there have been numerous reports of TSTs (a.k.a. rhodaneses),
especially under stress inducing conditions. Florczyk et al., (2001) suggested a possible role of
TSTs in the assembly of iron-sulfur (Fe-S) clusters. Increased intracellular pools of Fe-S clusters
are required under conditions like low oxygen tension [8]. Another study with the TST isoforms
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showed these to function as thioredoxin oxidase in vitro suggesting that, their involvement in the
detoxification of intra-mitochondrial reactive oxygen species in vivo [13]. These functions of
TSTs have been proposed to be due to their ability to react with sulfur-containing anions such as
thiosulfate and transfers them to thiophilic acceptor molecules [14]. TSTs can generate enzymebased persulfides (activated sulfur), which serve as the building blocks for sulfur containing
compounds [15].

We were interested in knowing whether the homolog of A. cellulolyticus TST (Acel_0059) could
be involved in survival under stress and cysteine biosynthesis in mycobacteria. The M.
tuberculosis genome encodes a total of four putative sulfurtransferases, namely CysA2
(Rv0815c), CysA3 (Rv3117), SseA (Rv3283) and SseB (Rv2291). The presence of four different
homologs suggest an important role for these proteins in mycobacteria [8]. Among the four
genes, cysA2 (c909318-908485) and cysA3 (3483974-3484807) are 100% identical in their
nucleotide sequence. We used NCBI blastx feature (https://blast.ncbi.nlm.nih.gov/) to analyze
sequence similarity of the four sulfurtransferase homologs of M. tuberculosis H37Rv (Mtb) with
M. smegmatis mc2 155 (M. smegmatis), A. cellulolyticus 11B (A. cellulolyticus) and E. coli K-12
MG1655 (E. coli) strains (Table 1). The TST of A. cellulolyticus that was upregulated under
phenolic acid stress i.e. Acel_0059 (ACEL_RS00315) showed 74% sequence identity with M.
tuberculosis CysA2 (Rv0815c). M. smegmatis contains three different rhodanese domain
containing proteins, namely, MSMEG_1809, MSMEG_3238 and MSMEG_5789. The protein of
interest in M. smegmatis was MSMEG_5789, since it showed highest sequence identity with the
M. tuberculosis CysA2 (Table 1). The MSMEG_5789 (chromosomal location: 58596645860497 nt) protein shares 76% identity with A. cellulolyticus Acel_0059. The protein-protein
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BLAST (blastp) using the Uniprot/Swissprot database revealed that the closest sequence
homolog of A. cellulolyticus TST Acel_0059 was MSMEG_5789 from M. smegmatis mc2 155
(see Chapter 2). The MSMEG_5789 is 277 amino acids in length with a molecular weight of
30.98 kDa and contains two conserved rhodanese domains similar to Acel_0059.

There are multiple reports showing the involvement of TST and other rhodanese domain
containing proteins in mycobacteria under various conditions, however, the precise cellular
function is yet to be known. In a study with clinical isolates of M. tuberculosis, Rv0815c was
found to be upregulated in both sensitive and drug resistance isolates, suggesting its importance
in intracellular survival of the pathogen [16]. The M. tuberculosis TST gene has been shown to
be under the control of macrophage-induced promoters, suggesting its importance during
survival in host macrophages [17]. The M. tuberculosis MoeZR protein involved in
molybdopterin biosynthesis was predicted to contain a rhodanese-like domain at the C-terminus
[18]. This protein was later on shown to play an additional role in cysteine synthesis in vitro, and
it has been reported to be upregulated under oxidative stress conditions [19]. Cysteine is known
to be important during survival under oxidative stress conditions due to its role in generation of
redox mediators [20, 21]. Nakajima et al., (2008) demonstrated that rhodanese is induced by
radiation exposure and proposed that its induction might be related to its anti-oxidative functions
in cooperation with other anti-oxidative molecules such as glutathione and thioredoxin [22]. TST
has been shown to participate in sulfane sulfur transport along with mercaptopyuvate
sulfurtransferase and g-cystathionase in anaerobic L-cysteine metabolism, with reduced
rhodanese activity in Ehrlich ascites tumor-bearing mice compared to control mice [23].
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The difficulties in establishing the in vivo functions of these TSTs lie in the redundancy of
rhodanese modules and rhodanese activities [24]. An exception to this was observed in
Saccharopolyspora erythraea, where disruption of rhodanese-like gene resulted in cysteine
auxotrophy [25]. Deletion of rhodanese-like protein (RhdA) in Azotobacter vinelandii produced
an oxidative imbalance suggesting its role in anti-oxidative regulation of intracellular
homeostasis [26]. In the present study, we aimed at generating an in-frame gene deletion mutant
of MSMEG_5789 in M. smegmatis. The TST gene was replaced with hygromycin-resistance
cassette in the knockout mutant. The mutant was then exposed to various stress conditions, and
tested for cysteine dependence to understand the role of TST in M. smegmatis.

4.2 Materials and Methods
4.2.1 Bacteria, media and growth conditions. Mycobacterium smegmatis mc2 155 (ATCC®
700084TM) [1] was grown at 37°C with shaking at 150 rpm in Middlebrook 7H9 broth [27]. The
Middlebrook 7H9 broth (Difco) was supplemented with 10% albumin-dextrose catalase (ADC)
growth supplement (HIMEDIA), 0.2% (v/v) glycerol and 0.05% (v/v) Tween 80. For growth on
solid medium, Middlebrook 7H10 (Difco) medium supplemented with 10% (ADC) and 0.5%
glycerol was used. Antibiotics were added to the media as required: kanamycin (25 µg/ml) or
hygromycin (150 µg/ml). Tryptic soy agar (Difco) was used for growth on solid medium for disk
diffusion assays. Tryptic soy broth (Difco) was supplemented with Tween 80 (0.05%) when used
for growth analysis. For analysis of growth in different sulfur sources, bacteria were grown in
minimal M9 medium containing M9 salts (Difco) (1X), Tween 80 (0.05%), glycerol (0.5%),
MgCl2 (1 mM), CaCl2 (0.1 mM) and a specific sulfur source. The following sulfur sources were
used: MgSO4 (100 µM), Na2SO3 (100 µM), Na2S (100 µM), Na2S2O3 (100 µM) or cysteine (50
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µM). Escherichia coli was grown in Luria-Bertani medium [28] containing selective antibiotics,
kanamycin or hygromycin (50 µg/ml) at 37ºC with shaking at 250 rpm. Growth was monitored
using optical density at 600 nm (OD600).

4.2.2 Plasmids. Plasmid pYUB28b was a gift from Ted Baker (Addgene plasmid # 37277). It is
a 4921 bp shuttle vector between Mycobacteria and E. coli, that was used in this study to isolate
hygromycin resistance cassette [29]. The plasmid was supplied in E. coli TOP10 strain. The cells
containing pYUB28b were grown overnight in LB medium supplemented with hygromycin.
Plasmid pYUB28b was isolated after overnight growth using QIAprep Spin Miniprep kit
(Qiagen) and was quantified using Qubit dsDNA BR Assay kit and Qubit 2.0 Fluorometer (Life
Technologies). Plasmid pJV53 was a gift from Graham Hatfull (Addgene plasmid # 26904). The
plasmid contains the mycobacteriophage Che9c gp60 and gp61 recombinase genes fused to an
inducible acetamidase promoter [30]. The expression of recombinases through acetamide
induction in M. smegmatis was used for allelic exchange of MSMEG_5789 with hygromycin
resistance gene. The plasmid pJV53 (8812 bp) was supplied in E. coli DH5a strain. The cells
containing pJV53 were grown overnight in LB medium supplemented with kanamycin. Plasmid
was isolated after overnight growth using QIAprep Spin Miniprep kit (Qiagen) and was
quantified using Qubit dsDNA BR Assay kit and Qubit 2.0 Fluorometer (Life Technologies).

4.2.3 DNA extraction. Genomic DNA from M. smegmatis was isolated using DNeasy Plant
Mini kit (Qiagen). Briefly, 5ml overnight grown culture of M. smegmatis was harvested by
centrifugation at 10,000 rpm for 15 minutes. The cell pellet was frozen in liquid nitrogen and cell
disruption was achieved by grinding under liquid nitrogen using mortar and pestle. Genomic

131

DNA was further isolated in 200µl AE buffer including treatment with 4µl RNase stock solution
(100 mg/ml) as per manufacturer’s instructions. DNA obtained was quantified using Qubit
dsDNA BR Assay kit and Qubit 2.0 Fluorometer (Life Technologies).

4.2.4 Polymerase chain reaction (PCR) conditions and primers. PCR amplifications were
performed using Taq DNA Polymerase with Standard Taq Buffer (New England Biolabs). The
standard 50µl PCR reaction consisted of Standard Taq reaction buffer (1X), dNTPs (200µM),
forward and reverse primer (0.2 µM each), template DNA (1-10 ng) and Taq DNA Polymerase
(2.5 units). In addition, dimethyl sulfoxide (DMSO) at 5% and betaine at 1M final concentration
were added to the PCR mix. DMSO and betaine are widely used chemical agents that help in
decreasing secondary structure formation and minimizing high Tm during PCR amplification of
G+C-rich sequences [31]. Standard PCR amplifications were carried out as follows: initial
denaturation at 95ºC (30 seconds), 30 cycles of denaturation (95ºC, 30 seconds), annealing (4768ºC, 30 seconds), extension (68ºC, 1 minute/kb), and final extension at 68ºC for 5 minutes. The
sequences of primers used in the study are provided in Table 2. Sequences of genes of interest in
M. smegmatis were obtained from NCBI [32]. Sequence of pYUB28b was obtained from
Addgene. Primers were designed using OligoPerfect™ Designer (ThermoFisher Scientific).
Primer properties including melting temperature, hairpins or dimers formation were analyzed
using OligoAnalyzer® Tool (Integrated DNA Technologies).

For Overlap PCR, primers were designed to contain 10-20 bp identity with the sequence of
interest to be fused. Overlap PCR is a method in which two DNA sequences are fused together in
a PCR reaction due to the presence of common sequence in 5’ end of primers [33]. Quantitative
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real-time PCR (RT-PCR) was carried out using QuantiFast® SYBR® Green PCR kit (Qiagen)
and BioRad CFX96 Real-Time System. The 25 µl reaction mix consisted of QuantiFast SYBR
Green PCR Master Mix (1x), forward and reverse primer (0.3 µM each), and template DNA
(variable). Real-time cycler conditions included a PCR initial activation step at 95°C for 5
minutes, followed by 35 cycles of amplification (95°C, 10 seconds and 60°C, 30 seconds).

4.2.5 Generation of the UHD construct. A 594 bp fragment upstream and a 581 bp fragment
downstream of the thiosulfate sulfurtransferase encoding gene, MSMEG_5789 (NC_008596.1
[5859664..5860497]) were amplified from M. smegmatis genomic DNA. A 1130 bp region
containing the hygromycin resistance gene cassette (hygR) was amplified from plasmid
pYUB28b. The resulting amplified fragments contained 10-20 bp sequence identity with the
fragment to be fused. Fusion of the three PCR products (i.e. upstream fragment, hygR gene and
downstream fragment) was carried out using Overlap PCR technique in two steps (Figure 1). In
step 1, either the M. smegmatis upstream (U) region or downstream (D) was fused with hygR (H)
gene cassette to generate a ‘UH’ or ‘HD’ fusion product using PCR. The above overlap PCR
reactions included a total of 300 ng DNA template, which included U/D and H DNA in a 1:3
ratio. PCR amplifications were carried out as follows: initial denaturation at 95ºC (30 seconds),
30 cycles of amplification, and final extension at 68ºC for 5 minutes. The first 15 cycles of
amplification were carried out without any primers and annealing temperature (Ta) set at 68ºC.
In these cycles, common region among genes to be fused served as a primer. After 15 cycles, 5’
and 3’ end primers were added, and amplification was performed with Ta set at 47ºC. In step 2,
the UH and HD gene products were used as a template to generate UHD construct in similar
overlap PCR reaction (1 HD: 3 UH).
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The fused UHD gene product was reamplified using primers internal to the edges of the UHD
product to generate 127 bp shorter iUHD product. The re-amplification was carried out using
standard PCR amplification with annealing at 48ºC. Before their use in the next step, all
amplified fragments were analyzed using agarose gel electrophoresis. The DNA fragments were
then excised from agarose gels and purified using QIAquick gel extraction kit (Qiagen). Purified
DNA fragments were quantified using Qubit dsDNA BR Assay kit and Qubit 2.0 Fluorometer
(Life Technologies).

4.2.6 Preparation of electrocompetent cells and transformation. Electrocompetent M.
smegmatis were prepared as described previously [34]. The bacterial culture was inoculated into
500 ml of Middlebrook 7H9 media and grown to an OD600 of 0.6. The cells were incubated on
ice for 1.5 hours and harvested by centrifugation at 10,000 rpm for 15 minutes at 4ºC. The cell
pellet was resuspended in equal volume of ice-cold 10% glycerol. A total of three washes were
performed in ice-cold 10% glycerol. The cell pellet was resuspended to a final volume of 1 ml in
ice-cold 10% glycerol and 100 µl aliquots were prepared in 1.5 ml tubes. The tubes were frozen
in dry ice/ethanol and stored at -80°C until use.

Transformation was performed by gently mixing 200 µl electrocompetent M. smegmatis cells
with 660 ng of purified pJV53 plasmid DNA. The mixture was incubated on ice for 10 minutes.
Electroporation was carried out using Gene Pulser Xcell™ Electroporation System (Bio-Rad)
and pre-chilled 0.2 cm electrode gap cuvette. The mixture was electroporated at 2.5 KV, 25 µF
and 800 Ω. After electroporation cells were recovered in 2 ml Middlebrook 7H9 media at 37ºC
and 150 rpm for 3 hours. Recovered cells were harvested by centrifugation at 10,000 rpm for 15

134

minutes at 37°C. Cell pellet was resuspended in 200 µl Middlebrook 7H9 media and plated on
Middlebrook 7H10 media supplemented with kanamycin (25 µg/ml). After 3 days of growth on
plates, kanamycin resistant colonies were selected. The colonies were resuspended in
Middlebrook 7H9 media containing kanamycin. These M. smegmatis cells containing pJV53
cells were labelled as M53 cells.

M53 cells were then induced using acetamide to express Che9c gp60 and gp61 recombinases
from plasmid pJV53. Electrocompetent M53 cells expressing recombinases were prepared as
described previously [30]. A saturated bacterial culture of M53 cells was inoculated into 100 ml
of Middlebrook 7H9 media containing 0.2% succinate, 1mM calcium chloride and 25 µg/ml
kanamycin at OD600 0.020. The cells were incubated at 37ºC and 150 rpm till an OD600 of 0.400
was achieved. At this point, acetamide was added to a final concentration of 0.2% followed by
incubation for 3 hours to allow induction of Che9c gp60 and gp61 recombinases. After 3 hours,
cells were incubated on ice for 2 hours and harvested by centrifugation at 10,000 rpm for 15
minutes at 4ºC. Electrocompetent cells were prepared as described above, but with total of 4
washes with ice-cold 10% glycerol. The cells were resuspended to a final volume of 4 ml in icecold 10% glycerol (1/25th of original volume) and 100 µl aliquots were prepared in 1.5 ml tubes.
The tubes were frozen in dry ice/ethanol and stored at -80°C until use. These acetamide induced
M53 cells was labelled as M53I.

4.2.7. Deletion of the chromosomal MSMEG_5789 gene in M. smegmatis. Electrocompetent
cells expressing mycobacteriophage Che9c gp60 and gp61 recombinase genes from pJV53
(M53I) were electroporated with re-amplified UHD construct (iUHD). Transformation was
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carried out as described above. The mixture of 110 µl cells (M53I) and 1.5 µg iUHD DNA was
incubated on ice for 10 minutes. Electroporation was carried out at 2.5 KV, 25 µF and 800 Ω.
After electroporation cells were recovered in 4 ml Middlebrook 7H9 media at 37 ºC and 150 rpm
for 4 hours. Cells were plated on Middlebrook 7H10 media supplemented with hygromycin (150
µg/ml). After 3 days of growth on plates, hygromycin resistant colonies were selected. The
colonies were resuspended in Middlebrook 7H9 media containing hygromycin. Overnight grown
cultures were analyzed for replacement of MSMEG_5789 with hygR through colony PCR using
quantitative real time-PCR (RT-PCR). Genomic DNA was isolated from MsmegΔTST as
described earlier, and was verified for replacement of MSMEG_5789 with hygR using PCR. The
genomic DNA from wild type M. smegmatis mc2155 was used as control. The PCR products
obtained were further sequenced to confirm the replacement of MSMEG_5789 with hygR.

4.2.8 Colony PCR. A 50 µl of culture was centrifuged at 15,000 rpm for 10 minutes. The
supernatant was discarded, and cell pellet were kept at -80 ˚C for 5 minutes. The pellet was
resuspended in 0.001% Triton-X and incubated in 100°C water bath for 15 minutes. This was
followed by centrifugation at 15,000 rpm for 10 minutes to separate the supernatant from the cell
debris. 5 µl supernatant was used as template for PCR analysis.

4.2.9 Glycerol stocks of cultures. Glycerol stocks of all bacterial cultures used were prepared
for their long-term storage. Typically, 500 µl overnight grown culture was mixed with 500 µl of
40% sterile glycerol and transferred to 2 ml cryo-vial. The vial was snap chilled in liquid
nitrogen and stored at -80˚C.
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4.2.10 Disk diffusion assay. The sensitivity of wild type M. smegmatis and MsmegΔTST to
various antimicrobial compounds was determined by disk diffusion assays [35]. Wild type M.
smegmatis and MsmegΔTST were grown to an OD600 of 0.3 and plated on TSA plates using
sterile cotton swabs. Sterile filter paper disks (8 mm) were saturated with 20 µl antimicrobial
compound to be tested and allowed to air dry. The following compounds were tested for disk
diffusion assay: sodium dodecyl sulfate (SDS) (10%), formaldehyde (10%), dithiothreitol (DTT)
(2 M), hydrogen peroxide (H2O2) (1 M), chloramphenicol (32 mg/ml), phenolic acid mixture
(equal proportions of hydroxybenzoic acid, vanillic acid, coumaric acid, syringic acid, ferulic
acid) (0.5 M), 4-hydroxybenzoic acid (HA) (2 M), nalidixic acid (50 mg/ml), rifampicin (50
mg/ml), 2-mercaptoethanol (2 M) and hygromycin (100 mg/ml). Air dried filter paper disks were
placed on culture plates and incubated at 37°C for two to three days. The diameter of zone of
inhibition (mm) was recorded for each compound.

4.2.11 Spot assay. The effect of four different compounds on wild type M. smegmatis and
MsmegΔTST was analyzed using spot assays. Wild type M. smegmatis or MsmegΔTST were
grown in M9 media containing MgSO4 to an OD600 of 0.4. A total of 100 µl volume in each well
of 96-well plates, contained 99 µl cell cultures and 0-1 µl of compound to be tested (final
volume made to 100 µl using sterile water). The following compounds were tested: SDS (0.00,
0.01, 0.02, 0.05, 0.10%), formaldehyde (0.00, 0.01, 0.02, 0.05, 0.10%), diamide (0, 20, 40, 60,
80 mM), H2O2 (0.0, 2.5, 5.0, 7.5, 10.0 mM). The 96-well plates containing diamide were
incubated in dark for 6 hours at 37°C. The 96-well plates containing H2O2, SDS and
formaldehyde were incubated for 3 hours at 37°C. After incubation, ten-fold dilutions of each
treatment were prepared in TSB. A volume of 3 µl from each dilution was used for plating spots
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on TSA plates. The plates were incubated at 37°C for 1-2 days and growth was observed.

4.2.12 Survival under aerobic and microaerophilic conditions. The role of TST during
survival under oxygen limitation conditions was analyzed. Wild type M. smegmatis or
MsmegΔTST were grown in M9 media containing MgSO4 to an OD600 of 0.3. Cultures were
inoculated into fresh media at 1:1000 dilution. Three different types of media were used for
growth analysis i.e. Middlebrook 7H9 media, M9 media containing MgSO4 (1 mM) as a sulfur
source, M9 media containing cysteine (100 µM) as a sulfur source. After inoculations, 1 ml
culture was used for measurement of OD600 at 0 hours. Oxygen limitation was induced as
described previously with modifications [36]. A 10 ml culture was incubated in 15 ml screwcapped tubes (head to space ratio of 0.5). The screw-caps were tightly secured and tubes were
incubated for 24 days at 37˚C without agitation. After incubation, culture tubes were vortexed
vigorously for 2 hours to allow for breakage of clumps. The OD600 was measured using 1 ml
culture. For growth under aerobic conditions, 4 ml culture was incubated in 50 ml tubes and
incubated at 37˚C with shaking at 150 rpm for 48 hours. The OD600 was measured using 1 ml
culture.

4.2.13 Growth in presence of different sulfur sources. Growth of MsmegΔTST in the presence
of different sulfur sources was observed. Starter cultures of wild type M. smegmatis or
MsmegΔTST were grown in Middlebrook 7H9 media without and with hygromycin respectively
to an OD600 of 1.2. Cultures were pelleted by centrifugation at 21,000 g and supernatant was
discarded. The pellets were resuspended in equal volume of 1x M9 salts containing 0.05%
Tween 80. A total of 7 washes were performed and cultures were finally resuspended in 1x M9
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salts containing 0.05% Tween 80. Resuspended cultures were inoculated into 10 ml fresh media
at 1:500 dilution. The media contained either MgSO4, Na2SO3, Na2S, Na2S2O3 or cysteine as the
sole sulfur source. Cultures were grown in 50 ml tubes under aerobic conditions at 37ºC and
shaking at 150 rpm. Growth was monitored for 72 hours at regular intervals by measuring OD600
using 1 ml culture. To observe growth under microaerophilic conditions, cultures prepared in the
same way were grown in glass vials secured with rubber caps and sealed with aluminum caps. A
2 ml culture was added to each 3 ml glass vial, to maintain a head-to-space ratio of 0.5. The vials
also contained sterile magnetic stir bars (8x1-1.2 mm) to allow for agitation to prevent cell
clumping. Growth was monitored every day for a total of 6 days by measuring OD600 using 1 ml
culture. The cultures were passed through 27 mm gauge needle 7 times to disperse cell clumps
before measuring OD600.

4.2.14 Murine macrophage mycobacterial infection. Macrophage infection with mycobacteria
was carried out as described previously with modifications [37]. Single-cell suspension of
murine mononuclear macrophage cell line were seeded at 105 cells /ml in RPMI (Roswell Park
Memorial Institute) medium containing 10% FBS (fetal bovine serum) and 1X AntibioticAntimycotic solution (Gibco). The cultures were maintained in 24-well plates at 500 µl/well.
Cells were passaged at 1:10 dilution and maintained till 70-80% confluency was achieved. One
day prior to culturing with mycobacteria, the macrophage cells were washed three times with
PBS (phosphate buffered saline) and cultured in media without antibiotics.

Wild type M. smegmatis and MsmegΔTST strains were grown overnight in Middlebrook 7H9
media without or with hygromycin, respectively. Ten-fold serial dilutions of cultures were
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prepared to determine colony forming units/ml (CFU/ml). Mycobacteria at 3*106 cells/ml were
added to each well containing 3*105 cells/ml macrophages without antibiotic to achieve a
multiplicity of infection (MOI) of 10:1 (bacteria per macrophage). The co-cultures were
incubated at 37ºC in 0.5% CO2 for 6 hours to allow phagocytosis of mycobacteria by
macrophages. After 6 hours, phagocytosis was stopped and extracellular bacteria were removed
by washing two times in ice-cold PBS. The macrophages were further incubated in fresh media
containing gentamicin (50 µg/ml) to inhibit the growth of extracellular bacteria. Macrophages
were harvested at various time points (6, 24, 48 and 72 hours) and lysed with ice-cold water to
determine the number of surviving mycobacteria in infected macrophages. Ten-fold serial
dilutions of the lysates were prepared in TSB and 100 µl each dilution was plated on TSA plates.
After 3 days of incubation, colonies were counted and CFU/ml were determined.

4.3 Results
4.3.1 UHD construct generation. All PCR amplified products that were obtained and further
used for the generation of the UHD construct are shown in the agarose gel (Fig. 2). A 594 bp
upstream (U) and 581 bp downstream (D) sequence of MSMEG_5789 were amplified using PCR
and the M. smegmatis genomic DNA template. Gene cassette encoding for hygromycin
resistance, hygR (H) was amplified from plasmid pYUB28b [29]. The U and D products were
fused separately with the H product using overlap PCR to generate a 1690 bp UH and a 1686 bp
HD constructs, respectively. The 2246 bp UHD construct was generated by fusing UH and HD
products using PCR (Fig. 2). To generate more UHD DNA for downstream experiments, the
UHD construct was further amplified using internal primers and the resulting linear DNA
(iUHD) was used for transformation in M. smegmatis containing a recombineering plasmid
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pJV53 [30].

4.3.2 Deletion of the chromosomal MSMEG_5789 gene in M. smegmatis. The transformation
of acetamide-induced pJV53 containing M. smegmatis cells (M53I) with iUHD construct yielded
four colonies after 3 days of growth on plates containing 150 µg/ml hygromycin. The colonies
were labelled as MsmegΔTST, MsmegΔTST2, MsmegΔTST3, MsmegΔTST4 and analyzed for
presence of hygR and deletion of MSMEG_5789 using RT-PCR. The genomic DNA from
MsmegΔTST and wild type M. smegmatis were analyzed using PCR for further verification of
for replacement of MSMEG_5789 with hygR. PCR products obtained after amplification using
different combination of primers (Table 3) confirmed the presence of hygR and absence of
MSMEG_5789 in the genomic DNA of MsmegΔTST (Fig. 3). The same combination of primers
confirmed the absence of hygR and presence of MSMEG_5789 in the genomic DNA of wild type
M. smegmatis (Fig. 3).

4.3.3 Disc diffusion assay. Disc diffusion assays were used to test the sensitivity of wild type M.
smegmatis or MsmegΔTST to various antimicrobial compounds. The zone of inhibition was
measured in mm. It was observed that MsmegΔTST was significantly more sensitive than its
parent strain to formaldehyde, DTT, hydrogen peroxide and PA (Fig. 4). MsmegΔTST was
slightly more sensitive to SDS and 2-mercaptoethanol. On the contrary, the wild type strain was
more sensitive than MsmegΔTST to HA, however the difference was not significant. In addition,
no significant difference between the sensitivities of the wild type strain and MsmegΔTST was
observed upon exposure to antibiotics chloramphenicol, nalidixic acid and rifampicin (Fig. 4).
Antibiotic hygromycin was used as a control - as expected, the wild type strain was significantly
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highly sensitive to hygromycin, while the MsmegΔTST was resistant to hygromycin due to the
presence of hygR gene inserted in place of the TST gene in the chromosome.

4.3.4 Spot assay. Spot assays were employed to analyze the antimicrobial effect of four different
compounds on MsmegΔTST compared to the wild type M. smegmatis. The four compounds
tested included: SDS, formaldehyde, diamide and hydrogen peroxide. The size of the spot
indicated qualitative differences in growth of the two strains in different treatments. In case of
SDS, there was no difference in spot size among the two strains at 0.01%. However, the
MsmegΔTST showed lesser growth compared to wild type when exposed to SDS at 0.02, 0.05
and 0.1% concentration. The growth difference increased with increasing SDS concentrations
(Fig. 5A). Similar effect was observed with formaldehyde. There was no significant difference in
spot size among the two strains at 0.01 and 0.02% formaldehyde. However, the MsmegΔTST
showed lesser growth compared to wild type at 0.05 and 0.1% formaldehyde concentration (Fig.
5B). No decrease in growth in either wild type or MsmegΔTST strain was observed after
exposure to diamide or H2O2 (Fig. 5C, 5D).

4.3.5 Survival under aerobic and microaerophilic conditions. Under microaerophilic
conditions, there was a significant decrease in growth of MsmegΔTST compared to wild type
when MgSO4 was used as a sole sulfur source (Fig. 6). However, when cysteine was used as a
sulfur source, MsmegΔTST grew equally well as the wild type strain. These data indicated that
TST may play a role in the synthesis of cysteine from inorganic sulfate during microaerophilic
conditions since the MsmegΔTST strains lacking the TST could not efficiently utilize MgSO4 as
the sole sulfur source. There was no significant difference in growth observed in MsmegΔTST
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compared to wild type in Middlebrook 7H9 media under microaerophilic conditions. Under
aerobic conditions, MsmegΔTST strain grew equally well as the wild type strain on M9 minimal
media. The deletion of TST did not seem to have an effect on the organism’s ability to utilize
MgSO4 or cysteine as a sole sulfur source under aerobic conditions (Fig. 7). There was slight
increase in growth observed in MsmegΔTST compared to wild type in Middlebrook 7H9 media,
however, the difference in the growth was not significant.

4.3.6 Growth in presence of different sulfur sources. Growth of MsmegΔTST in M9 minimal
media containing either MgSO4, Na2SO3, Na2S, Na2S2O3 or cysteine as the sole sulfur source
was observed under aerobic condition. There was no significant difference observed in the
growth pattern of MsmegΔTST compared to wild type in the presence of different sulfur sources
(Fig. 8). The deletion of TST did not seem to have significant effect on the ability of the
organism to utilize different sulfur sources for growth under aerobic conditions. We could not
conclude results on the preference of sulfur sources under microaerophilic conditions, due to
variations among replicates and tube to tube variations among different growth points.

4.3.7 Murine macrophage mycobacterial infection. The number of surviving phagocytosed
mycobacteria in macrophages was calculated at 24, 48 and 72 hours. Both wild type and
MsmegΔTST survival decreased at 24 and 48 hours. At 72 hours, an increase in the number of
phagocytosed mycobacteria was observed possibly due to macrophage cell death (Fig. 9A). The
number of surviving wild type mycobacteria was 2-fold lesser than MsmegΔTST at 24 hours,
however, there was no significant difference in CFU/ml of both strains at 48 hours (Fig. 9B). The
percentage of surviving CFU/ml at 24 and 48 hours compared to starting 6 hours was calculated
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(the mycobacteria were allowed to be phagocytosed by macrophages for first 6 hours of coculturing). There was no significant difference in percent survival among M. smegmatis or
MsmegΔTST strain (Fig. 9C).

4.4 Discussion
TST gene deletion in M. smegmatis was carried out using a process called recombineering [30].
van Kessel and Hatfull (2007) reported the development of a gene replacement strategy in
mycobacteria using a Rec-ET like enzyme system from mycobacteriophage Che9c [30].
Mycobacteriophage Che9c proteins gp60 and gp61 were reported to show exonuclease and DNA
binding activity, respectively, that facilitated allelic exchange in both fast growing M. smegmatis
and slow growing M. tuberculosis. The authors constructed pJV53 plasmid containing Che9c
gp60 and gp61 fused to an inducible acetamidase promoter to allow for controlled expression of
phage recombinases in the host. This plasmid was used in our study to facilitate the replacement
of MSMEG_5789 (TST) with hygromycin resistance gene cassette (hygR) in M. smegmatis. The
linear gene construct for replacement was constructed as described by Mao et al., (2016) with
modifications [38]. In-frame deletion of TST was carried out by fusing homologous arms of the
target gene to hygR. Electroporation of the resulting linear construct into M. smegmatis
expressing the phage recombinases yielded hygromycin resistant colonies indicating allelic
exchange of hygR for TST.

The three gene fragments of interest i.e. upstream region of MSMEG_5789 (U), hygromycin
resistance gene cassette (hygR) and downstream region of MSMEG_5789 (D) were fused using
Overlap PCR. The method was modified in several ways to achieve increased yield of the fusion
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product. Firstly, the primers for PCR amplification were designed to have Tm around 55°C. The
primers containing the overlapping extension from the neighboring gene, however, had higher
Tm due to longer length and high G+C content of the sequences to be fused. Secondly, addition
of DMSO (5%) and betaine (1M) to the reaction mixture increased PCR product yields. Thirdly,
the first 15 cycles of amplification were carried out without any primers. The common region
among two genes to be fused served as a primer. After 15 cycles, end primers were added and
amplification of fused gene products was carried out. The addition of end primers to the reaction
mix in the beginning of reaction yielded poor results. In addition, the three genes were fused in
two steps: firstly, U or D were fused to H, yielding UH and HD; secondly, UH and HD were
fused together to generate UHD where the entire hygR region served as an overlap template.
Amplification reactions where all three genes were simultaneously added to the reaction mixture
for fusion, resulted in poor yields in our case. It was also observed that for fusion, having the
genes in 1:3, 1:5 or 1:7 ratio yielded more fusion product compared to 1:1 ratio. For all fusion
PCRs, 1:3 ratio of genes was used as similar yields were obtained with 1:5 and 1:7 ratio.

Disc diffusion assay was employed to analyze the phenotypic differences between wild type and
MsmegΔTST. The sensitivity to multiple antimicrobial compounds was tested. We observed that
the deletion of TST gene resulted in increased sensitivity of the organism to formaldehyde, DTT,
hydrogen peroxide, 2-mercaptoethanol, SDS and PAs. Exposure to formaldehyde discs resulted
in the most significant difference among sensitivity between wild type and MsmegΔTST.
Formaldehyde, despite its simple structure, is highly toxic to microorganisms because of its
electrophilic nature [39]. Most microorganisms, especially bacterial pathogens, employ a thioldependent (glutathione [GSH], mycothiol [MSH] or bacillithiol [BSH]) formaldehyde
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detoxification system to render it into non-toxic formate or carbon dioxide [40-42]. It has
previously been observed in M. smegmatis, that oxidation of formaldehyde results in the
formation of formate and MSH and vice-versa [43]. Cellular cysteine pools are important for
generation of mycothiol in mycobacteria. We hypothesize that the possible role of TST in
cysteine generation, might be the reason for the inability of MsmegΔTST mutants to detoxify
formaldehyde, resulting in increased sensitivity after exposure compared to wild type strain.
Similar results were obtained with spot assays, wherein, formaldehyde exposure led to lesser
growth of MsmegΔTST compared to wild type at concentrations as low as 0.05%. These results
suggest a possible role of TSTs in maintaining cysteine and mycothiol pools in cells, that help in
detoxification of toxic electrophilic compounds.

Due to the presence of rhodanese domain, TSTs have been predicted to have a role in
maintaining redox balance of cells. In Azotobacter vinelandii, a rhodanese domain containing
protein, RhdA, was found to participate in redox reactions using its cysteine thiol to maintain
cellular redox balance [26, 44]. The RhdA deletion mutants were found to have lower reduced
glutathione levels compared to wild type strain. We tested the effect of few oxidizing and
reducing agents on cells lacking TST. SDS, 2-mercaptoethanol and DTT are commonly used
reducing agents used for the reduction of disulfide bonds and other disulfides. At higher
concentrations these agents reduce the cysteine residues on proteins, prevent disulfide bond
within or among different protein molecules, possibly hampering cellular functions.

DTT exhibits low oxidation-reduction potential, that ensures quantitative reduction of disulfides
in an almost irreversible reaction [45]. Rhodaneses have been shown to interact with DTT,
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resulting in the formation of a sulfide and oxidized DTT [46]. We observed that cells lacking
TST were more sensitive to DTT as compared to the wild type strain. Another reducing agent
tested, 2-mercaptoethanol, also has strong reducing properties, and is used when complete
disulfide reduction is required [47]. This might be the reason for increased sensitivity of
MsmegΔTST to 2-mercaptoethanol compared to DTT. The MsmegΔTST was also found to be
slightly more sensitive to SDS compared to wild type. The sulfhydryl groups on TST enzyme are
converted into disulfide during denaturation induced by SDS in a reversible reaction [48]. The
engagement of SDS by these enzymes might be a mechanism to protect the other cellular
proteins from denaturation.

There are numerous reports of TST upregulation under oxidative stress conditions. Our previous
studies indicated that TST aids in protection from stress, through its role in the generation of
cysteine. In A. cellulolyticus, the addition of cysteine alleviated the upregulation of TST in
response to stress induced by hydroxybenzoic acid (see Chapter 2). Cysteine is an important
component of sulfur metabolism, which along with rhodanese has been proposed to serve as an
anti-oxidative stress system [49]. Voss et al., (2011) observed that a mycobacterial
molybdopterin biosynthesis protein, MoeZR, showed thiosulfate:sulfurtransferase activity and
was involved in cysteine biosynthesis in a pathway involving a sulfur carrier protein, CysO and a
cysteine synthase, CysM [19]. It has been previously observed that the expression of MoeZR is
upregulated along with the expression of CysO and CysM under oxidative stress conditions [50].
We exposed MsmegΔTST to 1 M H2O2 in a disk diffusion assay. The deletion of TST in these
cells resulted in increased sensitivity to hydrogen peroxide. This observation correlates with the
previous findings of Nambi et al., (2015), where the deletion mutants of the MSMEG_5789
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paralog, MSMEG_1809 and the corresponding mutant in M. tuberculosis (Rv3283) were found to
show increased sensitivity to oxidative stressors tert-butyl-hydroperoxide and cumene
hydroperoxide [51]. In their study, TST was shown to form a membrane-associated
oxidoreductase complex (MRC) along with superoxide-detoxifying enzyme (SodA) and an
integral membrane protein (DoxX), and relieve oxidative stress by maintaining thiol homeostasis
[51]. The authors, however, did not observe any toxicity of either the wild type or the mutants
with hydrogen peroxide. The toxic effects in their study were analyzed at 1 mM H2O2
concentration, which is 10 times lower than what we used for the disc assays. Similar to their
observations, we also did not observe any toxicity when H2O2 was used at concentrations 2.5-10
mM in spot assays. Possibly, the presence of multiple TST homologs compensates for the
deletion of one TST homolog during H2O2 induced oxidative stress. The toxic effect increases at
higher concentration, which might not be completely compensated by the other homologs,
resulting in increased sensitivity. Since the predicted function TST in maintaining cellular redox
balance is through thiol recycling, we looked at the effect of thiol-specific oxidant, diamide. The
MsmegΔTST were exposed to 20-80 mM diamide for 6 hours. We did not observe any toxicity
to diamide in either wild type or the deletion strain.

Phenolic acids are small aromatic compounds that have been shown to trigger oxidative stress
response in microorganisms at high concentrations [52]. Our disc diffusion assays showed that
PA mixture was significantly more toxic to MsmegΔTST compared to wild type strain. These
results are in agreement with the previous results, where E. coli cells overexpressing A.
cellulolyticus TST were significantly less sensitive to PA mixture compared to wild type (see
Chapter 2). The results on the toxicity of HA were however different. We observed that
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MsmegΔTST strain was less sensitive to HA, compared to wild type. HA derivatives have been
predicted to play a different role in mycobacteria. These have been shown to be secreted by M.
tuberculosis during infection and have the ability to suppress the pro-inflammatory response to
infection [53, 54].

We looked at the toxic effects of three commonly used antibiotics: chloramphenicol, nalidixic
acid and rifampicin on MsmegΔTST. Chloramphenicol is an inhibitor of protein synthesis in M.
tuberculosis [55]. We did not observe any significant differences on the toxicity of
chloramphenicol to wild type or MsmegΔTST. Nalidixic acid is a selective inhibitor of DNA
synthesis and is shown to result in decreased the DNA/protein ratio in M. smegmatis [56].
Rifampicin blocks the DNA-dependent RNA polymerase in M. smegmatis, blocking the
initiation of RNA chain synthesis [57]. We observed that MsmegΔTST was slightly more
sensitive compared to wild type strain, when exposed to either nalidixic acid or rifampicin,
however, the difference in sensitivity was not significant. Analysis of global protein levels of a
clinical isogenic pair of Beijing genotype M. tuberculosis revealed that TST (Rv3283) was less
abundant in cells that acquired multi-drug resistance (MDR) to isoniazid and rifampicin [58].
However, it was previously shown that another TST homolog (Rv0815c) was present in both
intracellular MDR and sensitive isolates and was proposed as potential drug target against drugresistant and sensitive M. tuberculosis [16]. We did not observe high sensitivity to rifampicin as
expected. It is possible that the presence of its paralog MSMEG_1809 compensates for the
deletion of MSMEG_5789 in these cells. Hygromycin B, was used as a control in our disc
diffusion assay. Hygromycin is widely used in mycobacteria as a selectable marker and inhibits
translocation of mRNA and tRNAs on the ribosome [59, 60]. As expected, the replacement of
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MSMEG_5789 with hygR in MsmegΔTST resulted in no zone inhibition with hygromycin, while
the wild type strain was found to be highly sensitive to hygromycin.

A study with M. avium subsp. paratuberculosis showed that TST was one of the 10 proteins
whose expression was upregulated during infection [61]. TST has been predicted to be important
in intracellular survival of drug resistant/sensitive M. tuberculosis [16]. The intracellular
environment of granuloma is characterized by an acidic pH, the presence of toxic fatty acids, and
the low availability of oxygen [62]. We investigated the involvement of TST during survival in
low availability of oxygen. In addition, we tested whether TST aids in alleviating hypoxic stress
through generation of cysteine under such conditions. We observed that when MgSO4 was used
as the sole sulfur source, the growth was significantly decreased in MsmegΔTST compared to
wild type under microaerophilic conditions. However, in the presence of cysteine, the growth of
MsmegΔTST under microaerophilic conditions was comparable to that of wild type. Under
aerobic conditions, there was no effect of deletion of MSMEG_5789 during growth in any of the
growth medium.

Florczyk et al., (2001) previously reported that the amount of the two putative TSTs, CysA2 and
CysA3 (Rv0815c and Rv3117, respectively) were approximately six-fold greater in standing
culture conditions than under shaking culture conditions [8]. Their data suggest that TST is
important for survival under stress induced by low availability of oxygen [8]. The possible
mechanism by which TST helps in alleviating such stress is by being either directly or indirectly
involved in generation of cysteine, a precurser for antioxidant redox molecules such as
glutathione. Lyubetsky et al., (2014) studied cysteine dependent regulation of TST in
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Actinomycete Gordonia polyisoprenivorans VH2, wherein, the transcription level of TST was
predicted to slightly decrease with increase in cysteine concentration [64]. It has been shown that
there is a significant increase in reactive oxygen species along with a significant decrease in
glutathione peroxidase, glutathione reductase and reduced glutathione levels in the neuronal
hippocampal cells exposed to hypoxia [63]. N-acetyl cysteine, a precurser for the formation of
glutathione, has been shown to have a protective effect on the such hypoxia-induced cytotoxicity
[63].

We hypothesized that TST might be involved in cysteine biosynthesis in a sulfur reduction [65].
We grew the MsmegΔTST in presence of different sulfur sources including sulfate, sulfite,
sulfide, thiosulfate and cysteine. Under aerobic growth conditions, we did not observe any
significant differences in the growth of MsmegΔTST compared to wild type on various sulfur
sources (Fig. 8). These results were similar to our previous observations (Fig. 7). It was expected
that a clear phenotypic difference based on the preference for sole sulfur source might be
observed during growth under microaerophilic conditions. However, there were tube to tube
variations among replicates and the results could not be concluded. This could be attributed to
the possibility that consistent microaerophilic conditions were not maintained in these tubes due
to the possible entry of oxygen through the puncture in the rubber stopper caused by needle used
to add cultures to these tubes. Our studies with mycobacterial macrophage infections did not
yield significant conclusions (Fig. 9). It is possible that an MOI of 10:1 used was high, resulting
in increased survival for both strains. The high number of cells might have masked the
significant differences in survival among the two strains. In order to avoid achieving high cell
numbers within macrophages, we tried infection with an MOI of 50:1. However, in this case, we
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did not obtain any growth of bacteria at all. So the effect of deletion of TST on survival in
macrophages could not be assessed.
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4.5 Tables
Table 1. Percent (%) identity among different thiosulfate sulfurtransferase homologs based on
blastx
M. smegmatis
A. cellulolyticus
E. coli

Mtb

Locus tag
Rv0815c
Rv3117
Rv3283
Rv2291

MSMEG
_5789

MSMEG
_1809

MSMEG
_3238

Acel
_0059

Acel
_1417

b2521

b1757

88
88
50
26

49
49
84
27

26
26
63

74
74
52
28

28
28
33
39

29
29
28
33

27

Table 2. List of primers used in the study.
Primer name
5’-3’ Sequence
U1
TCGGAATTTTCTGTTCC
U2

GTTGACGATGACGGGGTAGGAGATCCTTTCGATT

D1

CCGGCGCCTGATATGTGCTCTGCACCC

D2

GCGCTCAGGAGTGTC

H1

AATCGAAAGGATCTCCTACCCCGTCATCGTCAAC

H2

GTGCAGAGCACATATCAGGCGCCGGGG

UH2

GGGTGCAGAGCACATATCAGGCGCCGG

HD1
iUHD1

AATCGAAAGGATCTCCTAC
TTTCATGTCATCTTCGATCA

iUHD2

GAACCACGTGATGACCAG

qPCR_TST_F
qPCR_TST_R
qPCR_hygR_F
qPCR_hygR_R
UP_MSMEG_F

AAGACCGTTTTCGTGGAGGT
GTGCCCGTAGAGCTTGAAGT
GAGGTCTTCCCGGAACT
GAAGTCGTGCAGGAAGG
CTCGACGAATTCAGCAAC

153

Table 3. List of primer sets used in the study.
Primer set
Product description
U1/U2
Upstream region of MSMEG_5789 with 15 bp
sequence identity to hygR at 3' end (U)
D1/D2
Downstream region of MSMEG_5789 with 11 bp
sequence identity to hygR at 5' end (D)
H1/H2
hygR with 19 bp sequence identity to U at 5' end,
and 14 bp sequence identity to D at 3' end (H)
U1/UH2
Upstream region of MSMEG_5789 fused to hygR
with 16 bp sequence identity to D at 3' end (UH)
HD1/D2
hygR fused to downstream region of MSMEG_5789
with 19 bp sequence identity to U at 5' end (HD)
U1/D2
Upstream region of MSMEG_5789 fused to hygR
and downstream region of MSMEG_5789 (UHD)
iUHD1/iUHD2
qPCR_TST_F/
qPCR_TST_R
qPCR_hygR_F/
qPCR_hygR_R
UP_MSMEG_F/
qPCR_hygR_R
UP_MSMEG_F/
qPCR_TST_R

Product length (bp)
594
581
1130
1690
1686
2246
(MsmegΔTST);
1983 (wild type M.
smegmatis)
2119

Upstream region of MSMEG_5789 fused to hygR
and downstream region of MSMEG_5789 amplified
with primers internal to UHD (iUHD)
Region within MSMEG_5789
249
Region within hygR

390

Region starting at 758 bp upstream of U and ending
within hygR
Region starting at 758 bp upstream of U and ending
within MSMEG_5789

2332

154
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4.6 Figures

Figure 1. Schematic representation of MSMEG_5789 gene replacement with hygR. Arrows
indicate primers used.
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Figure 2. Agarose gel electrophoresis of PCR amplified products. 50 ng purified PCR products
were analyzed on agarose gel. Lane M, 4 µl 1 kb DNA ladder (New England Biolabs); lane 1,
PCR product of the upstream (U) region of MSMEG_5789 using primers U1/U2; lane 2, PCR
product of the hygR (H) from pYUB28b using primers H1/H2; lane 3, PCR product of
downstream (D) region of MSMEG_5789 using primers D1/D2; lane 4, PCR products of overlap
PCR using U and H fragments as template (UH) using primers U1/UH2; lane 5, PCR products of
overlap PCR using H and D fragments as template (HD) using primers HD1/D2; lane 6, PCR
products of overlap PCR using UH and HD fragments as template (UHD) using primers U1/D2;
lane 7, PCR products of reamplification of UHD (iUHD) using internal primers iUHD1/iUHD2.
Volume of PCR product or concentration of DNA loaded.
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Figure 3. Agarose gel electrophoresis of PCR amplified products. 50 µl each PCR product was
mixed with 10 µl 6X loading dye. 10 µl each sample was analyzed using agarose gel
electrophoresis. lane M, 4 µl 1 kb DNA ladder (New England Biolabs); lane 1, PCR
amplification product of MSMEG_5789 from MsmegΔTST genomic DNA using primers qPCR_TST_F/ qPCR_TST_R; lane 2, PCR amplification product of MSMEG_5789 from wild type M.
smegmatis genomic DNA using primers qPCR_TST_F/ qPCR_TST_R; lane 3, PCR
amplification product of hygR from MsmegΔTST genomic DNA using primers qPCR_hygR_F/
qPCR_hygR_R; lane 4, PCR amplification product of hygR from wild type M. smegmatis
genomic DNA using primers qPCR_hygR_F/ qPCR_hygR_R; lane 5, PCR amplification product
of region starting at 758 bp upstream of U (see Table 3) and ending within hygR from
MsmegΔTST genomic DNA using primers UP_MSMEG_F/qPCR_hygR_R; lane 6, PCR
product of region starting at 758 bp upstream of U and ending within hygR from wild type M.
smegmatis genomic DNA using primers UP_MSMEG_F/qPCR_hygR_R; lane 7, PCR
amplification product of region starting at 758 bp upstream of U and ending within
MSMEG_5789 from MsmegΔTST genomic DNA using primers UP_MSMEG_F/qPCR_TST_R;
lane 8, PCR amplification product of region starting at 758 bp upstream of U and ending within
MSMEG_5789 from wild type M. smegmatis genomic DNA using primers
UP_MSMEG_F/qPCR_TST_R; lane 9, PCR amplification product of 594 bp upstream to 581 bp
downstream region of MSMEG_5789 from MsmegΔTST genomic DNA using primers U1/D2;
lane 10, PCR amplification product of 594 bp upstream to 581 bp downstream region of
MSMEG_5789 from wild type M. smegmatis genomic DNA using primers U1/D2.
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Figure 4. Sensitivity to various antimicrobial compounds using disk diffusion assay. Zone of
inhibition (mm) of wild type M. smegmatis (white bars) or MsmegΔTST (grey bars). Zone of
inhibition were measured after growth on TSA plates containing filter paper disks saturated with
the compound to be tested. Error bars represent standard error values from duplicates. The
asterisk (*) indicates statistically significant (*** p£0.005, ** p£0.01, * p£0.05) difference
compared to the wild type.
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Figure 5. Spot assay of wild type M. smegmatis and MsmegΔTST. Qualitative differences in
growth in the presence of different antimicrobial compounds was analyzed by plating 3 µl spots
of cultures after exposure (3 hours for SDS, formaldehyde and H2O2, 6 hours for diamide) in M9
media to the various concentrations of the compounds. Ten-fold dilutions were prepared, and
non-diluted (ND), 10-1 to 10-5 diluted cultures were spotted on TSA plates as indicated.
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Figure 6. Growth under microaerophilic conditions. Wild type M. smegmatis (black bars) or
MsmegΔTST (grey bars) were grown in either Middlebrook 7H9, M9-MgSO4 or M9-cysteine
media for 24 days without agitation under oxygen limitation conditions (air tight screw cap
vials). Growth was monitored using optical density at 600 nm. Error bars represent standard error
values from triplicates. ** indicates statistically significant (p<0.01) difference compared to the
wild type.
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Figure 7. Growth under aerobic conditions. Wild type M. smegmatis (black bars) or
MsmegΔTST (grey bars) were grown in either Middlebrook 7H9, M9-MgSO4 or M9-cysteine
media aerobically for 48 hours at 37°C and shaken at 150 rpm for aeration. Growth was
monitored using optical density at 600 nm. Error bars represent standard error values from
triplicates.
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Figure 8. Growth in presence of different sole sulfur sources. Wild type M. smegmatis (grey
lines) or MsmegΔTST (black lines) were grown in M9 mineral salts media containing different
sulfur sources aerobically for 72 hours at 37°C and 150 rpm. Panel A, indicates growth in the
presence of MgSO4 (circles) as the sole sulfur source; panel B, indicates growth in the presence
of Na2SO3 (squares) as the sole sulfur source; panel C, indicates growth in the presence of Na2S
(diamonds) as the sole sulfur source; panel D, indicates growth in the presence of Na2S2O3
(triangles) as the sole sulfur source; panel E, indicates growth in the presence of cysteine (x) as
the sole sulfur source. Growth was monitored using optical density at 600 nm. Error bars
represent 5% standard error value.
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Figure 9. Murine macrophage mycobacterial infection. Murine mononuclear macrophage cell
line infected with either M. smegmatis or MsmegΔTST was harvested at various time points i.e.
6, 24, 48 and 72 hours and phagocytosed mycobacteria were isolated and plated on agar plates to
calculate CFU/ml. Panel A, represents CFU/ml of M. smegmatis (white bars) or MsmegΔTST
(grey bars) at 6, 24, 48 and 72 hours; panel B, represents CFU/ml of M. smegmatis (white bars)
or MsmegΔTST (grey bars) at 24 and 48 hours; panel C, represents percentage of surviving M.
smegmatis (white bars) or MsmegΔTST (grey bars) in murine macrophages after 24 or 24 hours
of infection.
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4.7 Supplementary figures

1

2

Figure S1. Verification of presence of pJV53 plasmid in M. smegmatis M53 cells. lane 1, 50 ng
pJV53 plasmid; lane 2, 50 µl cell cracking supernatant of M53 cells.
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Chapter 5
Physiological and transcriptomic analyses of the bioactivity of oxidized graphene in Escherichia
coli

5.1 Introduction
Graphene is an allotrope of carbon, made up of monolayer of carbon atoms arranged into a twodimensional (2D) honey-comb lattice [1]. It was originally observed under electron microscopes
in 1962 and was named by Hanns-Peter Boehm and his coworkers describing it as single sheets
of graphite [2, 3]. Graphene was later rediscovered and isolated through micromechanical
exfoliation of graphite in 2004 by Andre Geim and Konstantin Novoselov at the University of
Manchester [4]. In 2010, Geim and Novoselov were awarded the Nobel Prize in Physics for their
experiments regarding graphene [5]. Graphene serves as a basic structural element for various
allotropes of carbon. Graphene layers comprised in a planar structure, form graphite. Graphene
oxide (GO) is a graphene sheet with carboxylic groups at its edges and phenol hydroxyl and
epoxide groups on its basal plane [6]. Graphene is the thinnest and strongest material ever tested
with high elasticity and flexibility [7, 8 ]. It exhibits exceptional thermal and electrical
conductivity, impermeability to gases and other electronic and mechanical properties [9]. A
recent study showed that the melting temperature of graphene is approximately 4510 K, that is
around 250 K higher than that of graphite [10]. Graphene is highly stable since the carbon atoms
are present in a sp2 orbital hybridization. The presence of p electrons in the outer orbital allows
for free moving electrons, which is responsible for graphene's excellent electronic properties
[11].
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Graphene and its derivatives are gaining interest in applications such as nanoelectronics, supercapacitors, optoelectronics, nanosensors, nanomedicine [12-15]. Apart from high elasticity and
flexibility, graphene-based materials possess adaptability to flat or irregular surfaces making
them suitable as support and adhesion materials used for tissue engineering [16]. The presence of
delocalized p electrons, allows graphene to bind to various aromatic compounds via p-p stacking
interactions, in addition to the hydrophobic interactions, ensuring a number of possible
applications [17, 18]. GO nanocarriers covalently bound to folic acid molecules, were used in
drug delivery to cells overexpressing the folic acid receptors [19]. The growing interest in
graphene-family nanomaterials is driving the study of their biological activity [20].
Nanomaterials can penetrate skin, lungs and also pass the blood-tissue barriers after intravenous
injections and accumulate in organs [21]. In order to implement the use graphene towards its
various applications, potential hazards on human and environmental health need to be evaluated.

There have been contradictory reports on the toxicity of graphene; some studies show no risks
involved with graphene, while some studies suggest that graphene family materials might
become health hazards [22]. The cytotoxicity of graphene and single-wall carbon nanotubes has
been studied in neural phaeochromocytoma-derived PC12 and it was proposed that graphene
may induce oxidative stress and mitochondrial injury in cells at 10 µg/ml [23]. A study on
neurite maturation using a mouse hippocampal culture model, however, demonstrated that
graphene had no negative influence on cell viability, and significantly enhanced the number of
neurites and their length [24]. Graphene has been shown to specifically accelerate the
differentiation of human mesenchymal stem cells into bone cells [16]. Akhavan and Ghaderi
(2010) showed that graphene and graphene oxide nanowalls showed antibacterial activity due to
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membrane stress induced by sharp edges of graphene nanosheets [25]. The studies on
antibacterial activity of graphite, graphite oxide, graphene oxide and reduced graphene oxide in
Escherichia coli showed that cytotoxicity was due to both membrane and oxidative stress [26]. It
was shown that most of bacterial inactivation occurred in the first hour of incubation, and there
was an increase in cell death with an increase in concentration [26]. However, another study by
Zhang et al., (2011) showed that E. coli had the ability to accumulate on a graphene electrode
surface without any growth inhibition [27]. GO at doses less than 20 µg/ml was found non-toxic,
but induced cell apoptosis at higher than 50 µg/ml in human fibroblast cells [28].

The contradictions in the toxicity reports of graphene could be attributed to the varying
characteristics of the graphene material tested, including its size, solubility, concentration, shape,
crystallinity and surface functionalization [18, 29]. The techniques employed at enhancing
dispersion of otherwise hydrophobic graphene are gaining interest to cater to graphene’s end
applications [30]. The solubility of graphene in aqueous solutions depends on the number and
kind of functional groups attached. These determine the structure and surface properties of
graphene, and hence are important factors in dictating the interaction of graphene with its
environment. Functionalization of graphene family nanomaterials has been proposed to greatly
change their cytotoxicity, by attenuating the hydrophobic interactions between graphene and
cells [31]. The oxidized graphene tested in our study, also referred to as functionalized graphene,
is pristine graphene that has been oxidized by treating with concentrated sulfuric acid and nitric
acid for enhanced hydrophilicity [29]. This study focuses on how oxidation of pristine graphene
affects its cytotoxicity on E. coli. The gene expression profiles after exposure to oxidized
graphene (OG) relative to that of pristine graphene (PG) was studied. Several genes showed
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differential expression in the presence of OG. The potential role of these genes during survival in
the presence of stress induced by OG is discussed.

5.2 Materials and methods
5.2.1 Bacterial growth conditions and chemicals. Escherichia coli DH5α was grown in Luria
Bertani (LB) medium at 37°C with shaking at 250 rpm [32]. Bacterial growth was monitored
using optical density at 600 nm. PG, OD, GO and single-walled carbon nanotubes (SWCNT)
were obtained from McNabb’s lab. PG and OG stock solutions were prepared in sterile water at
2 mg/ml concentration and stored at room temperature. GO (4.3 mg/ml) and SWCNT (3 mg/ml)
stock solutions in water were stored at room temperature. The solutions were thoroughly
vortexed before each use.

5.2.2 Cytotoxicity assays. Cytotoxicity assays were carried out in 96-well plates. Overnight
grown cells (≈ 5 x 108 cells/ml) were inoculated into 100 µl LB broth at 1:1000 dilution ratio.
Media was supplemented with graphene at concentrations 0, 80, 160, 320, 640, and 1280 µg/ml.
Plates were incubated for 6 hours at 37°C without shaking. After 6 hours, 10-1 to 10-7 dilutions
were made for each treatment. From each dilution, 3 µl was used for plating spots on LB agar
plate for spot test analysis. The spot plate was incubated for 24 hours at 37°C. In addition, 100 µl
of each dilution was spread plated on LB agar plates to assess the number of cells surviving after
graphene exposure. The plates were incubated at 37°C for 48 hours and the number of colonies
were counted to measure number of colony forming units per ml (CFU/ml).
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5.2.3 RNA extraction and mRNA enrichment. PG or OG were added to LB Broth at 640
µg/ml concentration. Media was inoculated with overnight grown cells at 1:1000 ratio and
incubated at 37°C. After 6 hours of graphene exposure, RNA extraction was carried out using
RNeasy Mini kit (Qiagen) as per manufacturer’s protocol. In order to avoid any genomic DNA
contamination, one round of on-column treatment with RNase-Free DNase (Qiagen) was
included in the isolation process. RNA obtained was quantified using Qubit RNA HS Assay Kit
and Qubit 2.0 Fluorometer (Life Technologies). Quality of RNA was analyzed using 2100
Bioanalyzer (Agilent) and Agilent RNA ScreenTape system (Agilent Technologies). A total of 5
µg of each RNA sample was used for further processing. Firstly, ribosomal RNA was removed
from total RNA isolated using Ribo-Zero Magnetic Kit for Bacteria (Epicenter, Illumina). The
rRNA depleted samples were purified using Agencourt RNAClean XP system (Beckman
Coulter). The rRNA depletion from total RNA was validated using 2100 Bioanalyzer (Agilent)
and Agilent RNA ScreenTape system (Agilent Genomics). The samples were quantified using
Qubit RNA HS Assay Kit and Qubit 2.0 Fluorometer (Life Technologies). The RNA was stored
at -80°C until use.

5.2.4 cDNA Library Preparation and MiSeq run. Double stranded cDNA libraries were
prepared from mRNA enriched samples using the TruSeq Stranded mRNA LT Sample
Preparation kit (Illumina) following the TruSeq Stranded mRNA Sample Preparation Guide
(Illumina) as described earlier (Chapter 3). A 5 µl of mRNA enriched template was denatured,
fragmented and primed using random hexamers (Illumina). The first strand cDNA was
synthesized using SuperScript II Reverse Transcriptase (Thermo Fisher Scientific) and First
Strand Synthesis Act D mix (Illumina). The second strand cDNA synthesis was carried out using

175

DNA polymerase I and RNase H present in the Second Strand Master Mix (Illumina). The
resulting double stranded cDNA obtained was purified using Agencourt AMPure XP beads
(Beckman Coulter) and was adenylated at 3’ ends and ligated with indexing adapters. For OG
sample Adapter index 6 (AR006; GCCAAT) was used, and for PG sample Adapter index 12
(AR012; CTTGTA) was used.

The adapter ligated cDNA was purified using AMPure XP beads and amplified using adapter
specific primers in PCR Primer Cocktail (Illumina). The PCR products were purified using
AMPure XP beads and quantified using Qubit dsDNA BR Assay Kit and Qubit 2.0 Fluorometer
(Life Technologies). The quality and the average library size for each sample were analyzed
using 2100 Bioanalyzer (Agilent) and Agilent High Sensitivity D1K ScreenTape system (Agilent
Technologies). The average library size of PG and OG libraries were 258 bp and 269 bp,
respectively. The libraries were then prepared for sequencing according to the Preparing
Libraries for Sequencing on MiSeq Guide (Illumina) as described earlier (Chapter 3). A 4 nM
each of PG and OG sample libraries were pooled together and denatured resulting in a final
concentration of 20 pM DNA library in 1 mM NaOH. In order to balance for low diversity
libraries, a PhiX control was used. The MiSeq Reagent Kit v2, 250 cycles (Illumina) was used
and the libraries were sequenced on the MiSeq platform (Carbonero lab).

5.2.5 Sequence assembly and analysis. The sequences obtained from the MiSeq Run were
analyzed as explained earlier (Chapter 3). The sequencing results obtained from BaseSpace
(Illumina) were used for analysis using DNAStar (Madison, WI, USA). The reads were mapped
onto the reference genome Escherichia coli str. K-12 substr. MG1655 on SeqMan NGen
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(DNAStar) platform. The GenBank file containing the complete sequence of E. coli genome
(NC_000913.gbk) was obtained from NCBI FTP (ftp://ftp.ncbi.nlm.nih.gov/). The undetermined
reads were not used for the analyses. Assembly was performed using Transcriptome/RNA-seq
workflow by launching SeqMan NGen. The mapping of sequence reads onto the reference
genome was then performed using the default settings for haploid genome with few changes
(merSkipQuery:2; maxGap: 25; minDepth: 5; pNotRef: 75). The PG and OG reads were run as
separate assemblies.

The sequence assemblies generated were analyzed using ArrayStar (DNAStar). The PG and OG
assemblies were combined into single project for analysis. The gene expression was quantified
using QSeq and normalized by RPKM. Gene expression levels were obtained based on log2 fold
change values. The heat map showing gene expression pattern was obtained using hierarchical
clustering, Euclidean (distance metric) and centroid (fast) linkage method in ArrayStar. The
scatter plots showing log2 expression profile of all genes of OG treatment compared to PG
treatment were generated using ArrayStar. The genes whose expression was up or downregulated
at ³ 2-fold change were curated and the genes of interest were selected. The up and
downregulated gene information was collected using NCBI (https://www.ncbi.nlm.nih.gov/),
KEGG (https://www.genome.jp/kegg/) and Uniprot (https://www.uniprot.org/proteomes/)
databases.

5.2.6 Real-time PCR. The list of genes of interest selected for analysis is provided in Table 1.
The primers for detection of genes of interest using one-step real-time reverse transcriptase
polymerase chain reaction (RT-qPCR) were designed using OligoPerfectTM Designer (Thermo
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Fisher Scientific). Gene specific primers used in the study are listed in Table 2. Total RNA
extracted from cells exposed to either PG or OG (640 µg/ml) for 6 hours were used as template.
The relative gene expression level was quantified using QuantiFast SYBR Green RT-PCR kit
(Qiagen) and BioRad CFX96 Real-Time System. The 25 µl reaction mix consisted of: 2x
QuantiFast SYBR Green RT-PCR Master Mix (1x), QuantiFast RT Mix (0. 25 µl), forward and
reverse primer (1 µM each), template RNA (10 ng) and double autoclaved RNase-free water.
The reaction mix was incubated at 50°C for 10 minutes for reverse transcription, followed by
PCR initial activation at 95°C for 5 minutes and 35 cycles of PCR (10 seconds at 95°C and 30
seconds at 60°C).

5.2.7 Knockout mutants of genes of interest. In-frame, single gene deletion mutants of genes
of interest were obtained from E. coli Keio Knockouts (GE Dharmacon). Mutants had their openreading frame coding regions replaced with a kanamycin cassette in Parent E. coli K-12
BW25113 [rrnB3 DElacZ4787 hsdR514 DE(araBAD)567 DE(rhaBAD)568 rph-1] [33].
Knockout mutant for b4593 (ymgI, uncharacterized protein) was not available, which indicates
that it might be an essential gene required for survival in E. coli. Knockout mutant for gene
b2763 was also chosen for analysis. The gene is present in an operon with the upregulated gene
of interest b2764 and is also upregulated in the transcriptome of cells exposed to OG. Knockout
mutant for gene b2699 (recA) was selected in order to account for difference between parent
strain and DH5a, as the latter strain contains recA mutation. The Parent strain was revived from
its glycerol stock by plating on LB agar. Knockout mutants were revived from their respective
glycerol stocks by plating on LB agar supplemented with 25 µg/ml kanamycin. Cultures were
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maintained by regular sub-culturing in LB broth with or without kanamycin and by incubation at
37°C with shaking at 225 rpm.

5.2.8 OG cytotoxicity on knockout deletion mutants. Cytotoxicity assays were carried out as
described above. Media with/without kanamycin was supplemented with OG at 640 µg/ml. Each
strain was inoculated at 1 x 106 cells/ml final concentration and plates were incubated for 6 hours
at 37°C for graphene exposure. After 6 hours, 10-1 to 10-7 dilutions were made for each treatment.
3 µl from each dilution was used for plating spots on LB agar plate for spot test analysis. 100 µl
of each dilution was spread plated on LB agar plates to assess the cell survival after graphene
exposure.

5.3 Results
5.3.1 Graphene cytotoxicity. The effect of graphene on cell survival was first analyzed using
spot test assays for a quick visible reference (Fig. 1). There was no significant difference in cell
survival after exposure to PG at various concentrations (0-1280 µg/ml). The OG was found to be
more inhibitory than PG. The spot test did not show significant reduction in growth upon OG
exposure at 0-320 µg/ml. The OG was observed to be toxic to cells at 640 µg/ml and the toxicity
was much higher at 1280 µg/ml (Fig. 1). For a more specific analysis of graphene exposure on
cell survival, the dilution plates were analyzed and the colony forming units/ml (CFU/ml) were
measured to assess the number of cells surviving after graphene exposure (Fig. 2). In case of PG,
at lower concentrations (80 and 160 µg/ml) it stimulated growth with more growth at 160 µg/ml.
With increase in concentration the number of surviving cells were lesser as compared to 160
µg/ml. However, the exposure of PG did not seem to have inhibitory effect when compared to its

179

no graphene control at 0 µg/ml (Fig. 2). In case of OG, at 80 and 160 µg/ml the OG exposure
seemed to have a positive effect on cell survival. However, OG exposure at 320 µg/ml drastically
decreased the cell survival and the toxicity increased with increase in concentration of OG (Fig.
2).

GO and SWCNT both had inhibitory effect on the growth of bacteria when compared to no
graphene control at 0 µg/ml (Fig. S1). At 80 µg/ml, both GO and SWCNT were more toxic than
160 µg/ml. Generally, the toxicity was dose dependent with increased loss of cell viability with
increase in concentration. However more trials would have been beneficial in making definite
conclusions.

5.3.2 Comparative cytotoxicity of graphene materials. Percent survial upon exposure to
graphene was used to compare cytotoxicity of various graphene materials. Percent survival was
calculated by comparing the CFU/ml obtained after 6 hour at 640 µg/ml (or 1240 µg/ml) with no
graphene control (0 µg/ml) as a baseline. Overall, OG was the most toxic to E. coli cells,
followed by GO and SWCNT (Fig. 3). PG did not inhibit the growth of E. coli. At 640 µg/ml,
approximately 8%, 36% and 89% cells survived after exposure to OG, GO and SWCNT
respectively (Fig. 3a). At 1280 µg/ml, approximately 1%, 47% and 71% cells survived after
exposure to OG, GO and SWCNT respectively (Fig. 3b). PG was not toxic to growth and
approximately 120% and 112% cells survived at 640 µg/ml and 1280 µg/ml, respectively.

5.3.3 Whole transcriptome analysis. Total RNA extracted from E. coli exposed to PG or OG at
640 µg/ml for 6 hours was processed to remove rRNA, resulting in mRNA enrichment (Fig. S2).
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The mRNA was used to generate transcript libraries. The sequencing of libraries on MiSeq
generated 32,241,576 total reads including 26,671,848 passing filter (PF) reads with a coefficient
of variation of 0.1951. The percentage reads identified (PF) were 96.18%, with 41.45% and
54.72% reads (PF) each for PG and OG respectively. The scatter plot showing log2 expression
levels of all genes upon exposure to PG and OG is shown in Fig. S3. The heat map showing gene
expression obtained using hierarchical clustering is shown in Fig. S4.

There were a total of 183 genes upregulated and 125 genes downregulated at ³ 2-fold change
upon exposure to OG. The list of upregulated genes is provided in Table 3, and the list of
downregulated genes is provided in Table 4. The genes that were upregulated in the presence of
OG were grouped based on their predicted functions: sulfur metabolism (5 genes), stress
resistance and response proteins (16 genes), iron-sulfur (Fe-S) cluster proteins (3 genes), formate
dehydrogenases and other hydrogenases (19 genes), membrane proteins (9 genes), transporters
and two-component system proteins (25 genes), regulators (6 genes), oxidoreductases (6 genes),
other enzymes (9 genes), amino acid metabolism (6 genes), pyrimidine and purine metabolism (6
genes), ribosomal RNA proteins (24 genes), tRNA (4 genes), miscellaneous (32 genes),
uncharacterized (13 genes). The list of these groups and their respective genes involved is
provided in Table 5.

The differentially expressed genes selected to confirm RNA-seq analysis data using RT-qPCR
included: b2158, UPF0324 family inner membrane protein (15.03 fold upregulated in OG);
b2764, sulfite reductase alpha subunit flavoprotein (7.02 fold upregulated in OG); b4593,
uncharacterized protein (9.53 fold downregulated in OG); b1167, Blue light, low temperature
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and stress induced protein (7.66 fold downregulated in OG). Two genes with similar expression
in OG and PG were also selected: b1731, cell division modulator (1.07 fold upregulated in OG)
and b1322, UPF0283 family inner membrane protein (1.07 fold upregulated in OG). The
membrane protein coding gene b1322 was selected as a control membrane protein in order to
check that the upregulation of b2158 was specific to this particular protein and not to all
membrane proteins.

5.3.4 Real time PCR. The relative gene expression of differentially expressed genes correlated
with expression data obtained from RNA-seq analysis. The relative fold expression of genes of
interest is shown in Fig. 4. The genes coding for UPF0324 family inner membrane protein
(b2158) and sulfite reductase alpha subunit flavoprotein (b2764) were 7.74 fold and 4.38 fold
upregulated respectively in OG. These genes were consistently upregulated in OG in both RNAseq and RT-qPCR analysis. The genes coding for uncharacterized protein (b4593) and blue light,
low temperature and stress induced protein (b1167) were 2.24 fold and 9.17 fold downregulated,
respectively. These genes were consistently downregulated in OG in both RNA-seq and RTqPCR analysis. The cell division modulator (b1731) was 1.15 fold downregulated in OG. This
gene was 1.07 fold upregulated in OG in the RNA-seq data. The UPF0283 family inner
membrane protein (b1322) was 1.49 fold downregulated in OG. This gene was 1.07 fold
upregulated in OG in the RNA-seq data. For both of these genes, the gene expression was neither
significantly upor downregulated in OG and we concluded that not all the membrane protein
were essentially upregulated in the presence of OG.
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5.3.5 OG cytotoxicity on knockout deletion mutants. The strains tested included: Parent strain
BW25113 (WT); single gene deletion knockout strains of genes coding for inner membrane
protein (b2158), sulfite reductase a subunit (b2764), sulfite reductase b subunit (b2763), low
temperature stress induced protein (b1167), cell division modulator (b1731), inner membrane
protein (b1322). Compared to the parent strain, all the knockout mutants were more sensitive to
OG (Fig. 5). The knockout mutant for b1167 grew better than the other mutants. This correlates
with the downregulation of this gene in the presence of OG. The gene knockout mutants of
respective genes that were upregulated in OG (namely, b2158, b2764 and b2763) were more
sensitive to OG toxicity compared to the rest of the genes.

In some of the preliminary cytotoxicity tests that were conducted, E. coli DH5a was found to be
much more sensitive to OG than the parent strain of knockout mutant (Fig. S5). The DH5a has
recA (DNA recombination and repair protein) mutation. We suspected that this might be the
reason for difference in behavior among the two strains upon graphene exposure. The respective
knockout mutant with recA mutation (Db2699) in the BW25113 background was selected to
investigated for this behavior. As expected, the knockout mutant of DNA recombination protein
coding gene (b2699) was much more sensitive to the parent strain (Fig. S6).

5.4 Discussion
We tested the effect of graphene exposure on E. coli. Owing to its hydrophobic nature, graphene
materials were not completely soluble in water. Therefore, all solutions were thoroughly and
equally vortexed before each use to enhance its dispersion in solution. Sonication in water bath
was tried to increase dispersion, however, it did not completely disperse the graphene into
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solution. In addition, sonication can break the graphene sheets, resulting in differences in size
among molecules. Flake size affects graphene’s internalization in cells, as well as how long it
stays in circulation [29]. Hence, vortexing was used for dispersion. We observed that at lower
concentrations (80 and 160 µg/ml) both PG and OG stimulated the growth of E. coli when
compared to no graphene control. However at higher concentrations (320-1280 µg/ml), OG was
highly toxic to cells. The PG did not seem to have an inhibitory effect on cell survival in E. coli.
OG was the most inhibitory out of all forms of graphene tested (Fig. 3). This could be due to the
presence of reactive functional groups in OG. The oxidation process adds functional groups,
such as hydroxyl, epoxide, carbonyl and carboxylic acid to graphene [29]. This results in a more
negative surface charge; and some disruption to the internal sp2 lattice domains [29]. Various
studies conducted on graphene show that the dose, functional groups attaches, hydrophobicity,
size and number of layers determine its toxicity [34-36]. The presence of functional groups on
OG and GO might be responsible for their higher toxicity possibly due to enhanced penetration
and interaction with the bacterial cells. The SWCNTs were not as toxic OG and GO, but still led
to growth inhibition with a 30% loss of cell viability. The SWCNTs are 1-D structures with their
length often exceeding micrometers [37]. Ema et al., (2016) suggested that oxidative stress and
inflammation might be the reason for their inhibitory properties [38].

The toxicity of graphene is still debated, as some reports suggest that graphene acts as a growth
enhancer, while others suggest that it is a growth inhibitor. Ruiz et al., (2011) had previously
reported that GO acted as an enhancer for mammalian and bacterial growth [39]. The exposure
of E. coli to GO (25 µg/mL) for 16 hours, resulted in bacteria growing faster and forming dense
biofilms. The authors concluded that GO does not have antibacterial and cytotoxic effects and
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may be used in biomedical and drug delivery applications. Several reports have shown that GO
paper promotes the adhesion and proliferation of osteoblasts and kidney cells [40, 41]. Another
study conducted in the same year, however, reported contradictory results, wherein GO at 20
µg/mL and 50 µg/mL lead to 20% and 50% loss in cell viability, respectively [42]. In case of
human erythrocytes and skin fibroblasts, it was observed that graphene and GO materials were
cytotoxic to these cell lines [43]. A study with E. coli and Staphylococcus aureus, showed that
GO caused growth reductions by about 51 and 61% respectively [44].

In order to understand how OG induces toxicity in cells, we looked at the relative gene
expression of cells in the presence of OG using transcriptomic analysis. The mechanism of
cytotoxicity of graphene in cells is not yet clearly understood. It has been proposed that in case
of cultured kidney tubular epithelial cells, graphene induces oxidative injury and DNA
fragmentation using endonucleases, leading to cell death [45]. GO and other carbon
nanomaterials have been shown to cause chromosomal DNA damage and interference with DNA
replication [46, 47]. We observed that some of the genes involved in DNA biosynthesis were
downregulated in the presence of OG. A ribonucleoside diphosphate reductase operon dedicated
towards biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides was found
to be downregulated upon exposure to OG [48]. This operon included genes coding for a
glutaredoxin-like hydrogen donor for nrdEF (b2673, 2.20-fold¯), an nrdEF cluster assembly
flavodoxin (b2674, 2.54-fold¯), ribonucleoside-diphosphate reductase 2, alpha subunit nrdE
(b2675, 2.48-fold¯) and ribonucleoside-diphosphate reductase 2, beta subunit nrdF (b2676, 2.16fold¯). In addition, some of the genes involved in nucleotide sugar metabolism were also
downregulated: purine nucleoside phosphorylase 2 (b2407, 2.15-fold¯); inhibitor of replication

185

at Ter, DNA-binding protein (b1610, 2.44-fold¯); alpha-D-ribose 1-methylphosphonate 5phosphate C-P lyase (b4098, 3.97-fold¯); ribose 1,5-bisphosphate phosphokinase (b4094, 2.38fold¯); phosphodeoxyribose mutase (b4383, 2.36-fold¯); pyridine nucleotide-dependent
disulfide oxidoreductase, a stress response protein (b0304, 4.86-fold¯). This indicates that DNA
synthesis is impacted in the presence of OG.

GO treatments have previously been shown to alter gene expression patterns, and the
differentially expressed genes were shown to mediate DNA-damage control [47]. We observed
that among the upregulated genes, six genes were directly involved in pyrimidine and purine
metabolism (Table 5). These included genes coding for anaerobic ribonucleotide reductase
activating protein (b4237, 3.21-fold) and anaerobic ribonucleoside-triphosphate reductase
(b4238, 2.41-fold), that are arranged in an operon. Ribonucleoside-triphosphate reductases are
class III reductases containing [4Fe-4S]2+ center, that provide a balanced supply of DNA
precursors to cell by reducing ribonucleotides into deoxyribonucleotides [49]. A DNA-packaging
protein (b0560, 2.39-fold) and a putative DNA repair protein (b2644, 2.73-fold) were also
upregulated. In addition, a DNA utilization protein HofO (b4238, 2.41-fold), required for the
use of extracellular DNA as a nutrient was upregulated [50]. The upregulation of these genes
along with other pyrimidine/purine metabolism genes might be in response to the DNA damage
caused by graphene.

Graphene materials produce reactive oxygen species (ROS), that in turn lead to oxidative stress
and damage to membranes, proteins and DNA [51-53]. Sulfur metabolism plays an important
role in cell survival under oxidative stress conditions and in the presence of xenobiotics. Sulfur
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assimilation and its integration into cysteine and methionine are crucial steps for the formation of
sulfur containing defense compounds such as glutathione [54]. In Pseudomonas aeruginosa,
multiwall carbon nanotubes and graphene were shown to induce the expression of sulfur
metabolism genes [55]. We were interested in looking at the effect of OG on the expression of
genes involved in sulfur metabolism. Table 5 shows the five genes involved in sulfur metabolism
that were upregulated. Of these, three genes present in an operon dedicated towards the
formation of sulfide from 3'-Phosphoadenosine-5'-phosphosulfate (PAPS) via sulfite, were of
interest. These genes included: PAPS reductase, cysH (b2762, 6.76-fold); sulfite reductase bsubunit, cysI (b2763, 6.37-fold); sulfite reductase a-subunit, cysJ (b2764, 7.02-fold). The
sulfide generated serves as a S-source for incorporation into cysteine. Cysteine is used to transfer
sulfur to various redox molecules, iron-sulfur clusters (Fe-S) and vice-versa in oxidative stress
response. A tauC (b0367, 2.10-fold) was also upregulated. In E. coli tauABCD gene cluster
was shown to be involved in the utilization of taurine as sulfur source, and was found to be
expressed only under conditions of sulfate or cysteine starvation [56].

The sulfite reductase a-subunit (b2764) was selected as a candidate gene for RT-qPCR analysis.
It was observed that the relative gene expression was 4.38 fold more in OG than in PG (Fig. 4).
Furthermore, the knockout mutants of sulfite reductase b-subunit (b2763) and sulfite reductase
a-subunit (b2764) were used to test for cytotoxicity of OG. The mutants Db2763 and Db2764
were much more sensitive to OG as compared to the wild type strain (Fig. 5) indicating the
importance of sulfur assimilation under graphene toxicity. A few genes coding for Fe-S cluster
proteins were also upregulated (Fig. 5). However, we did not observe any significant change in
the expression of genes involved in glutathione biosynthesis: glutamate-cysteine ligase, gshA
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(b2688, 1.03-fold¯); glutathione synthetase, gshB (b2947, 1.01-fold), glutathione reductase,
gor (b3500, 1.00-fold). Genes coding for oxidoreducates and formate dehydrogenses were
upregulated in the presence of OG (Table 5). The formate dehydrogenase-H selenopolypeptide
subunit (b4079, 3.56-fold), formate dehydrogenase-H, [4Fe-4S] ferredoxin subunit (b2713,
3.18-fold) and other related proteins were upregulated. The formate dehydrogenases due to
their electron transfer element have been shown to help in oxidative stress tolerance and survival
in E. coli [57]. These have been shown to act as stress response proteins with their amount
increasing more than ten-fold under stress [58].

In a study conducted by Efremova et al., (2015), graphene shells (GS), GO and graphene oxide
paper (GO-P) were evaluated with luminescent E.coli for toxicity and bioactivity mechanisms.
While GS and GO-P were non-toxic, GO expressed bioactivity in aqueous suspension [20]. The
authors suggested, direct membrane interaction and membrane stress to be a possible mechanism
of toxicity [20]. Our study showed that nine genes coding for membrane proteins were
upregulated in the presence of OG (Table 5). Among those, one of the genes showed the highest
expression in the presence of OG: UPF0324 family inner membrane protein (b2158, 15.03fold). The upregulation was confirmed using RT-qPCR analysis showing the relative gene
expression was 7.74 fold more in OG than in PG (Fig. 4). The knockout mutant of this gene was
most sensitive out of all the mutants tested for toxicity of PG (Fig. 5). Another gene coding for
membrane protein, UPF0283 family inner membrane protein (b1322, 1.07-fold) was selected to
serve as a control. The knockout mutant of this gene was not as sensitive to OG (Fig. 5)
indicating that not all the membrane proteins were affected by OG.
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Genes coding for a number of regulators, stress resistance and response proteins including
membrane stress resistance protein (b4682, 19.18-fold), DUF2527 family heat-induced protein
(b1824, 3.73-fold) and multiple acid-resistance proteins were also upregulated in response to
OG (Table 5). However, not all the stress response proteins were upregulated. A gene coding for
blue light, low temperature and stress induced protein (b1167, 7.66-fold¯) was downregulated in
the presence of OG as confirmed by both RNA-seq and RT-qPCR analysis. This protein, also
known as Uncharacterized protein ymgC, is induced at 16°C with blue light irradiation in E. coli
[59]. The genes involved in the operon along with b1167 were also significantly downregulated
in the presence of OG. These genes code for: RcsB connector protein for regulation of biofilm
and acid-resistance, ycgZ (b1164, 5.28-fold¯); RcsB connector protein for regulation of biofilm,
ymgA (b1165, 4.96-fold¯); RcsB connector protein for regulation of biofilm and acid-resistance,
ymgB (b1166, 6.27-fold¯); blue light, low temperature and stress induced protein, ymgC (b1167,
7.66-fold¯); putative membrane-anchored cyclic-di-GMP phosphodiesterase, ycgG (b1168,
4.07-fold¯).

The ymgABC gene cluster has been shown to play an important role in biofilm formation and
acid resistance in E. coli [60, 61]. Brominated furanones, that are disrupters of quorum sensing,
have been shown to repress ymgAB [62]. The expression of ymgABC has also been shown to be
downregulated upon addition of indole, a stationary phase signal shown to have an impact on
biofilm formation [63]. In a study conducted on E. coli MG1655 and Bacillus subtilis 168, it was
observed that the biofilm formation was inhibited at high concentration of GO, due to the loss of
enough number of cells to trigger biofilm formation [64]. Recently, a number of studies have
shown that graphene and GO coatings inhibit bacterial growth and biofilm development [65-67].
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The downregulation of the ymgABC operon genes indicates that OG targets the biofilm
formation genes in E. coli. The knockout mutant Db1167 grew better than the knockout mutants
of other genes tested (Fig. 5). However, more studies on how these genes are affected by OG are
needed to understand the mechanism of toxicity.

A gene coding for uncharacterized protein, ymgI (b4593, 9.53-fold¯) was highly downregulated
in the presence of OG in both RNA-seq and RT-qPCR analysis. The ymgI gene was seen to be
downregulated in the presence of butanol [68]. The knockout mutant for this gene was not
available in the knockout mutant library, suggesting the importance of this gene in cell survival.
The other two genes present in an operon with ymgI: ymgD (b1171, 1.61-fold¯) and ymgG
(b1172, 1.42-fold¯) did not show >2-fold change in presence of OG. The results of the RNA-seq
analysis are shown from one trial conducted. It was observed that the second set of data varied
and did not show significant results. We observed that the OG samples lost toxicity over time.
The discrepancies in results could originate from loss of oxidation over time due to long term
storage, storage temperatures, exposure to light or differences in the method of preparation.

Our study indicates that cytotoxicity of OG to E. coli could therefore be due to oxidative stress,
membrane stress, DNA damage and possible inhibition of biofilm formation. Liu et al., (2011)
proposed that graphene-based materials use a three-step antimicrobial mechanism: initial cell
deposition on graphene-based materials, membrane stress caused by direct contact with sharp
nanosheets, and superoxide anion-independent oxidation [26]. At low concentrations, graphene
based materials have been shown to be biocompatible with mammalian cells by promoting cell
adhesion [39]. It is important to evaluate the surface properties, size, and the degree of
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functionalization first, in order to correlate the toxicity of graphene materials to bacteria and
other organisms. The structure and functionalization could be tailored to reduce the human and
environmental hazard risks.
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5.5 Tables
Table 1. The list of genes of interest selected from transcriptome analysis. The genes were either
highly upregulated (b2158, b2764) or downregulated (b1167, b4593) in the presence of OG. The
genes with similar expression (b1322, b1761) in both OG and PG were selected to serve as a
reference.
Locus tag Fold
Gene
Gene description
change
symbol
b1167
ymgC
Blue light, low temperature and stress induced
7.66¯
protein
b1322
ycjF
UPF0283 family inner membrane protein
1.07
b1731
cedA
cell division modulator
1.07
b2158
yeiH
UPF0324 family inner membrane protein
15.03
b2764
cysJ
sulfite reductase, alpha subunit, flavoprotein
7.02
b4593
ymgI
uncharacterized protein
9.53¯
Table 2. List of primers used in RT-qPCR studies.
Locus tag Forward and reverse primer sequence
b1167
1. CTCGAGAGGGAGGTGTTCA
2. GCACGGATTCCCTGTCAT
b1322
1. GACGAAGCGCAGGAAGAA
2. GCCAGGCATTCATTGTCC
b1731
1. CAGCAAAACCGCCAGATT
2. ACGTTGGGCAGATTCAGG
b2158
1. TGTCGGTATCAGTGGGATCA
2. TACTGGCTTCCGCTTTCACT
b2764
1. ATCGCCAGCGAAAAACTG
2. CTGGCAGCAGCCTGGTAT
b4593
1. CAGCCACGCTCATTTTGA
2. TGTCCGGTATTAAGTAAGTTGCAC
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Product length
187 bp
157 bp
183 bp
188 bp
269 bp
108 bp

Table 3. List of genes upregulated upon exposure to OG compared to PG.
Locus tag

193

Gene description

b4677

Up
Fold
change
163.86

b4010

112.65

5S ribosomal RNA of rrnE operon

b2849

101.55

Uncharacterized protein YqeK

141

b4674

81.93

Uncharacterized protein YnbG

21

b3273

71.15

tRNA-Thr

b1575

57.22

Division inhibition protein DicB

b2588

45.06

5S ribosomal RNA of rrnG operon

Ribosome

b3272

22.53

5S ribosomal RNA of rrnD operon

Ribosome

b3274

22.53

5S ribosomal RNA of rrnD operon

Ribosome

b4682

19.18

Uncharacterized protein YqcG

46

b2158

15.03

UPF0324 inner membrane protein YeiH

349

b3342

12.95

30S ribosomal protein S12 (Small ribosomal subunit protein uS12)

124

b0317

10.86

Uncharacterized protein YahC

165

b2764

7.02

Sulfite reductase [NADPH] flavoprotein alpha-component (SiR-FP) (EC 1.8.1.2)

599

Sulfur metabolism

b0617

6.99

Citrate lyase acyl carrier protein (Citrate lyase gamma chain)

98

Two-component system

b2762

6.76

244

Sulfur metabolism

b1155

6.71

Phosphoadenosine phosphosulfate reductase (EC 1.8.4.8) (3'-phosphoadenylylsulfate reductase)
(PAPS reductase, thioredoxin dependent) (PAPS sulfotransferase) (PAdoPS reductase)
Uncharacterized protein YmfS

b2763

6.37

Sulfite reductase [NADPH] hemoprotein beta-component (SiR-HP) (SiRHP) (EC 1.8.1.2)

570

b2851

5.87

Uncharacterized protein YgeG

163

b1492

5.32

Probable glutamate/gamma-aminobutyrate antiporter (Extreme acid sensitivity protein)

511

b2725

5.13

Formate hydrogenlyase regulatory protein HycA

153

b2166

4.83

Pseudouridine kinase (EC 2.7.1.83)

313

b4705

4.71

Small protein MntS

42

b0699

4.62

Uncharacterized protein YbfA

68

Uncharacterized protein YobI

Uniprot
protein
length
21

KEGG pathway annotation

Ribosome

Aminoacyl-tRNA
biosynthesis
62

Ribosome

137
Sulfur metabolism
Quorum sensing
Pyrimidine metabolism

Table 3 (con’t)
Locus tag

194

Gene description

b1493

Up
Fold
change
4.39

Glutamate decarboxylase beta (GAD-beta) (EC 4.1.1.15)

Uniprot
protein
length
466

KEGG pathway annotation

b0336

4.29

Cytosine permease

419

b2724

4.24

Formate hydrogenlyase subunit 2 (FHL subunit 2) (Hydrogenase-3 component B)

203

b0337

4.21

427

b4684

4.20

Cytosine deaminase (CD) (CDA) (CDase) (EC 3.5.4.1) (Cytosine aminohydrolase) (Isoguanine
deaminase) (EC 3.5.4.-)
Uncharacterized protein YqfG

b0485

4.17

Glutaminase 1 (EC 3.5.1.2)

310

b0484

4.11

834

b2723

3.95

Copper-exporting P-type ATPase (EC 3.6.3.54) (Copper-exporting P-type ATPase A) (Cu(+)exporting ATPase) (Soluble copper chaperone CopA(Z))
Formate hydrogenlyase subunit 3 (FHL subunit 3) (Hydrogenase-3 component C)

b2721

3.90

Formate hydrogenlyase subunit 5 (FHL subunit 5) (Hydrogenase-3 component E)

569

b1258

3.88

Protein YciF

166

b1824

3.73

Protein YobF

47

b0334

3.72

483

b3756

3.60

2-methylcitrate dehydratase (2-MC dehydratase) (EC 4.2.1.79) ((2S,3S)-2-methylcitrate
dehydratase) (Aconitate hydratase) (ACN) (Aconitase) (EC 4.2.1.3)
16S ribosomal RNA of rrnC operon

b2591

3.58

16S ribosomal RNA of rrnG operon

b2094

3.58

150

b4079

3.56

b0201

3.56

PTS system galactitol-specific EIIA component (EIIB-Gat) (Galactitol-specific
phosphotransferase enzyme IIA component)
Formate dehydrogenase H (EC 1.17.1.9) (EC 1.17.99.7) (Formate dehydrogenase-H subunit
alpha) (FDH-H) (Formate-hydrogen-lyase-linked, selenocysteine-containing polypeptide)
16S ribosomal RNA of rrnH operon

b2243

3.53

Anaerobic glycerol-3-phosphate dehydrogenase subunit C (G-3-P dehydrogenase)

396

b3851

3.50

16S ribosomal RNA of rrnA operon

Glycerophospholipid
metabolism
Ribosome

b4007

3.48

16S ribosomal RNA of rrnE operon

Ribosome

b0901

3.46

Uncharacterized NAD(P)H oxidoreductase YcaK (EC 1.6.99.-)

196

b2722

3.42

Formate hydrogenlyase subunit 4 (FHL subunit 4) (Hydrogenase 3 component D)

307

Alanine, aspartate and
glutamate metabolism

Pyrimidine metabolism

41
Arginine biosynthesis

608

Propanoate metabolism
Ribosome
Ribosome
Galactose metabolism

715
Ribosome

Table 3 (con’t)
Locus tag

195

Gene description

b0486

Up
Fold
change
3.40

Inner membrane transport protein YbaT

Uniprot
protein
length
430

KEGG pathway annotation

b2718

3.38

Formate hydrogenlyase maturation protein HycH

136

b0733

3.36

522

Oxidative phosphorylation

b0734

3.36

379

Oxidative phosphorylation

b1409

3.36

Cytochrome bd-I ubiquinol oxidase subunit 1 (EC 1.10.3.14) (Cytochrome bd-I oxidase subunit
I) (Cytochrome d ubiquinol oxidase subunit I)
Cytochrome bd-I ubiquinol oxidase subunit 2 (EC 1.10.3.14) (Cytochrome bd-I oxidase subunit
II) (Cytochrome d ubiquinol oxidase subunit II)
Uncharacterized protein YnbB

298

Glycerophospholipid
metabolism

b2110

3.36

Probable fimbrial chaperone YehC

239

b3577

3.36

2,3-diketo-L-gulonate TRAP transporter small permease protein YiaM

157

b4299

3.36

Uncharacterized HTH-type transcriptional regulator YjhI

262

b3278

3.33

16S ribosomal RNA of rrnD operon

Ribosome

b3968

3.32

16S ribosomal RNA of rrnB operon

Ribosome

b3517

3.24

Glutamate decarboxylase alpha (GAD-alpha) (EC 4.1.1.15)

466

b2095

3.21

D-tagatose-1,6-bisphosphate aldolase subunit GatZ

420

b4237

3.21

154

b0735

3.21

Anaerobic ribonucleoside-triphosphate reductase-activating protein (EC 1.97.1.-) (Class III
anaerobic ribonucleotide reductase small component)
Uncharacterized protein YbgE

b2713

3.18

Electron transport protein HydN

175

b2093

3.13

94

b3508

3.05

PTS system galactitol-specific EIIB component (EIIB-Gat) (Galactitol-specific
phosphotransferase enzyme IIB component) (EC 2.7.1.200)
Putative magnesium transporter YhiD

b1312

3.04

Inner membrane ABC transporter permease protein YcjP

280

b1729

3.03

L-cystine transporter YdjN

463

b2483

3.02

Hydrogenase-4 component C (EC 1.-.-.-)

315

b1443

3.01

Inner membrane ABC transporter permease protein YdcV

264

b2343

3.01

UPF0381 protein YfcZ

94

Alanine, aspartate and
glutamate metabolism
Galactose metabolism

97
Galactose metabolism

215

Quorum sensing

Table 3 (con’t)
Locus tag

Gene description

b3315

Up
Fold
change
2.95

196

Uniprot
protein
length
110

KEGG pathway annotation

b1011

2.94

230

Pyrimidine metabolism

2.94

Peroxyureidoacrylate/ureidoacrylate amidohydrolase RutB (EC 3.5.1.110) (Ureidoacrylate
amidohydrolase)
Inner membrane protein YnbA

b1408
b1576

2.94

Uncharacterized protein YdfD

63

b2054

2.94

Putative colanic acid biosynthesis acetyltransferase WcaF (EC 2.3.1.-)

182

b0123

2.91

Blue copper oxidase CueO (Copper efflux oxidase)

516

b0836

2.90

Biofilm regulator BssR

127

b1905

2.90

Bacterial non-heme ferritin (EC 1.16.3.2) (Ferritin-1)

165

b2720

2.88

Formate hydrogenlyase subunit 6 (FHL subunit 6) (Hydrogenase-3 component F)

180

b3512

2.86

Transcriptional regulator GadE

175

b0977

2.86

Hydrogenase-1 operon protein HyaF

285

b3985

2.85

50S ribosomal protein L10 (50S ribosomal protein L8) (Large ribosomal subunit protein uL10)

165

b2589

2.85

23S ribosomal RNA of rrnG operon

b2719

2.84

Formate hydrogenlyase subunit 7 (FHL subunit 7) (Hydrogenase-3 component G)

b3854

2.81

23S ribosomal RNA of rrnA operon

b0573

2.80

Cation efflux system protein CusF

b3970

2.78

23S ribosomal RNA of rrnB operon

b1957

2.77

Uncharacterized protein YodC

b0204

2.76

23S ribosomal RNA of rrnH operon

b2644

2.73

UPF0758 protein YfjY

160

b4075

2.69

Formate-dependent nitrite reductase complex subunit NrfF

127

b3748

2.66

D-ribose pyranase (EC 5.4.99.62)

139

b1304

2.65

Phage shock protein A

222

b3758

2.65

23S ribosomal RNA of rrnC operon

50S ribosomal protein L22 (Large ribosomal subunit protein uL22)

Ribosome

201

Ribosome
Ribosome

255
Ribosome
110

Two-component system
Ribosome

60
Ribosome

ABC transporters
Ribosome

Table 3 (con’t)
Locus tag

197

Gene description

b4009

Up
Fold
change
2.64

Uniprot
protein
length

b0953

2.63

Ribosome modulation factor (RMF) (Hibernation factor RMF) (Protein E)

55

b2096

2.62

284

b3275

2.59

D-tagatose-1,6-bisphosphate aldolase subunit GatY (TBPA) (TagBP aldolase) (EC 4.1.2.40)
(D-tagatose-bisphosphate aldolase class II) (Tagatose-bisphosphate aldolase)
23S ribosomal RNA of rrnD operon

b3513

2.58

Multidrug resistance protein MdtE

385

b3311

2.57

30S ribosomal protein S17 (Small ribosomal subunit protein uS17)

84

b3922

2.56

UPF0381 protein YiiS

99

b3507

2.56

HTH-type transcriptional regulator DctR

176

b2728

2.55

90

b2425

2.55

Hydrogenase maturation factor HypC (Chaperone-type protein HypC) (Hydrogenase accessory
chaperone HypC)
Thiosulfate-binding protein

b4379

2.54

287

b2726

2.53

Putative glycyl-radical enzyme activating enzyme YjjW (GRE activating enzyme YjjW) (EC
1.97.1.-)
Hydrogenase maturation factor HypA

b1156

2.52

200

b1549

2.52

Prophage tail fiber assembly protein homolog TfaE (Tail fiber assembly protein homolog from
lambdoid prophage e14)
Uncharacterized protein YdfO

b3511

2.51

Protein HdeD

190

b2847

2.50

Uncharacterized protein YqeI

269

b0284

2.46

Putative xanthine dehydrogenase YagR molybdenum-binding subunit (EC 1.17.1.4)

732

b1141

2.46

Prophage excisionase-like protein (Excisionase-like protein from lambdoid prophage 14)

81

b4035

2.44

Maltose/maltodextrin import ATP-binding protein MalK (EC 3.6.3.19)

371

b0904

2.43

Probable formate transporter 1 (Formate channel 1)

285

b3314

2.42

30S ribosomal protein S3 (Small ribosomal subunit protein uS3)

233

Ribosome

b4238

2.42

712

Purine metabolism

b4527

2.41

Anaerobic ribonucleoside-triphosphate reductase (EC 1.1.98.6) (Class III ribonucleosidetriphosphate reductase)
Uncharacterized protein YdaF

23S ribosomal RNA of rrnE operon

KEGG pathway annotation
Ribosome
Galactose metabolism
Ribosome

338

Ribosome

Sulfur metabolism

116

136

51

Purine metabolism
ABC transporters

Table 3 (con’t)
Locus tag

Gene description

b4126

Up
Fold
change
2.40

198

Uniprot
protein
length
76

KEGG pathway annotation

b2242

2.40

419

Glycerophospholipid
metabolism

2.39

Anaerobic glycerol-3-phosphate dehydrogenase subunit B (Anaerobic G-3-P dehydrogenase
subunit B) (Anaerobic G3Pdhase B) (EC 1.1.5.3)
DNA-packaging protein NU1 homolog

b0560
b4535

2.37

Uncharacterized protein YniD

35

b1802

2.36

374

b2013

2.34

Carnitine monooxygenase oxygenase subunit (EC 1.14.13.-) (Carnitine monooxygenase alpha
subunit)
UPF0394 inner membrane protein YeeE

b2402

2.34

tRNA-Val

b4201

2.33

Primosomal replication protein N

104

b2392

2.33

Divalent metal cation transporter MntH

412

b1800

2.32

361

b1388

2.31

b1481

2.31

D-malate dehydrogenase [decarboxylating] (EC 1.1.1.83) (D-malate degradation protein A) (Dmalate oxidase)
1,2-phenylacetyl-CoA epoxidase, subunit A (EC 1.14.13.149) (1,2-phenylacetyl-CoA
epoxidase, catalytic subunit alpha) (1,2-phenylacetyl-CoA monooxygenase, subunit A)
Protein bdm (Biofilm-dependent modulation protein)

b1984

2.29

tRNA-Asn

b0974

2.29

Probable Ni/Fe-hydrogenase 1 B-type cytochrome subunit

235

b3506

2.29

Outer membrane protein slp

188

b1672

2.28

Uncharacterized protein YdhW

215

b3001

2.28

L-glyceraldehyde 3-phosphate reductase (GAP reductase) (EC 1.1.1.-)

346

b2148

2.28

Galactoside transport system permease protein MglC

336

ABC transporters

b0973

2.27

597

Nitrotoluene degradation

b4152

2.27

Hydrogenase-1 large chain (HYD1) (EC 1.12.99.6) (Membrane-bound hydrogenase 1 large
subunit) (NiFe hydrogenase)
Fumarate reductase subunit C (Fumarate reductase 15 kDa hydrophobic protein)

131

Citrate cycle (TCA cycle)

b4317

2.26

Outer membrane usher protein FimD

878

Uncharacterized protein YjdI

181

352

309

Aminoacyl-tRNA
biosynthesis
Homologous recombination
Glyoxylate and
dicarboxylate metabolism
Phenylalanine metabolism

71
Aminoacyl-tRNA
biosynthesis
Two-component system

Table 3 (con’t)
Locus tag

199

b1593

Up
Fold
change
2.26

Gene description

Uniprot
protein
length
231

KEGG pathway annotation

b4153

2.25

ATP-dependent dethiobiotin synthetase BioD 2 (EC 6.3.3.3) (DTB synthetase 2) (DTBS 2)
(Dethiobiotin synthase 2)
Fumarate reductase iron-sulfur subunit (EC 1.3.5.1)

244

Citrate cycle (TCA cycle)

b4239

2.24

Trehalose-6-phosphate hydrolase (EC 3.2.1.93) (Alpha,alpha-phosphotrehalase)

551

Starch and sucrose
metabolism
Glycine, serine and
threonine metabolism
Glycolysis /
Gluconeogenesis

b3117

2.24

329

b2097

2.23

b1256

2.22

L-threonine dehydratase catabolic TdcB (EC 4.3.1.19) (L-serine dehydratase) (EC 4.3.1.17)
(Threonine deaminase)
Fructose-bisphosphate aldolase class 1 (EC 4.1.2.13) (Fructose-bisphosphate aldolase class I)
(FBP aldolase)
Outer membrane protein W

b2126

2.20

Sensor histidine kinase BtsS (EC 2.7.13.3)

561

b3113

2.20

Putative reactive intermediate deaminase TdcF (EC 3.5.4.-)

129

b3410

2.20

Probable [Fe-S]-dependent transcriptional repressor FeoC (Fe(2+) iron transport protein C)

78

b1730

2.18

Uncharacterized protein YdjO

267

b0994

2.18

Periplasmic protein TorT

342

b1444

2.16

474

b1244

2.16

Gamma-aminobutyraldehyde dehydrogenase (EC 1.2.1.19) (1-pyrroline dehydrogenase) (4aminobutanal dehydrogenase) (ABALDH)
Oligopeptide transport system permease protein OppB

306

Arginine and proline
metabolism
beta-Lactam resistance

b0564

2.14

HTH-type transcriptional regulator AppY (M5 polypeptide)

249

Two-component system

b0513

2.13

Putative purine permease YbbY

433

b1992

2.13

247

b4199

2.13

Adenosylcobinamide-GDP ribazoletransferase (EC 2.7.8.26) (Cobalamin synthase)
(Cobalamin-5'-phosphate synthase)
Uncharacterized protein YjfY

b4119

2.12

Alpha-galactosidase (EC 3.2.1.22) (Melibiase)

451

Galactose metabolism

b2367

2.12

Probable multidrug resistance protein EmrY

512

Two-component system

b3491

2.11

Inner membrane protein YhiM

350

b3588

2.10

Aldehyde dehydrogenase B (EC 1.2.1.-)

512

350

Biotin metabolism

212

Porphyrin and chlorophyll
metabolism

91

Glycolysis /
Gluconeogenesis

Table 3 (con’t)
Locus tag

200

b3114

Up
Fold
change
2.10

Gene description

Uniprot
protein
length
764

KEGG pathway annotation

b0367

2.10

PFL-like enzyme TdcE (Keto-acid formate acetyltransferase) (Keto-acid formate-lyase)
(Ketobutyrate formate-lyase) (KFL) (EC 2.3.1.-) (Pyruvate formate-lyase) (PFL) (EC 2.3.1.54)
Taurine transport system permease protein TauC

275

Sulfur metabolism

b1148

2.10

Uncharacterized protein YmfM

112

b1441

2.10

Uncharacterized ABC transporter ATP-binding protein YdcT

337

Quorum sensing

b4085

2.10

D-allulose-6-phosphate 3-epimerase (EC 5.1.3.-)

231

b3751

2.09

Ribose import binding protein RbsB

296

Fructose and mannose
metabolism
ABC transporters

b3408

2.09

Fe(2+) transport protein A (Ferrous iron transport protein A)

75

b1732

2.09

Catalase HPII (EC 1.11.1.6) (Hydroxyperoxidase II)

753

Tryptophan metabolism

b0613

2.08

292

Two-component system

b2403

2.08

2-(5''-triphosphoribosyl)-3'-dephosphocoenzyme-A synthase (2-(5''-triphosphoribosyl)-3'dephospho-CoA synthase) (EC 2.4.2.52)
tRNA-Val

NA

Aminoacyl-tRNA
biosynthesis

b1257

2.08

Protein YciE

168

b3393

2.08

DNA utilization protein HofO

146

b4316

2.08

Chaperone protein FimC

241

b2204

2.07

Ferredoxin-type protein NapH (Ubiquinol--[NapC cytochrome c] reductase NapH subunit)

287

b2809

2.07

Uncharacterized lipoprotein YgdI

75

b1003

2.05

Uncharacterized protein YccJ

75

b1581

2.04

Starvation-sensing protein RspA

404

b2717

2.04

Hydrogenase 3 maturation protease (EC 3.4.23.51) (HycI protease)

156

b1838

2.03

Serine/threonine-protein phosphatase 1 (EC 3.1.3.16)

218

b1101

2.03

477

b1582

2.03

PTS system glucose-specific EIICB component (EIICB-Glc) (EII-Glc) [Includes: Glucose
permease IIC component (PTS system glucose-specific EIIC component); Glucose-specific
phosphotransferase enzyme IIB component (EC 2.7.1.199) (PTS system glucose-specific EIIB
component)]
UPF0060 membrane protein YnfA

108

Pyruvate metabolism

Pentose and glucuronate
interconversions

Glycolysis /
Gluconeogenesis

Table 3 (con’t)
Locus tag

Gene description

b3509

Up
Fold
change
2.02

Acid stress chaperone HdeB (10K-L protein)

Uniprot
protein
length
108

b2057

2.02

Putative colanic acid biosynthesis glycosyl transferase WcaC

405

b1311

2.01

Inner membrane ABC transporter permease protein YcjO

293

b2727

2.01

290

b0872

2.01

Hydrogenase maturation factor HypB (Hydrogenase isoenzymes nickel incorporation protein
HypB)
NADH oxidoreductase HCR

322

KEGG pathway annotation

201

Table 4. List of genes downregulated upon exposure to OG compared to PG.
Locus
tag

202

Gene description

b1717

Down
Fold
change
73.11

b0205

53.70

5S ribosomal RNA of rrnH operon

b4341

39.05

Uncharacterized protein YjiS

54

b1041

28.26

Minor curlin subunit

151

b4047

25.27

Uncharacterized protein YjbL

84

b3307

13.69

30S ribosomal protein S14 (Small ribosomal subunit protein uS14)

101

Ribosome

b4202

11.52

30S ribosomal protein S18 (Small ribosomal subunit protein bS18)

75

Ribosome

b4593

9.53

Uncharacterized protein YmgI

57

b0272

8.49

Uncharacterized HTH-type transcriptional regulator YagI

252

b1167

7.66

Blue light, low temperature and stress induced protein, YmgC

82

b0273

6.41

Ornithine carbamoyltransferase subunit F (OTCase-2) (EC 2.1.3.3)

334

Arginine biosynthesis

b2609

6.29

30S ribosomal protein S16 (Small ribosomal subunit protein bS16)

82

Ribosome

b1166

6.27

RcsB connector protein for regulation of biofilm and acid-resistance, YmgB AriR

88

b4513

5.96

29

Two-component system

b3301

5.85

Potassium-transporting ATPase KdpF subunit (ATP phosphohydrolase [potassiumtransporting] F chain) (Potassium-binding and translocating subunit F) (Potassium-translocating
ATPase F chain)
50S ribosomal protein L15 (Large ribosomal subunit protein uL15)

144

Ribosome

b1301

5.59

426

b1300

5.57

Arginine and proline
metabolism
Arginine and proline
metabolism

b1020

5.50

Gamma-glutamylputrescine oxidoreductase (Gamma-Glu-Put oxidase) (Gammaglutamylputrescine oxidase) (EC 1.4.3.-)
NADP/NAD-dependent aldehyde dehydrogenase PuuC (ALDH) (EC 1.2.1.5) (3hydroxypropionaldehyde dehydrogenase) (Gamma-glutamyl-gamma-aminobutyraldehyde
dehydrogenase) (Gamma-Glu-gamma-aminobutyraldehyde dehydrogenase)
Protein PhoH (Phosphate starvation-inducible protein PsiH)

b1611

5.47

467

b1164

5.28

Fumarate hydratase class II (Fumarase C) (EC 4.2.1.2) (Aerobic fumarase) (Iron-independent
fumarase)
RcsB connector protein for regulation of biofilm and acid-resistance, YcgZ

b1165

4.96

RcsB connector protein for regulation of biofilm, YmgA

90

50S ribosomal protein L35 (Large ribosomal subunit protein bL35) (Ribosomal protein A)

Uniprot
protein
length
65

KEGG pathway annotation
Ribosome
Ribosome

495

Biofilm formation

354

78

Citrate cycle (TCA cycle)

Table 4 (con’t)
Locus
tag
b0304

Down
Fold
change
4.86

b0328

4.79

b1302

4.78

b4511

Gene description
Probable pyridine nucleotide-disulfide oxidoreductase RclA (Reactive chlorine resistance
protein A)
Uncharacterized membrane protein YahN

Uniprot
protein
length
441

KEGG pathway annotation

223

203

421

4.21

4-aminobutyrate aminotransferase PuuE (EC 2.6.1.19) (GABA aminotransferase) (GABA-AT)
(Gamma-amino-N-butyrate transaminase) (GABA transaminase) (Glutamate:succinic
semialdehyde transaminase)
Enterobactin biosynthesis protein YbdZ

b1168

4.07

Putative membrane-anchored cyclic-di-GMP phosphodiesterase, YcgG

507

b0330

4.06

Propionate catabolism operon regulatory protein

528

b0805

4.02

760

b4098

3.97

Catecholate siderophore receptor Fiu (Ferric iron uptake protein) (TonB-dependent receptor
Fiu)
Alpha-D-ribose 1-methylphosphonate 5-phosphate C-P lyase (PRPn C-P lyase) (EC 4.7.1.1)

b1746

3.88

492

b1747

3.79

N-succinylglutamate 5-semialdehyde dehydrogenase (EC 1.2.1.71) (Succinylglutamic
semialdehyde dehydrogenase) (SGSD)
Arginine N-succinyltransferase (AST) (EC 2.3.1.109) (AOST)

b1297

3.74

472

b1058

3.58

Gamma-glutamylputrescine synthetase PuuA (Gamma-Glu-Put synthetase) (EC 6.3.1.11)
(Glutamate--putrescine ligase)
Uncharacterized protein YceO

b4533

3.58

Uncharacterized protein YnfO (Uncharacterized protein YnfO from Qin prophage)

77

b1748

3.56

406

b0585

3.50

Succinylornithine transaminase (SOAT) (EC 2.6.1.81) (Carbon starvation protein C)
(Succinylornithine aminotransferase)
Enterochelin esterase (Ferric enterobactin esterase)

b0590

3.46

Ferric enterobactin transport system permease protein FepD

334

b3924

3.36

248

b0589

3.26

Flavodoxin/ferredoxin--NADP reductase (EC 1.18.1.2) (EC 1.19.1.1) (Ferredoxin
(flavodoxin):NADP(+) oxidoreductase) (Ferredoxin--NADP reductase) (FNR) (Flavodoxin-NADP reductase) (FLDR) (Methyl viologen resistance protein A) (dA1)
Ferric enterobactin transport system permease protein FepG

b1088

3.26

Large ribosomal RNA subunit accumulation protein YceD (23S rRNA accumulation protein
YceD) (G30K)

173

Alanine, aspartate and
glutamate metabolism

72

281

344

Phosphonate and
phosphinate metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism

46
Arginine and proline
metabolism

400

330

ABC transporters

ABC transporters

Table 4 (con’t)
Locus
tag

204

Gene description

b3320

Down
Fold
change
3.15

50S ribosomal protein L3 (Large ribosomal subunit protein uL3)

Uniprot
protein
length
209

b4062

3.15

Regulatory protein SoxS

107

b1229

3.13

Protamine-like protein

29

b1296

3.03

Putrescine importer PuuP

461

b0044

2.98

Ferredoxin-like protein FixX

95

b1032

2.98

tRNA-Ser

NA

b0346

2.89

DNA-binding transcriptional activator MhpR (mhp operon transcriptional activator)

277

b1351

2.83

Protein RacC

91

b0138

2.82

Uncharacterized fimbrial-like protein YadM

189

b4203

2.80

50S ribosomal protein L9 (Large ribosomal subunit protein bL9)

149

Ribosome

b4100

2.78

194

b2417

2.78

b3637

2.78

Alpha-D-ribose 1-methylphosphonate 5-triphosphate synthase subunit PhnH (RPnTP synthase
subunit PhnH) (EC 2.7.8.37)
PTS system glucose-specific EIIA component (EIIA-Glc) (EIII-Glc) (Glucose-specific
phosphotransferase enzyme IIA component)
50S ribosomal protein L28 (Large ribosomal subunit protein bL28)

78

Phosphonate and
phosphinate metabolism
Glycolysis /
Gluconeogenesis
Ribosome

b0333

2.75

389

Propanoate metabolism

b3321

2.73

2-methylcitrate synthase (2-MCS) (MCS) (EC 2.3.3.5) ((2S,3S)-2-methylcitrate synthase)
(Citrate synthase) (EC 2.3.3.16)
30S ribosomal protein S10 (Small ribosomal subunit protein uS10)

103

Ribosome

b4291

2.71

Fe(3+) dicitrate transport protein FecA (Iron(III) dicitrate transport protein FecA)

774

b1660

2.68

Inner membrane transport protein YdhC

403

b1745

2.66

N-succinylarginine dihydrolase (EC 3.5.3.23)

447

b2210

2.63

Malate:quinone oxidoreductase (EC 1.1.5.4) (MQO) (Malate dehydrogenase [quinone])

548

Arginine and proline
metabolism
Citrate cycle (TCA cycle)

b2458

2.59

Ethanolamine utilization protein EutD

338

Pyruvate metabolism

b0804

2.58

PKHD-type hydroxylase YbiX (EC 1.14.11.-)

225

b2674

2.54

Protein NrdI

136

b1021

2.52

Biofilm PGA synthesis protein PgaD

137

169

KEGG pathway annotation
Ribosome

Aminoacyl-tRNA
biosynthesis

Biofilm formation

Table 4 (con’t)
Locus
tag

205

b0347

Down
Fold
change
2.51

Gene description

b0591

2.51

b0586

2.50

Enterobactin synthase component F (EC 2.7.7.-) (Enterochelin synthase F) (Serine-activating
enzyme) (Seryl-AMP ligase)

1293

b2675

2.48

714

b1378

2.47

Ribonucleoside-diphosphate reductase 2 subunit alpha (EC 1.17.4.1) (R1E protein)
(Ribonucleotide reductase 2)
Probable pyruvate-flavodoxin oxidoreductase (EC 1.2.7.-)

b2634

2.44

Uncharacterized HTH-type transcriptional regulator YfjR

233

b1610

2.44

DNA replication terminus site-binding protein (Ter-binding protein)

309

b2155

2.42

Colicin I receptor

663

b3452

2.42

sn-glycerol-3-phosphate transport system permease protein UgpA

295

ABC transporters

b0723

2.41

Succinate dehydrogenase flavoprotein subunit (EC 1.3.5.1)

588

Citrate cycle (TCA cycle)

b1161

2.40

Uncharacterized protein YcgX

134

b1495

2.39

Uncharacterized protein YddB (CDS103)

790

b4672

2.38

Putative protein YmiB

34

b1347

2.38

Double-strand break reduction protein

69

b4526

2.38

Uncharacterized protein YdaE

56

b1744

2.38

Succinylglutamate desuccinylase (EC 3.5.1.96)

322

b4541

2.38

Uncharacterized protein YehK

105

b2387

2.38

108

b3759

2.38

PTS system fructose-like EIIB component 1 (EC 2.7.1.202) (Fructose-like phosphotransferase
enzyme IIB component 1)
5S ribosomal RNA of rrnC operon

NA

Ribosome

b4094

2.38

Ribose 1,5-bisphosphate phosphokinase PhnN (EC 2.7.4.23) (Ribose 1,5-bisphosphokinase)

185

Pentose phosphate pathway

b4101

2.38

Alpha-D-ribose 1-methylphosphonate 5-triphosphate synthase subunit PhnG (RPnTP synthase
subunit PhnG) (EC 2.7.8.37)

150

Phosphonate and
phosphinate metabolism

3-(3-hydroxy-phenyl)propionate/3-hydroxycinnamic acid hydroxylase (3-HCI hydroxylase) (3HPP hydroxylase) (EC 1.14.13.127)
Enterobactin exporter EntS (Protein p43)

Uniprot
protein
length
554

KEGG pathway annotation
Phenylalanine metabolism

416

1174

Biosynthesis of siderophore
group nonribosomal
peptides
Purine metabolism
Glycolysis /
Gluconeogenesis

Arginine and proline
metabolism

Table 4 (con’t)
Locus
tag

Gene description

b4105

Down
Fold
change
2.38

206

KEGG pathway annotation

Phosphonates-binding periplasmic protein

Uniprot
protein
length
338

b4383

2.36

Phosphopentomutase (EC 5.4.2.7) (Phosphodeoxyribomutase)

407

Pentose phosphate pathway

b4367

2.36

Ferric iron reductase protein FhuF

262

b3605

2.35

L-lactate dehydrogenase (EC 1.1.-.-)

396

b3047

2.35

Uncharacterized fimbrial chaperone YqiH

249

b0849

2.35

Glutaredoxin 1 (Grx1)

85

b4366

2.32

Transcriptional activator protein BglJ

225

b1102

2.29

729

b2459

2.24

FhuE receptor (Outer-membrane receptor for Fe(III)-coprogen, Fe(III)-ferrioxamine B and
Fe(III)-rhodotrulic acid)
Ethanolamine utilization cobalamin adenosyltransferase (EC 2.5.1.17)

b1496

2.22

Inner membrane ABC transporter ATP-binding protein YddA (CDS102)

561

b2673

2.20

Glutaredoxin-like protein NrdH

81

b4407

2.20

Sulfur carrier protein ThiS (Thiamine biosynthesis protein ThiS)

66

Sulfur relay system

b3069

2.19

tRNA-Ile

NA

Aminoacyl-tRNA
biosynthesis

b2462

2.18

Ethanolamine utilization protein EutS

111

b4292

2.18

Protein FecR

317

b4290

2.17

Fe(3+) dicitrate-binding periplasmic protein (Iron(III) dicitrate-binding periplasmic protein)

300

ABC transporters

b2676

2.16

319

Purine metabolism

b0150

2.15

b2407

2.15

b0593

2.13

Ribonucleoside-diphosphate reductase 2 subunit beta (EC 1.17.4.1) (R2F protein)
(Ribonucleotide reductase 2)
Ferrichrome outer membrane transporter/phage receptor (Ferric hydroxamate receptor) (Ferric
hydroxamate uptake) (Ferrichrome-iron receptor)
Purine nucleoside phosphorylase 2 (EC 2.4.2.1) (Inosine-guanosine phosphorylase) (Purine
nucleoside phosphorylase II) (PNP II) (Xanthosine phosphorylase)
Isochorismate synthase EntC (EC 5.4.4.2) (Isochorismate mutase)

b4455

2.12

Protein HokA

50

267

ABC transporters

Pyruvate metabolism

Porphyrin and chlorophyll
metabolism
ABC transporters

747
277

Purine metabolism

391

Ubiquinone and other
terpenoid

Table 4 (con’t)
Locus
tag

b1396

2.09

[Citrate [pro-3S]-lyase] ligase (EC 6.2.1.22) (Acetate:SH-citrate lyase ligase) (Citrate lyase
synthetase)
Acyl-coenzyme A thioesterase PaaI (EC 3.1.2.-) (Phenylacetic acid degradation protein PaaI)

b2003

2.09

Uncharacterized protein YeeT

73

b0592

2.09

Ferrienterobactin-binding periplasmic protein

318

ABC transporters

b0724

2.08

Succinate dehydrogenase iron-sulfur subunit (EC 1.3.5.1)

238

Citrate cycle (TCA cycle)

b2505

2.07

Uncharacterized lipoprotein YfgH

172

b3143

2.05

Probable fimbrial chaperone YraI

231

b4289

2.05

332

b0587

2.05

Fe(3+) dicitrate transport system permease protein FecC (Iron(III) dicitrate transport system
permease protein FecC)
Ferric enterobactin transport protein FepE

b0349

2.04

288

b3820

2.03

2-hydroxy-6-oxononadienedioate/2-hydroxy-6-oxononatrienedioate hydrolase (EC 3.7.1.14)
(2-hydroxy-6-ketonona-2,4-diene-1,9-dioic acid 5,6-hydrolase) (2-hydroxy-6-oxonona-2,4,7triene-1,9-dioic acid 5,6-hydrolase) (2-hydroxy-6-oxonona-2,4-diene-1,9-dioic acid 5,6hydrolase)
Uncharacterized protein YigI

b3299

2.03

50S ribosomal protein L36 (Large ribosomal subunit protein bL36-A) (Ribosomal protein B)

38

Ribosome

b4477

2.03

205

Galactose metabolism

b4061

2.02

2-dehydro-3-deoxy-6-phosphogalactonate aldolase (EC 4.1.2.21) (2-oxo-3-deoxygalactonate
6-phosphate aldolase) (6-phospho-2-dehydro-3-deoxygalactonate aldolase) (6-phospho-2-keto3-deoxygalactonate aldolase) (KDPGal)
Probable cyclic di-GMP phosphodiesterase PdeC (EC 3.1.4.52)

b4106

2.02

Phosphonates import ATP-binding protein PhnC (EC 3.6.3.28)

262

b3070

2.02

NADPH-dependent ferric-chelate reductase (EC 1.16.1.9) (Ferric siderophore reductase)

254

b3604

2.01

Putative L-lactate dehydrogenase operon regulatory protein

258

b0588

2.01

Ferric enterobactin transport ATP-binding protein FepC

271

b2163

2.00

Regulatory protein YeiL

219

b0271

2.00

Putative beta-xylosidase (EC 3.2.1.37) (1,4-beta-D-xylan xylohydrolase) (Xylan 1,4-betaxylosidase)

536

207

b0618

Down
Fold
change
2.09

Gene description

Uniprot
protein
length
352

KEGG pathway annotation

140

Phenylalanine metabolism

Two-component system

ABC transporters

377
Phenylalanine metabolism

155

528
ABC transporters

ABC transporters
Amino sugar and nucleotide
sugar metabolism

Table 5. The list of genes upregulated upon exposure to OG (compared to PG), grouped into
respective metabolic categories.
Sulfur metabolism
Locus tag Fold change
b2764
7.02
b2762
6.76
b2763
b2425

6.37
2.55

b0367

2.10

KEGG, NCBI Description
sulfite reductase, alpha subunit, flavoprotein
phosphoadenosine phosphosulfate reductase; PAPS reductase, thioredoxin
dependent
sulfite reductase, beta subunit, NAD(P)-binding, heme-binding
cysP, thiosulfate-binding protein, sulfate transport system substrate-binding
protein
taurine transport system permease protein

Stress Resistance and Response proteins
Locus tag Fold change
KEGG, NCBI Description
b4682
19.18
membrane stress resistance protein
b2851
5.87
SycD-like chaperone family TPR-repeat-containing protein
b1492
5.32
glutamate:gamma-aminobutyric acid antiporter
b4705
4.71
Mn(2)-response protein, MntR-repressed
b1824
3.73
DUF2527 family heat-induced protein
b3508
3.05
putative Mg(2+) transport ATPase, inner membrane protein
b0836
2.90
repressor of biofilm formation by indole transport regulation
b3512
2.86
gad regulon transcriptional activator
b2644
2.73
CP4-57 prophage; putative DNA repair protein
b3513
2.58
anaerobic multidrug efflux transporter, ArcA-regulated
b3507
2.56
Putative LuxR family repressor for dicarboxylate transport
b3511
2.51
acid-resistance membrane protein
b3491
2.11
acid resistance protein, inner membrane
b1257
2.08
putative rubrerythrin/ferritin-like metal-binding protein
b1582
2.03
UPF0060 family inner membrane protein
b3509
2.02
acid-resistance protein
Fe-S Cluster proteins
Locus tag Fold change
b4126
2.40
b1802
2.36
b2204
2.07
Hydrogenases and Formate
dehydrogenase
Locus tag Fold change
b2724
4.24
b2723
3.95
b2721
3.90

KEGG, NCBI Description
putative 4Fe-4S mono-cluster protein
putative YeaWX dioxygenase alpha subunit; 2Fe-2S cluster
ferredoxin-type protein essential for electron transfer from ubiquinol to
periplasmic nitrate reductase (NapAB)

KEGG, NCBI Description
hydrogenase 3, Fe-S subunit
hydrogenase 3, membrane subunit
hydrogenase 3, large subunit

208

Table 5 (con’t)
Locus tag
b4079
b2722
b2718
b2713
b2483
b2720
b0977
b2719
b4075
b2728

Fold change
3.56
3.42
3.38
3.18
3.02
2.88
2.86
2.84
2.69
2.55

b2726
b0904
b0974
b0973
b2717
b2727

2.53
2.43
2.29
2.27
2.04
2.01

Membrane proteins
Locus tag Fold change
b2158
15.03
b0317
10.86
b0735
3.21
b1408
2.94
b2013
2.34
b3506
2.29
b4317
2.26
b1256
2.22
b1311
2.01

KEGG, NCBI Description
formate dehydrogenase-H, selenopolypeptide subunit
hydrogenase 3, membrane subunit
hydrogenase 3 maturation protein
formate dehydrogenase-H, [4Fe-4S] ferredoxin subunit
hydrogenase 4, membrane subunit
formate hydrogenlyase complex iron-sulfur protein
hydrogenase-1 protein nickel incorporation factor
hydrogenase 3 and formate hydrogenase complex, HycG subunit
formate-dependent nitrite reductase complex subunit NrfF
hydrogenase maturation protein, hydrogenase expression/formation protein
HypC
hydrogenase nickel incorporation protein HypA/HybF
formate transporter
hyaC, hydrogenase 1, b-type cytochrome subunit
hyaB, hydrogenase 1, large subunit
protease involved in processing C-terminal end of HycE
GTP hydrolase involved in nickel liganding into hydrogenases

KEGG, NCBI Description
UPF0324 family inner membrane protein
putative inner membrane protein
putative inner membrane protein in cydABX-ybgE operon
inner membrane protein
UPF0394 family inner membrane protein
outer membrane lipoprotein
fimbrial usher outer membrane porin protein; FimCD chaperone-usher
outer membrane protein W
inner membrane putative ABC superfamily sugar transporter permease

Transporters and Two-component system
Locus tag Fold change
KEGG, NCBI Description
b0617
6.99
citrate lyase, acyl carrier (gamma) subunit
b0336
4.29
cytosine transporter
b0484
4.11
copper transporter
b1258
3.88
putative rubrerythrin/ferritin-like metal-binding protein
b0486
3.40
putative amino acid transporter
b3577
3.36
2,3-diketo-L-gulonate TRAP transporter small permease protein
b1312
3.04
putative sugar ABC transporter permease
b1729
3.03
putative transporter
b1443
3.01
putative spermidine/putrescine transporter subunit

209

Table 5 (con’t)
Locus tag
b0573
b3748
b4035

Fold change
2.80
2.66
2.44

b2392
b2148
b4152
b4153
b2126
b0994

2.33
2.28
2.27
2.25
2.20
2.18

b1244
b0513
b2367
b1441
b3751
b3408
b0613

2.16
2.13
2.12
2.10
2.09
2.09
2.08

Regulators
Locus tag
b2725
b4299
b1304
b2847
b3410

Fold change
5.13
3.36
2.65
2.50
2.20

b0564

2.14

Oxidoreductases
Locus tag Fold change
b0901
3.46
b0123
2.91
b1905
2.90
b1672
2.28
b3001
b0872

2.28
2.01

Other enzymes
Locus tag
Fold change
b0334
3.72

KEGG, NCBI Description
Cu(I)/Ag(I) efflux system periplasmic protein CusF
D-ribose pyranase
fused maltose transport subunit, ATP-binding component of ABC
superfamily/regulatory protein
manganese/divalent cation transporter
methyl-galactoside transporter subunit
fumarate reductase subunit C, membrane anchor subunit
fumarate reductase (anaerobic), Fe-S subunit
inner membrane putative sensory kinase in two-component system with YehT
periplasmic sensory protein associated with the TorRS two-component
regulatory system
oligopeptide ABC transporter permease
putative uracil/xanthine transporter
MFS transporter, DHA2 family, multidrug resistance protein
putative spermidine/putrescine transport system ATP-binding protein
D-ribose transporter subunit
ferrous iron transporter, protein A
triphosphoribosyl-dephospho-CoA synthase

KEGG, NCBI Description
regulator of the transcriptional regulator FhlA
putative DNA-binding transcriptional regulator
regulatory protein for phage-shock-protein operon
putative transcriptional regulator
putative DNA-binding transcriptional regulator, ferrous iron transport
protein C
global transcriptional activator; DLP12 prophage

KEGG, NCBI Description
putative NAD(P)H-dependent oxidoreductase
multicopper oxidase (laccase)
ferritin iron storage protein (cytoplasmic)
FNR, Nar, NarP-regulated protein; putative subunit of YdhYVWXUT
oxidoreductase complex
L-glyceraldehyde 3-phosphate reductase
HCP oxidoreductase, NADH-dependent

KEGG, NCBI Description
2-methylcitrate dehydratase
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Table 5 (con’t)
Locus tag
b0733
b0734
b1409
b2054
b1141
b3113
b1838
b2057

Fold change
3.36
3.36
3.36
2.94
2.46
2.20
2.03
2.02

Amino acid metabolism
Locus tag
Fold change
b1493
4.39
b0485
4.17
b3517
3.24
b3117
2.24
b1444
2.16
b1732
2.09

KEGG, NCBI Description
cytochrome d terminal oxidase, subunit I
cytochrome d terminal oxidase, subunit II
putative CDP-diglyceride synthase
putative acyl transferase
e14 prophage; putative excisionase
putative reactive intermediate deaminase
serine/threonine-specific protein phosphatase 1
putative colanic acid biosynthesis glycosyltransferase

KEGG, NCBI Description
glutamate decarboxylase B, PLP-dependent
glutaminase 1
glutamate decarboxylase A, PLP-dependent
L-threonine dehydratase, catabolic
gamma-aminobutyraldehyde dehydrogenase
catalase HPII, heme d-containing

Pyrimidine and Purine metabolism
Locus tag
Fold change KEGG, NCBI Description
b2166
4.83
pseudouridine kinase
b0337
4.21
cytosine/isoguanine deaminase
b4237
3.21
anaerobic ribonucleotide reductase activating protein
b1011
2.94
ureidoacrylate amidohydrolase
b0284
2.46
PaoABC aldehyde oxidoreductase, Moco-containing subunit, xanthine
dehydrogenase YagR molybdenum-binding subunit
b4238
2.42
anaerobic ribonucleoside-triphosphate reductase
Ribosomal RNA proteins
Locus tag
Fold change
b4010
112.65
b2588
45.06
b3272
22.53
b3274
22.53
b3342
12.95
b3756
3.60
b2591
3.58
b0201
3.56
b3851
3.50
b4007
3.48
b3278
3.33

KEGG, NCBI Description
5S ribosomal RNA of rrnE operon
5S ribosomal RNA of rrnG operon
5S ribosomal RNA of rrnD operon
5S ribosomal RNA of rrnD operon
30S ribosomal subunit protein S12
16S ribosomal RNA of rrnC operon
16S ribosomal RNA of rrnG operon
16S ribosomal RNA of rrnH operon
16S ribosomal RNA of rrnA operon
16S ribosomal RNA of rrnE operon
16S ribosomal RNA of rrnD operon
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Table 5 (con’t)
Locus tag
b3968
b3315
b3985
b2589
b3854
b3970
b0204
b3758
b4009
b0953
b3275
b3311
b3314
tRNA
Locus tag
b3273
b2402
b1984
b2403

Fold change
3.32
2.95
2.85
2.85
2.81
2.78
2.76
2.65
2.64
2.63
2.59
2.57
2.42

Fold change
71.15
2.34
2.29
2.08

Miscellaneous
Locus tag Fold change
b1575
57.22
b0560
2.39
b4201
2.33
b1481
2.31
b0699
4.62
b2343
3.01
b3922
2.56
b4199
2.13
b2094
3.58
b2243
3.53
b2242

2.40

b2110
b1156
b2095
b2093
b2096

3.36
2.52
3.21
3.13
2.62

KEGG, NCBI Description
16S ribosomal RNA of rrnB operon
50S ribosomal subunit protein L22
50S ribosomal subunit protein L10
23S ribosomal RNA of rrnG operon
23S ribosomal RNA of rrnA operon
23S ribosomal RNA of rrnB operon
23S ribosomal RNA of rrnH operon
23S ribosomal RNA of rrnC operon
23S ribosomal RNA of rrnE operon
ribosome modulation factor
23S ribosomal RNA of rrnD operon
30S ribosomal subunit protein S17
30S ribosomal subunit protein S3

KEGG, NCBI Description
tRNA-Thr
tRNA-Val
tRNA-Asn
tRNA-Val

KEGG, NCBI Description
Qin prophage; cell division inhibition protein
DLP12 prophage; DNA packaging protein
primosomal protein N
biofilm-dependent modulation protein
DUF2517 family protein
UPF0381 family protein
UPF0381 family protein
YhcN family protein, periplasmic
galactitol-specific enzyme IIA component of PTS
anaerobic sn-glycerol-3-phosphate dehydrogenase, C subunit, 4Fe-4S ironsulfur cluster
sn-glycerol-3-phosphate dehydrogenase (anaerobic), membrane anchor
subunit
putative periplasmic pilin chaperone
e14 prophage; putative tail fiber assembly protein
D-tagatose 1,6-bisphosphate aldolase 2, subunit
galactitol-specific enzyme IIB component of PTS
D-tagatose 1,6-bisphosphate aldolase 2, catalytic subunit
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Table 5 (con’t)
Locus tag
b4119
b4379
b1800
b1388
b1593
b4239
b1992
b2097
b1101
b3588
b3114
b4085
b3393
b4316
b2809
b1581

Fold change
2.12
2.54
2.32
2.31
2.26
2.24
2.13
2.23
2.03
2.10
2.10
2.10
2.08
2.08
2.07
2.04

Uncharacterized
Locus tag
Fold change
b4677
163.86
b2849
101.55
b4674
81.93
b1155
6.71
b4684
4.20

KEGG, NCBI Description
alpha-galactosidase, NAD(P)-binding
putative pyruvate formate lyase activating enzyme
D-malate oxidase, NAD-dependent; putative tartrate dehydrogenase
ring-1,2-phenylacetyl-CoA epoxidase subunit PaaA
putative dethiobiotin synthetase
trehalose-6-P hydrolase
cobalamin synthase
fructose-bisphosphate aldolase class I
fused glucose-specific PTS enzymes: IIB component/IIC component
aldehyde dehydrogenase B
pyruvate formate-lyase 4/2-ketobutyrate formate-lyase
allulose-6-phosphate 3-epimerase
DNA catabolic protein
periplasmic chaperone
DUF903 family verified lipoprotein
bifunctional D-altronate/D-mannonate dehydratase

Locus tag
b1576
b1957
b1549
b4527

Fold change
2.94
2.77
2.52
2.41
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Locus tag
b4535
b1730
b1148
b1003

Fold change
2.37
2.18
2.10
2.05

5.6 Figures

µg/ml of graphene
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Dilution spotted
Figure 1. Spot test assay for graphene toxicity. 3 µl spots of E. coli exposed to either PG or OG
at the indicated concentrations for 6 hours were plated on LB agar plates. Plates were incubated
for 12-24 hours. . Size of the spot shows qualitative differences in growth of bacteria in different
treatments.
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Figure 2. Survival of E. coli DH5a upon exposure to PG and OG. Graph shows the number
colony forming units per ml (CFU/ml) obtained after 6 hours of exposure to 0, 80, 160, 320, 640,
and 1280 µg/ml of PG (diamond) or OG (square). The x-axis represents concentration (µg/ml);
the y-axis represents CFU/ml. Data represent the mean values with standard error.
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Figure 3. Percent survival of E. coli DH5a upon exposure to graphene. The graphs show
percentage of cells surviving after 6 hours of exposure to graphene vs no graphene control. The
x-axes represent the type of graphene tested: PG (gray bars), OG (black bars), GO (bars with
diagonal lines), SWCNT (bars with dotted fill). The y-axes represent percentage of surviving
cells. Panel (a) shows percent survival after exposure to 640 µg/ml graphene; panel (b) shows
percent survival after exposure to 1280 µg/ml graphene. Error bars show standard error values.
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Figure 4. Effect of PG and OG on the expression of genes of interest. Total RNA was isolated
from bacteria exposed to graphene for 6 hours. Relative transcript abundance was quantified
using qRT-PCR. Fold expression of the genes in the presence of OG (gray bars) relative to their
expression in the presence of PG (black bars) is shown. Error bars represent standard error
values.
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Figure 5. Survival of knockout mutants of genes of interest upon exposure to OG. Cytotoxicity
assays were performed wherein 1 x 106 cells/ml of each culture was exposed to 640 µg/ml of OG
for 6 hours. Graph shows the number of surviving cells after exposure for different cell types
tested. The x-axis represents cell type: Parent strain BW25113 WT (white bar); knockout
mutants of upregulated genes (gray bars): inner membrane protein (Db2158), sulfite reductase a
subunit (Db2764), sulfite reductase b subunit (Db2763); knockout mutants of downregulated
gene (black bars): low temperature stress induced protein (Db1167); knockout mutants of genes
with similar expression in OG and PG (bars with diagonal lines): cell division modulator
(Db1731), inner membrane protein (Db1322). The y-axis represents colony forming units per ml
(CFU/ml). Error bars represent standard error.
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5.7 Supplementary figures

Figure S1. Survival of E. coli DH5a upon exposure to GO and SWCNT. Graph shows the
number colony forming units per ml (CFU/ml) obtained after 6 hours of exposure to 0, 80, 160,
320, 640, and 1280 µg/ml of GO (diamonds) or SWCNT (squares). The x-axis represents
concentration (µg/ml); the y-axis represents CFU/ml. Data represent the mean values with
standard error.
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Figure S2. mRNA enrichment from total RNA. The gel image and graphs represent snapshots of
RNA quality analyses before and after rRNA depletion. The x-axis on graph represent size (nt);
the y-axis represent sample intensity [FU]. (a) total RNA from PG; (b) total RNA from OG; (c)
rRNA depleted RNA from PG; (d) rRNA depleted RNA from OG. The images show one
representative sample of the two replicates.
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OG

PG
Figure S3. Scatter plot of gene expression levels. Each gene (4,313 total genes) is represented as
an individual data point and is plotted on a log2 scale based on its expression in PG and OG. The
x-axis represents control, PG; the y-axis represents treatment, OG. The middle blue line is the
identity line showing genes expressed at the same level in both control and treatment. The outer
two green lines show genes with at least 2-fold change in expression value in either control (blue
data points) or treatment (red data points). The increase in color intensity of a data point
represent increase in expression level. The dashed purple line is the linear regression line that
passes as near to as many data points as possible.
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Figure S4. Heat map displaying the expression levels of all E. coli genes across PG and OG
treatments. Each row corresponds to one gene (4,313 rows) and each column represents a
treatment. The color displays expression levels of genes across treatments. Red indicates positive
expression and blue indicates negative expression.
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Figure S5. Survival of E. coli upon exposure to oxidized graphene. Cytotoxicity assays were
performed wherein 1 x 106 cells/ml of each culture was exposed to 640 µg/ml of OG for 6 hours.
Graph shows the number of surviving cells after exposure for different cell types tested. The xaxis represents cell type: parent strains (white bars): E. coli DH5a, Parent strain BW25113;
knockout mutants of upregulated genes (gray bars): inner membrane protein (Db2158), sulfite
reductase a subunit (Db2764), sulfite reductase b subunit (Db2763); knockout mutants of
downregulated gene (black bar): low temperature stress induced protein (Db1167); knockout
mutants of genes with similar expression in OG and PG (bars with diagonal lines): cell division
modulator (Db1731), inner membrane protein (Db1322). The y-axis represents colony forming
units per ml (CFU/ml). Error bars represent standard error.
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Figure S6. Survival of E. coli upon exposure to oxidized graphene. Cytotoxicity assays were
performed wherein 1 x 106 cells/ml of each culture was exposed to 640 µg/ml of OG for 6 hours.
Graph shows the number of surviving cells after exposure for different cell types tested. The xaxis represents cell type: knockout mutant of recA gene, DNA recombination and repair protein
(Db2699) similar to E. coli DH5a (white bar); parent strain (white bar): Parent strain BW25113;
knockout mutants of upregulated genes (gray bars): inner membrane protein (Db2158), sulfite
reductase a subunit (Db2764), sulfite reductase b subunit (Db2763); knockout mutants of
downregulated gene (black bar): low temperature stress induced protein (Db1167); knockout
mutants of genes with similar expression in OG and PG (bars with diagonal lines): cell division
modulator (Db1731), inner membrane protein (Db1322). The y-axis represents colony forming
units per ml (CFU/ml). Error bars represent standard error.
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Chapter 6
Conclusions

6.1 Conclusions
The studies described in Chapters 2-5 were aimed at gaining a molecular understating of the
shared and unique molecular and cellular aspects of how different bacteria deal with hostile
environmental conditions. The genetic changes occurring in three bacteria exposed to different
stress conditions were studied and analyzed. A short summary of major findings and conclusions
from each study are presented below.

In Chapter 2, we looked at the effect of lignocellulose derived phenolic acids on the growth of
the Acidothermus cellulolyticus. Phenolic acids have been shown to have inhibitory effects on
the growth and survival of bacteria [1, 2]. The five phenolic compounds tested, namely,
hydroxybenzoic acid (HA), vanillic acid (VA), coumaric acid (CA), syringic acid (SA) and
ferulic acid (FA), tested were inhibitory to the growth of A. cellulolyticus. The cellular targets
and underlying mechanism of toxicity of phenolic acids is yet to be fully understood [3]. Our
studies of total protein profiles of A. cellulolyticus showed that the expression of a particular
protein was upregulated specifically in the presence of phenolic acids. Mass spectrometry
revealed the protein to be Acel_0059, a predicted thiosulfate sulfurtransferase (TST). We
predicted that Acel_0059 played a role in sulfur metabolism. Expression of the Acel_0059 gene
and the genes involved in sulfur assimilation (cysN, cysD, cysC, cysH, and cysM) was
upregulated in the presence of phenolic acids. The data suggested that phenolic acids upregulated
the expression of genes involved in assimilation of sulfate to cysteine. Reciprocally, the
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supplementation of cysteine relieved the inhibition by HA and the upregulation of Acel_0059.
The Acel_0059 gene was cloned and expressed in heterologous host Escherichia coli. Partially
purified protein showed thiosulfate sulfurtransferase activity in vitro, with low specific activity.
The heterologous expression of Acel_0059 in Escherichia coli increased its survival upon
exposure to HA and PA (equimolar mixture of HA, VA, CA, SA and FA). We conclude that
Acel_0059 is important in A. cellulolyticus survival in the presence of phenolic acids and
possibly has a role in cysteine biosynthesis.

To further expand our understanding of Acel_0059, in Chapter 3, we analyzed the genome-wide
gene expression profiles of A. cellulolyticus in the presence of HA, PA and lignin, using RNAseq technology. The gene expression profiles of the organism in response to a particular stress
aid in understanding the mechanism of toxicity and the factors involved in an adaptive response
to that stress [4]. The transcriptome expression patterns in the presence of HA and PA were more
similar, while the expression profile in the presence of lignin was more similar to that of control.
Our preliminary growth studies had showed that HA and PA were more toxic to A. cellulolyticus
cultures, compared to lignin. It has been reported that the inhibition mechanism of lignin could
be different from phenolic acids, due to the low molecular weight, dispersity and multiple
binding sites present in phenolic acids, as compared to the insoluble lignin [5, 6]. The number of
significantly differentially expressed genes (HA: 470 genes; PA: 521 genes; lignin: 559 genes)
correlated with the structural complexity of the compounds. Exposure to these inhibitory
compounds induced the expression of a number of genes coding for membrane proteins,
membrane related efflux proteins, multi-drug resistance ABC transporters, oxidative stress
response proteins, redox-sensors, MarR (multiple antibiotic resistance regulator) family
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transcriptional regulators, TST and sulfur assimilation pathway genes. Membrane proteins and
transporters act as a protective barrier to prevent membrane disruption and influx of inhibitory
compounds. Membrane permeabilization and inactivation of ABC transports have been proposed
to contribute to toxicity of phenolic compounds [7, 8]. Lignin and its related phenolic acids have
been shown to increase the generation of reactive oxygen species [9]. The enhanced expression
of redox-sensors, oxidative stress response factors and sulfur metabolism genes could be
attributed to the oxidative stress induced by the compounds tested. We conclude that lignin and
its related phenolic acids act by inducing oxidative stress and membrane damage in A.
cellulolyticus. The Acel_0059 gene and the genes involved in sulfate assimilation into cysteine
might play an important role in A. cellulyticus during survival in the presence of phenolic acids.

To further investigate the biological role of Acel_0059 using a genetic approach, in Chapter 4,
we used the surrogate organism Mycobacterium smegmatis mc2 155. Using this surrogate
organism, we studied whether the role of TST in survival under stress and cysteine synthesis was
specific to A. cellulolyticus or shared among bacteria. The closest sequence homolog of A.
cellulolyticus TST (Acel_0059) was identified as MSMEG_5789 of Mycobacterium smegmatis
mc2 155, using the Uniprot/Swissprot database in NCBI blastp search (Chapter 1, Table S2). M.
smegmatis mc2 155 (basonym for Mycolicibacterium smegmatis mc2 155) shares similarity with
A. cellulolyticus in being a rod shaped, high G+C, Gram-positive Actinobacteria belonging to the
order Actinomycetales. The knockout mutant of MSMEG_5789 was created using a process
called recombineering [10]. The MsmegΔTST knockout mutant strain was found to be
significantly more sensitive than the parent strain to a variety of stressors including
formaldehyde, hydrogen peroxide, dithiothreitol, 2-mercaptoethanol, sodium dodecyl sulfate and
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PA. TSTs have been shown to be induced under oxidative stress conditions and play a role in
maintaining cellular redox balance [11]. We hypothesized possible role of TST in cysteine
biosynthesis (Chapter 1), which is an important component of anti-oxidative stress system [12].
TST has been shown to be important in intracellular survival of mycobacteria in host
macrophages, where it faces low oxygen, oxidative and nitrosative environments [13]. We
investigated the ability of MsmegΔTST to use inorganic sulfate or cysteine as sole sulfur sources
during survival in low oxygen environment. Under microaerophilic conditions, the growth of
MsmegΔTST was significantly decreased when inorganic sulfate was used as the sole sulfur
source. However, when cysteine was used as a sulfur source, the knockout mutant grew equally
well as the parent strain. The transcriptional level of TST has been predicted to decrease with
increase in cysteine concentration suggesting cysteine dependent regulation of the protein [14].
Our studies showed that supplementation of cysteine had inverse effect on the upregulation of
TST by HA in A. cellulolyticus (Chapter 1). Thus TST might be directly or indirectly involved in
the generation of cysteine. We conclude that the deletion of MSMEG_5789 affects the cysteine
biosynthesis from sulfate under microaerophilic conditions, and increases the sensitivity of M.
smegmatis to a variety of stressors.

In a related but independent project, in Chapter 5, we studied the toxic effects of oxidized
graphene nanomaterial, the basic structural element of various allotropes of carbon, on
Escherichia coli. Growing interest in graphene-family nanomaterials in applications such as
nanomedicine, nanosensors etc. demands the study of their biological activity [15]. E. coli is one
of the most widely used model organism in understanding bacterial physiology and adaptation
mechanisms under stress. We studied the effect of pristine graphene (PG) and oxidized graphene
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(OG) on the growth of E. coli. At low concentrations, both were stimulatory to growth. However,
at higher concentrations, OG drastically decreased cell survival, and the toxicity increased with
increase in concentration. Other carbon nanomaterials, graphene oxide and single-walled carbon
nanotubes, also had inhibitory effect on the growth of this bacteria. Gene expression profiles
from E. coli exposed to PG and OG were compared. A total of 183 genes were induced and 125
genes were repressed upon exposure to OG. Graphene is known to induce oxidative stress, DNA
damage and membrane injury [16, 17]. Genes involved in DNA biosynthesis were repressed in
the presence of OG and consequently DNA repair genes were induced in response to OG. Genes
involved in sulfur metabolism and multiple formate dehydrogenases were upregulated to aid in
oxidative stress tolerance. Genes involved in the formation of sulfide, which serves as a sulfur
source for cysteine, were upregulated. A number of membrane proteins, stress resistance and
response proteins were also induced in response to OG. The genes of interest were selected for
further analysis. These included genes coding for: UPF0324 family inner membrane protein (up);
sulfite reductase alpha subunit flavoprotein (up); sulfite reductase beta subunit flavoprotein (up);
uncharacterized protein (down); blue light, low temperature and stress induced protein (down).
Cytotoxicity assays of the knockout mutants of genes of interest followed the trend of the gene
expression data. The cytotoxicity of OG to E. coli could therefore be attributed to oxidative
stress, membrane stress and DNA damage. Integration of sulfur into cysteine seems crucial for
cell survival under harmful environmental conditions.

In summary, our studies revealed that a thiosulfate sulfurtransferase (TST) is important for
survival during phenolic acid stress in A. cellulolyticus. The deletion of TST in M. smegmatis
increased its sensitivity to various stressors. Cysteine biosynthesis from inorganic sulfate under
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microaerophilic conditions was affected by the deletion of TST in M. smegmatis. We propose
that TST might play a role in the generation of cysteine under stress conditions. Sulfur
assimilation into cysteine seemed important for survival under different stress conditions studied
here.
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